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Background
The spine serves as the backbone of the human body: it makes vertical posture 
possible and protects the ascending and descending neurological network. 
A pathological shape of the spine may lead to impaired physical function. 
As a result of increased knowledge, diagnostic interventions and imaging 
technology, the aetiology of spinal pathology is better understood. This, in 
combination with advances in surgical techniques and the development 
of surgical implants, increases the chance of successful treatment and has 
already led to a 67% increase (from 17 to 28 per 10.000 population) in surgical 
procedures (excision of intervertebral disc and spinal fusion) during the period 
from 1996-1997 to 2006-2007.1 
Surgical treatment starts in the operating theatre by incising the skin. However, the 
surgical procedure itself only marks the beginning of the recovery process. After surgery, 
correct healing of the bony and soft tissue elements is required. By incising the skin, 
the natural barrier against bacterial contamination of subcutaneous tissue is breached. 
Performing surgery in a clean environment decreases the risk of contamination of the 
subcutaneous tissue. However, if contamination occurs this may lead to a surgical site 
infection (SSI). This in part may lead to healing disorders (hypertrophic or hypotropic) and 
instrumentation failure. 
Antibiotics play a central role in the treatment of SSIs. After surgical debridement, the 
remaining micro-bacteria can be treated with long-term intra-venous or oral antibiotics. 
However, as mentioned by the Centers for Disease Control and Prevention, the resistance 
of micro-bacteria to different types of antibiotics is increasing, making such drugs less 
effective.2 This will lead to reduced effectiveness in the treatment of SSIs and in prophylaxis.
The need for surgical intervention and antibiotic treatment in cases of SSI multiplies 
health care related costs by a factor of four.3 With the increased resistance of micro-
bacteria against antibiotics the treatment of SSIs will become more difficult. Therefore, 
determining how to prevent a SSI or how to decrease the risk of developing a SSI is 
becoming increasingly important.
Surgical site infection after spinal surgery
Various studies have been performed to identify risk factors for SSI (Panel 1), resulting 
in the identification of a wide variety of variables. However, as shown in Panel 1, only a 
few variables have been identified in more than one study. Most studies contained a small 
number of patients, were case-control studies and cases of SSI were not rooted down into 
deep and/or superficial. Given the wide variety of identified risk factors, further analysis 
should be performed including all potential risk factors.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 1
10
Panel 1. Past findings.
Patient characteristics Surgical characteristics
-Age4-6
-Obesity6-13
-Diabetes6, 8, 13-15
-Nonsteroidal anti-inflammatory drugs use16
-Tobacco use6, 8
-Poor nutritional status5, 17, 18
-Elevated preoperative or postoperative serum glucose13
-Alcohol abuse6
-Revision surgery8, 9
-Urinary incontinence7
-Previous SSI6
-Presence of more than 3 comorbid diseases7
-Posterior surgical approach7
-Combined approach6
-Tumor resection7
-Increased estimated blood loss8, 17
-Use of blood transfusion15
-Prolonged surgical time19
-Multilevel surgery fusion extending 
to the sacrum20
-Use of spinal instrumentation21
-More than 2 residents participating 
in surgery13
Definitions: Throughout this thesis, a SSI is defined as: “any postoperative wound that 
required treatment with oral or intravenous antibiotics or surgical debridement with a minimal 
follow-up of one year”. The definition used in this research project correctly suggests that 
no strict clinical criteria were used, as defined by the US Centre for Disease Control and 
Prevention and the American College of Surgeons.22 The definition given by the US centres 
for disease control and prevention and the American College of Surgeons was not used 
as it is known that SSIs can present a prolonged period of time after the spinal surgery(> 
1 year).23 If their definition had been used, this would have resulted in a reduction in the 
number of patients with a SSI in the current research project (Panel 2). A follow-up period 
of 1 year is also utilized in contemporary spinal literature.13 However, multiple case reports 
have shown that a SSI may present itself after multiple years.24, 25 SSI were rooted down 
into deep and superficial. 
Epidemiology: A SSI occurs in 0.7% to 12% 
of adult patient undergoing spinal surgery. 
The incidence is dependent on patient 
characteristics, surgical characteristics, and 
the follow-up period. A SSI results in higher 
postoperative morbidity, mortality and, as 
discussed previously, healthcare costs.7, 26-33 
Given the increasing rates of spinal surgery, 
the absolute number of SSI cases will increase.
Signs of infection: Patients who have a surgical 
site infection may present in a nonspecific 
manner. In general, patients present with erythema, fevers, chills, systemic signs and 
symptoms and prolonged drainage of the surgical wound (Figure 1).35, 36 In cases of deep 
SSI, local wound erythema and prolonged drainage of the surgical wound do not have 
Figure 1. Early deep postoperative spinal 
wound infection.34
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to be present since it is isolated beneath the fascia. Deep SSI can present with discitis, 
osteomyelitis, epidural abscess, and hardware failure due to destruction of bony elements 
due to the infection. Deep SSIs are not usually diagnosed directly after surgery, and may 
not be symptomatic during physical examination. 
Panel 2. Criteria for defining a surgical site infection (SSI) according to the Centers for Disease 
Control and Prevention.22
Superficial incisional SSI
A. Infection occurs within 30 days after the operation 
and 
B. Infection involves only skin or subcutaneous tissue of the incision 
and at least one of the following: 
C1. Purulent drainage, with or without laboratory confirmation, from the superficial incision.
C2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial 
incision. 
C3. At least one of the following signs or symptoms of infection: pain or tenderness, localized 
swelling, redness, or heat and superficial incision is deliberately opened by surgeon, unless incision 
is culture-negative. 
C4. Diagnosis of superficial incisional SSI by the surgeon or attending physician.
Deep incisional SSI
A. Infection occurs within 30 days after the operation if no implant is left in place or within one year 
if implant is in place and the infection appears to be related to the operation 
and 
B. Infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision 
and at least one of the following: 
C1. Purulent drainage from the deep incision but not from the organ/space component of the 
surgical site. 
C2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient 
has at least one of the following signs or symptoms: fever (>38° C), localized pain, or tenderness, 
unless site is culture negative. 
C3. An abscess or other evidence of infection involving the deep incision is found on direct 
examination, during reoperation, or by histopathologic or radiologic examination. 
C4. Diagnosis of a deep incisional SSI by a surgeon or attending physician.
Blood tests may indicate a SSI in the absence of symptoms. These include: C-reactive 
protein, erythrocyte sedimentation rate and white blood cell count.35, 37 An aspiration culture 
may also be performed. Differentiation between a deep or superficial SSI is not easily done. 
Additional radiographic tests can be performed to further assess the probability of a SSI 
(x-ray, CT and/or MRI). As shown in Figure 2, lucency may be a sign of SSI. Other signs of SSI 
are periosteal reactions, sequestra, bone sclerosis and abnormal surrounding soft tissue.38
Causative organism: When a patient is suspected of having a SSI an aspiration may be 
performed. However the negative predictive value of this test is low.39 When a debridement 
is performed routinely deep swaps are taken to determine the causative organism. By 
determining the causative organism, antibiotics can be adjusted to effectively treat the SSI. 
The most frequently identified causative organism for SSI is S. aureus (commensale).21, 41-44 
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Some strains are already resistant to 
methicillin. Therefore infection with 
methicillin resistant S. aureus can only be 
treated by a limited number of antibiotics. 
Treatment options: The treatment 
of a SSI following adult spinal surgery 
may depend on whether or not the SSI is 
isolated superficial to the muscular fascia 
or includes the spine deep to the fascia. In 
cases of deep infection, treatment includes 
debridement of the wound and initiating 
antibiotic therapy to treat the infection.46 
During debridement one could choose to 
retain the original instrumentation, remove 
and replace the implants during the debridement or re-implant new instrumentation 
during subsequent surgery. Between surgical procedures or after a surgical procedure an 
occlusive dressing with a suction drainage system can be used to approximate the wound 
edges and remove liquids (Figure 3). However the value of using this system remains 
under dispute.47 Intravenous antibiotic therapy plays the final critical role in treating the 
infection. Several small retrospective series have described different treatment methods 
for SSIs and the typical causative organisms. However, the limited sample sizes of these 
studies make it difficult to compare treatments and hamper 
the identification of optimal treatment methods for different 
causative organisms.
Morbidity and costs associated with SSI: The presence of a 
SSI leads to increased morbidity and mortality, and healthcare 
costs.7, 23, 26, 27, 30 During the last 30 years, the incidence of spinal 
surgery has increased significantly.48 If one takes into account 
that on average hospital bills exceed $ 34.000 per instrumented 
fusion, excluding professional fees, it is understandable that 
healthcare costs are also increasing.49 The occurrence of a 
SSI is estimated to increase healthcare costs up to 4-fold.3 
This can partly be attributed to prolonged hospital stays, the 
need for re-operation, the administration of (sometimes very 
expensive) antibiotics and other treatment related costs.
Figure 2. CT: Lucency around pedicle screw.40
Figure 3. Wound treat-
ment using Vacuum-as-
sisted closure device.45
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This thesis: Evaluation of surgical site infection after spinal surgery
As recently reviewed by Schuster et al.50 multiple studies have been performed to identify 
risk factors for SSI with contradictory outcomes. Different studies have identified different 
risk factors. The majority of these studies consisted of case control or lower volume cohort 
studies. To evaluate previous findings we performed a retrospective cohort study with a 
higher volume to minimize the risk of incorrect findings. Identification of risk factors will 
enable efforts to eliminate them, and thereby decrease the risk for SSI and the associated 
healthcare costs, morbidity and mortality.
Material and methods: After approval of the hospitals institutional review board, we 
conducted a retrospective study within a tertiary care university-affiliated medical centre 
in Baltimore, Maryland. The administrative database was used to identify those patients 
who had undergone orthopaedic spinal surgery in the Johns Hopkins hospital. All patient 
data (including clinical notes, inpatient operative and discharge summaries, records of 
readmission, laboratory tests and radiographic results) were reviewed with at least 1 year 
of follow-up.
The diagnosis of a SSI is often difficult as many infections do not present with all the 
above mentioned symptoms. Besides the clinical signs and symptoms that can be found 
during patient evaluation, laboratory findings can be helpful in diagnosing a SSI. Since not 
all signs and symptoms are always present, the initial treatment usually starts with a high 
index of suspicion. If one knows which signs and symptoms are most frequently seen, a 
correct index of suspicion can be obtained. In Chapter 2 we, retrospectively, evaluated 
all signs and symptoms in patients with a SSI. If a SSI is suspected antibiotics are started 
even when the causative organism is not yet known. Since all antibiotics have their own 
spectrum of bacteria against which they work, it is essential to know which organisms are 
most frequently seen in cases of SSI. Therefore, we also reviewed all cultures taken from 
patients with SSIs in Chapter 2. 
 
A wide variety of risk factors have previously been described. However most studies were 
limited by a small sample size and failed to include potential confounding risk factors, 
and thus their findings are difficult to interpret. Furthermore, since some factors were 
not confirmed in other studies, their applicability is limited. Therefore we retrospectively 
conducted a higher volume review of all medical charts of those adult patients who 
underwent spinal surgery in the orthopedic spine department. Patient characteristics were 
noted and an analysis were performed (Chapter 3). Sub analysis was performed for deep or 
superficial SSI. The identification of patient and preoperative characteristics as significant 
risk factors for SSI might influence the patient/ doctor evaluations for the proposed surgical 
treatment.
Based on recent findings that restrictive transfusion criteria in critically ill patients 
without heart disease leads to lower patient morbidity and mortality,52, 53 more restrictive 
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transfusion criteria have been developed for most 
patients. However, in patients with hip fractures, 
perioperative anaemia leads to a prolonged length of 
stay, and increased morbidity, mortality and readmission 
rates. Thus, extending restrictive transfusion criteria 
to other patient settings and patient groups might not 
have the intended effect.54 In Chapter 4, we report a 
retrospective study to evaluate whether the morbidity 
caused by SSI reported in the general orthopaedic 
literature are also applicable to adult patients undergoing 
spinal surgery.  
It is known that general complication rates in cases 
of deformity surgery can be as high as 40%.55, 56 The 
incidence of SSIs in revision patients is relatively high.57 
Therefore, it is important to understand which factors 
influence the risk of SSI. Deformity patients have a high risk of requiring additional surgery, 
and thus prevention of SSI is extremely important since a previous SSI is a significant risk 
factor for a new SSI in general spine surgery.58 The aim of Chapter 5 was to identify those 
factors that significantly increase the risk of SSI in cases of deformity surgery.
During spinal osteotomy procedures bone is taken out to correct a deformity of the 
spine in order to restore sagittal and coronal alignment. Osteotomy procedures are known 
to have increased blood loss and surgical times compared with other spinal surgeries. 
Both of these factors have previously been identified as significant risk factors for SSI.8, 17, 
58 Over the years, several types of spinal osteotomies have been described and currently 
four principal types of osteotomies are performed in the Johns Hopkins hospital. Each 
osteotomy has its own characteristics. For example, patients with a lower degree of 
deformity are usually treated by a PSO whereas patients with major deformities are 
treated with a VCR. In Chapter 6 we retrospectively reviewed all patients who have had 
one of these osteotomies in order to evaluate the risk of SSI each type of osteotomy and to 
identify risk factors for SSIs. By evaluating the SSI risk for each osteotomy one can take the 
calculated risk into account during preoperative surgical planning. 
Figure 4. SSI after debridement.51
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As shown in Table 2, multiple studies have previously been performed to identify risk 
factors for SSI. The findings of each study vary emphasizing the complex nature of SSIs. 
We performed a systematic review to evaluate the methodological aspects of previously 
performed studies that identified risk factors for SSI (Chapter 7) and prophylactic 
interventions for SSI (Chapter 8). Based on this methodological systematic review it was 
our goal to assess the methodological foundation of current literature and to provide 
recommendations to improve the quality and homogeneity of future clinical studies on 
SSIs. 
Chapter 9 provides a general discussion of the previous chapters and the English and 
Dutch summaries of this thesis are presented in Chapter 10 and 11.
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Abstract
Study design: Descriptive, retrospective cohort analysis.
Purpose: To evaluate the presentation, etiology and treatment of surgical site infections 
(SSIs) after spinal surgery.
Summary of background data: SSI after spine surgery is frequently seen. Small case 
control studies have been published reporting the results of treatment options for 
SSIs. We performed this study to indentify the most common clinical and laboratory 
presentation of a SSI, and the most frequent infective organism and to evaluate the 
effectiveness of current treatment.
Methods: All patients who underwent spinal surgery at the Johns Hopkins hospital for a 
diagnosis other than infection between June 1996 and December 2005 (N=3174) were 
reviewed. All cases of SSI were identified. Patient and operative characteristics were 
reviewed. Infection type (deep or superficial), treatment course, and laboratory and 
culture results were abstracted.
Results: A total of 132 cases of SSIs (84 deep and 48 superficial) were identified; 72.7% 
of the SSIs were detected in outpatients on average 28.7 days (deep 29.9; superficial 
25.2) after the index procedure. Wound drainage was the most common complaint 
(68.2%), CRP was elevated in 98.0%, ESR was elevated in 94.4%, but only 48.6% had 
elevated WBC’s. Staphylococcus aureus was isolated in 72.6% of deep and 85.7% of 
superficial positive cultures. Furthermore, 76.0% of deep SSIs could be treated with 
a single debridement to clear the SSI, 72.9% of superficial SSIs were treated without 
formal debridement in the operating room. Antibiotic treatment was longer for deep 
SSIs (40.8 versus 19.6 days). 
Conclusions: Deep SSIs following spinal surgery were effectively treated with single-
stage debridement and intravenous antibiotics. Superficial SSIs were effectively 
treated with local wound care and oral antibiotic therapy.
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Introduction
Within the literature, the incidence of surgical site infection (SSI) after adult spine surgery 
shows a wide variation from 0.7 to 12.0%.1,2,11,15,16,19,22,27,36 As a result of SSIs, health-care 
costs and rates of patient morbidity and mortality are all increased.7,13 Previous studies 
have identified different variables as being significant risk factors for SSI.4,22,23,30,37 However, 
the diagnosis of a SSI following spinal surgery can often be difficult as many deep infections 
do not always present with overt symptoms.
Typically, the clinical signs and symptoms of (deep and/-or superficial) SSIs include: 
fever, pain, erythema, swelling, warmth, tenderness to palpation, and/-or wound drainage. 
Laboratory tests such as white blood cell count (WBC), C-reactive protein level (CRP), 
erythrocyte sedimentation rate (ESR), and wound aspiration/culture can assist in diagnosing 
a SSI but often they are not reliable. During the normal postoperative course the CRP level 
increases8 and can take up to 2 weeks to normalize.33 The ESR will also increase following 
spinal surgery; it can reach a peak level after 2 weeks and requires up to 6 weeks to return 
to normal levels.33 An aspiration culture of the wound can also prove unreliable, with some 
authors reporting success rates as low as 70%.9 The formation of a pseudo-arthrosis might 
also indicate the presence of a low grade infection. In these cases a radiolucent zone is 
frequently seen surrounding the screws during radiological examination. The radiolucent 
zone leads to decreased pull-out resistance.29 Since many of the typical markers of infection 
are non-specific during the initial postoperative period, the reliable diagnosis of a SSI can 
require a high index of suspicion.
The treatment of a SSI following adult spinal surgery can depend on whether the SSI 
is isolated superficial to the muscular fascia or whether it includes the spine deep to the 
fascia. In cases of deep infection, treatment includes debridement of the wound and 
antibiotic therapy to treat the infection. During debridement one could choose to retain 
the original instrumentation, or remove and replace the implants during the debridement, 
or re-implant new instrumentation during a second surgery. Intravenous antibiotic therapy 
then plays the final critical role in treating the infection. Several small retrospective series 
have described different treatment methods for SSIs and the typical causative organisms. 
However, the limited size of these studies makes it difficult to compare treatments and 
identify whether or not there are optimal treatment methods for different causative 
organisms.
In the current study we retrospectively reviewed a large series of SSIs following spinal 
surgery. We looked at the utility of different patient symptoms and diagnostic tests at 
diagnosing these infections in order to determine which treatment method most effectively 
eradicated them.
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Material and Methods
After approval from the hospitals institutional review board, we used an administrative 
database to identify all adult patients who underwent orthopaedic spine surgery between 
June 1996 and December 2005 (N=3174) for a diagnosis other than infection. We reviewed 
and abstracted all patient data to identify cases of SSIs with a minimal follow-up period of 1 
year. For this chapter we reviewed all cases with SSIs in order to abstract patient symptoms, 
additional perioperative laboratory results, treatment and micro bacterial status. A 
clinically significant SSI was defined as: “any postoperative wound that required treatment 
with oral or intravenous antibiotics or surgical debridement”. All of the SSIs were rooted 
down into deep or superficial. Deep represents a SSI under the fascia that can also have 
a superficial component, whereas superficial SSI represented an isolated infection above 
the fascia. If a patient was suspected of having a SSI (deep or superficial), deep aspiration 
cultures were routinely taken to determine the presence of a deep SSI. We identified 132 
cases of SSIs. For these cases, the number of cultures taken, their outcome and their Gram 
characteristics were noted. All data was abstracted and stored in an electronic database. 
All index surgical procedures were performed by one of five fellowship trained 
orthopaedic spine surgeons, and all surgical procedures were performed in the same block 
of operating rooms. Infection control remained unchanged. Sterility and air handling 
characteristics were monitored by the institutional infection control department. Standard 
preparation of the surgical site was performed using DuraPrep. The surgical site was 
surrounded by sterile surgical drapes. The non-draped skin was covered with an Opsite 
sheet. First generation cephalosporins were used as antibiotic prophylaxis. Prophylaxis 
began at least 30 minutes prior to skin incision, was re-dosed every 4 hours or at every 
1500 cc of blood loss during the procedure and was then dosed every 6 hours for 24 hours 
postoperatively. In the case of iodine allergy, clorhexidine scrub was utilized followed by 
an alcohol wash. If a penicillin or cephalosporin allergy was present, clindamycin was used 
when no metallic implants were placed and vancomycin was used when implant placement 
was planned. When hair removal was requiring, electric clippers were used.
During the postoperative hospital stay each patient’s wound was inspected daily. 
Following hospital discharge the patient was seen for follow-up in the clinic. All patients 
were instructed to contact their surgeon in case of redness of the wound, wound drainage, 
increased pain, wound breakdown, fevers >38°C, or swelling. If any of these symptoms 
were present, a patient was asked to come into the clinic for wound evaluation. An interval 
history was taken and a physical examination was performed and, in cases of a suspected 
SSI routine blood testing was performed, including WBC, CRP, and ESR.
In case of a superficial wound infection the principal treatment usually consists of a 
limited incision and drainage of the involved area with culture. After a culture was obtained, 
an oral first generation cephalosporin antibiotic was started, except in cases of penicillin 
and/-or cephalosporin allergies, where clindamycin was used. Antibiotic coverage was 
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modified based upon culture results and normally discontinued once the wound was no 
longer purulent. Prior to initiating antibiotic therapy, aspiration cultures deep to the fascia 
was routinely performed. Routine local wound care with wet to dry dressing were used and 
the wound allowed to heal by secondary intention. If the wound failed to improve with 
local measures, a formal debridement and closure of the wound superficial to the fascia 
was performed in the operating room.
In cases where either the infection extended deep down into the fascia on inspection or 
aspiration cultures from deep into the fascia revealed the presence of a deep SSI, treatment 
consisted of surgical debridement combined with antibiotics. The initial antibiotic therapy 
consisted of a broad spectrum coverage including a combination of vancomycin and 
gentamycin in most cases. Based upon the culture results, the postoperative antibiotic 
regimen was modified based upon recommendation by an infectious disease specialists. 
During the debridement surgery the spinal instrumentation was routinely retained, 
except in cases where the instrumentation was loose or there was a bony failure. In these 
cases the instrumentation was removed and replaced with new instrumentation. During 
debridement, any loose bone graft material or necrotic debris was removed and the wounds 
were cleaned with 10 liter of pulsatile lavage bibiotic irrigation. The wounds were usually 
closed over suctions drains; however, a continuous suction irrigation system was placed 
in some cases. Following debridement the wounds were inspected daily and the drains 
were removed when the amount of drainage decreased. Each patient’s clinical course was 
followed and repeat debridement was performed if the patient continues to be febrile 
(<38.5°C), continued wound drainage or a downward trend in the laboratory markers of 
infection (WBC, CRP, and ESR) was not observed. Intravenous antibiotics were continued 
as outpatient treatment under the direction of an infectious disease specialist and then 
either discontinued or converted to an oral course based on each patients clinical course. 
The total number of debridement procedures required and the length of intravenous and 
oral antibiotic therapy was recorded in all cases.
Statistical analysis: The statistical analysis was performed by the third author (RLS). All 
descriptive statistics were performed using the Statistical Packages for Social Sciences® 
v15.0 (SPSS, Chicago, Illinois, USA). For comparison of proportions routine Chi-square 
analysis was performed with use of Fisher exact test for small cell populations. Two-tailed 
t-tests were routinely performed for comparison of means.
Results
A total of 132 patients were identified who had a SSI following adult orthopaedic spine 
surgery (132/3174 = 4.2%); 62 patients had an isolated deep SSI, 22 patients had a deep SSI 
combined with a superficial SSI, and 48 patients had an isolated superficial SSI. Patients 
with a deep and superficial component were considered a deep SSI only (n=84). The mean 
age in our study group was 56.4 years (sd. 14.9). The majority of our study group was female 
(56.1%). The index procedures are summarized in Table 1. 
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Table 1. Patient demographics.
SSI Deep SSI Superficial SSI
N 132 84 48
Mean Age (sd) 56.4 (±14.9) 58.6 (±14.9) 52.6 (±14.4)
Sex
-Male 58 (43.9%) 41 (48.8%) 17 (35.4%)
-Female 74 (56.1%) 43 (51.2%) 31 (64.6%)
Procedure
-Soft tissue 4 (3.0%) 3 (3.6%) 1 (2.0%)
-Discectomy 11 (8.3%) 6 (7.1%) 5 (10.2%)
-Decompression 72 (54.5%) 47 (56.6%) 25 (51.0%)
-Uninstrumented fusion 5 (3.8%) 4 (4.8%) 1 (2.0%)
-Instrumented fusion 105 (79.5%) 67 (79.8%) 38 (79.2%)
-Osteotomy 40 (30.3%) 27 (32.1%) 13 (27.1%)
-Removal of hardware 14 (10.6%) 10 (12.0%) 4 (8.2%)
Wound drainage was the most frequently observed sign indicating a SSI and was present 
in 67.9% of deep SSIs and 64.6% of isolated superficial SSIs. On average, ESR, CRP, and 
WBC levels were all elevated at the time of diagnosis, with ESR and CRP being elevated 
in 94.4% and 98.0% of all cases, respectively. The WBC was only elevated in 43.7% of all 
deep and 57.9% of superficial infections. The diagnosis of SSI was made, on average, on 
postoperative day 29 (range 6-730) for deep infections and postoperative day 25 (range 
5-85) for superficial cases. However, a few cases of late detection greatly affected these 
averages and the median time to detection was 15 days for deep infections and 18 days for 
superficial cases (Table 2).
Cases of a deep SSI were normally treated with surgical debridement (75/84, 89.3%), 
with most cases (57/75, 76.0%) only needing one debridement procedure. No surgical 
treatment was performed in four cases because the patient had a terminal disease and was 
too ill for surgery (two cases) or refused treatment (two cases). The spinal instrumentation 
was retained in 82.1% (55/67) of the cases, initially replaced in 16.4% (11/67), and replaced 
at a later debridement in 1.5% (1/67). The rate of additional debridements was 25.5% (14/55) 
when instrumentation was retained and 36.4% (4/11) when it was replaced (p=0.643). 
Therefore, we were unable to conclusively determine whether retention required a higher, 
lower, or essentially the same rate of additional debridements.
Isolated superficial SSIs were treated without formal debridement in 72.9% (35/48) of 
cases. Where surgical debridement was needed, 92.3% (12/13) of patients only needed one 
debridement. Instrumentation was present in 11 out of 13 cases and was replaced in one 
patient due to a malpositioned screw. Otherwise, none of the isolated superficial SSI cases 
needed debridement deep down into to the fascia.
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Table 2. Laboratory results and patient symptoms.
SSI Deep SSI Superficial SSI
Diagnostic location 132 84 48
-Inpatient 36 (27.3%) 27 (32.1%) 9 (18.8%)
-Outpatient 96 (72.7%) 57 (67.9%) 39 (81.3%)
Drainage 88 (68.2%) 57 (67.9%) 31 (64.6%)
Pain 36 (27.9%) 24 (29.3%) 12 (25.5%)
Fever 34 (26.4%) 30 (36.6%) 4 (8.5%)
Erythema 24 (18.6%) 13 (15.9%) 11 (23.4%)
Wound dehiscence 11 (8.5%) 2 (2.4%) 9 (19.1%)
Hematoma 5 (3.9%) 3 (3.7%) 2 (4.3%)
Radiographic evidence 5 (3.9%) 3 (3.7%) 2 (4.3%)
Wound fluctuation 3 (2.3%) 2 (2.4%) 1 (2.1%)
Exposed instrumentation 1 (0.8%) 1 (1.2%) 0
Meningitis 7 (5.3%) 6 (7.1%) 0
ESR*,1 76.7 (±28.7) 84.7 (±27.8) 60.6 (±23.7)
CRP*,2 11.6 (±10.7) 15.3 (±11.1) 5.2 (±5.8)
WBC*,3 11.318.2 (±4931.5) 11.401.4 (±5217.3) 11.162.6 (±4410.3)
Mean time after surgery, 
days (sd)
28.7 (±75.9) 29.9 (±87.0) 25.2 (±20.8)
Median time 15 15 18
*At the time of diagnosis. 1Normal range 4-30 mm/hr, 2Normal range: 0.0-0.5 mg/dL, 3Normal 
range: 4.500-11.000/cu mm.
All patients who were diagnosed with a SSI received antibiotic treatment for an average 
of 32.9 days. Patients with deep SSIs required a significantly longer course of antibiotic 
therapy than patients with superficial SSIs (40.8 versus 19.6 days, p=0.013) (Table3). 
Intravenous antibiotics was used more frequently in the deep SSI group (90% versus 44%, 
p<0.001) than in the superficial SSI group. Long-term antibiotic suppression therapy was 
not required in any patient.
Bacterial cultures were routinely taken in almost all cases of deep SSIs. A total of 95% 
of patients had cultures taken; 77.5% (62/80) of patients had a positive culture. 45 out of 62 
(72.6%) patients had a single organism isolated while the rest showed poly-micro bacterial 
growth. 56 out of 62 (90.3%) patients grew a Gram-positive organism and 19 out of 62 
(30.6%) had Gram-negative growth. Staphylococcus aureus was present in 72.5% (45/62) 
(37+8 MRSA) of positive cultures with 17% of these isolates demonstrating methicillin 
resistance. Enterococcus fecalis and Escherichia coli were the next most common 
organisms, present in 14.5% and 10.8% of all isolates, respectively (Table 4). 
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Table 3. Specific treatment of infection.
SSI Deep SSI Superficial SSI
No surgical debridement 44 (33.3 %) 9 (10.7 %) 35 (72.9 %)
Surgical debridement 88 (66.7 %) 75 (89.3 %) 13 (27.1 %)
-One surgery 69 (78.4 %) 57 (76.0 %) 12 (92.3 %)
-Two surgeries 14 (15.9 %) 13 (17.3 %) 1 (7.7 %)
-Three surgeries 4 (4.5 %) 4 (5.3 %) 0
-Four surgeries 1 (1.1 %) 1 (1.3 %) 0
No hardware 10 (11.4 %) 8 (10.7 %) 2 (15.4 %)
Hardware present 78 (88.6 %) 67 (89.3 %) 11 (84.6 %)
Hardware management:
-Hardware retained 65 (83.3 %) 55 (82.1 %) 10 (90.9 %)
-Exchanged, same surgery 12 (15.4 %) 11 (16.4 %) 1 (9.1 %)
-Exchanged, staged/ later 1 (1.3 %) 1 (1.5 %) 0
Drains placed 81 (92.0 %) 69 (92.0 %) 12 (92.3 %)
-Closed suction system  72 (88.9 %) 61 (88.4 %) 11 (91.7 %)
-Suction/ irrigation system 9 (11.1 %) 8 (11.6 %) 1 (8.3 %)
Antibiotic therapy
-Mean total treatment, 
days (sd) 40.8 (±17.0) 19.6 (±15.2)
-Mean iv treatment 40.6 (±14.3) 21.9 (±18.3)
-Oral after iv 23.8 (±14.5) 14.0
-Oral only 28.6 (±11.9) 14.5 (±11.8)
Cultures were taken less frequently in the superficial SSI group, with only 85.4% (41/48) of 
patients having cultures taken, of these, 48.8% (20/41) had wounds from which the cultures 
showed no growth, while 43.9% (18/41) grew a single organism. Furthermore, 100% of the 
wounds had Gram-positive isolates while only 9% (2/21) showed Gram-negative growth. 
S. aureus was present in 85.7% (18/21) of the positive cultures, with only 5.6% of these 
isolates demonstrating methicilline resistance (Table 4).
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Table 4. Microbacterial results. (Preoperative-) aspriration and swab cultures and intra-operative 
cultures.
SSI Deep SSI Superficial SSI
Taken cultures 121 (91.7 %) 80 (95.2 %) 41 (85.4 %)
No cultures 11 (8.3 %) 4 (4.8 %) 7 (14.6 %)
Outcome of cultures 
No growth (N) 38 (31.4 %) 18 (22.5 %) 20 (48.8 %)
Growth (N) 83 (68.6 %) 62 (77.5 %) 21 (51.2 %)
-One specie (N) 63 (52.1 %) 45 (56.3 %) 18 (43.9 %)
-Multiple species (N) 20 (16.5 %) 17 (21.3 %) 3 (7.3 %)
Causative organism:
Gram-positive (N) 77 ( 92.8 %) 56 (90.3 %) 21 (100.0 %)
-S. aureus 54 (65.1 %) 37 (59.7 %) 17 (81.0 %)
-E. fecalis 12 (14.5 %) 10 (16.1 %) 2 (9.5 %)
-MRSA 9 (10.8 %) 8 (12.9 %) 1 (4.8 %)
-S. anginosus 4 (4.8 %) 2 (3.2 %) 2 (9.5 %)
-Corynebacterium 2 (2.4 %) 2 (3.2 %) 0
-Lactobacillus 1 (1.2 %) 1 (1.6 %) 0
Gram-negative 21 (25.3 %) 19 (30.6 %) 2 (9.5 %)
-E. coli 9 (10.8 %) 9 (14.5 %) 0
-K. pneumonae 6 (7.2 %) 5 (8.1 %) 1 (4.8 %)
-Enterobacter 3 (3.6 %) 3 (4.8 %) 0
-B. vulgatus 2 (2.4 %) 2 (3.2 %) 0
-P. mesabilis 2 (2.4 %) 2 (3.2 %) 0
-Pseudomonas 2 (2.4 %) 1 (1.6 %) 1 (4.8 %)
-M. morganii 1 (1.2 %) 1 (1.6 %) 0
-Citrobacter 1 (1.2 %) 1 (1.6 %) 0
-S. marcescens 1 (1.2 %) 1 (1.6 %) 0
Discussion
SSI following spinal surgery occur in 0.7-12%1,2,11,14-16,19,22,26,27,36 of all patients and lead to 
increased rates of patient morbidity and mortality and increased healthcare costs.1,7,18,28,37 
The early identification of the SSI and the infecting organisms is extremely important, so 
that proper treatment can be initiated. In this study we evaluated the clinical presentation 
and treatment course of 132 patients with spinal SSIs. On average, the time to diagnosis 
was slightly longer for the deep SSIs in our cohort; however, this average was greatly 
affected by three cases diagnosed more than 100 days after surgery. In fact, the median 
time to diagnosis was shorter in the deep SSI group than the superficial group (15 versus 18 
days). The most common sign of SSI in our cohort was wound drainage, which agrees with 
the results of previous studies. 
On average, all of the laboratory markers for infection were elevated (WBC, ESR 
and CRP) at the time of diagnosis. The ESR has previously been identified as a sensitive 
marker for infection3 and in our cohort, it was elevated in 94.4% of deep and superficial 
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SSIs. As found in previous studies, the level of CRP was also a very sensitive indicator of 
infection,6,31,38 with 96.8% of deep and 100% of superficial SSIs having elevated levels of 
this marker. The WBC count was reported to be a much less reliable indicator of infection in 
the literature,32 and in our group it was elevated in 43.7% of deep and 57.9% of superficial 
SSIs. Among these indicators, the utility of CRP was greater than ESR or WBC in our 
cohort,24 since the median time to diagnosis was 15 days. By that time the levels of CRP had 
normalized whereas the ESR level was still peaking in normal spine fusion patients. This is 
consistent with the findings of other authors, who also found that the CRP value was more 
sensitive than the ESR or WBC values for the different types of SSI.33
The optimal treatment of deep SSIs following spinal surgery remains controversial. 
When instrumentation is present at the site of infection it has been suggested that 
aggressive surgical treatment and antibiotic therapy should be used.21,34 Some authors 
have recommended the removal of instrumentation with delayed re-implantation5,34 while 
others have suggested the retention of stable implants.12,35 It has also been suggested that 
one could primarily close the wound following debridement21 while others have suggested 
either a second look surgery34 or leaving the wound open and closing it at a second stage.35 
In our cohort the routine treatment for deep infections included aggressive debridement 
of the wound and soft tissues, the retention of all stable hardware and the primary 
replacement of instrumentation if fixation failure had occurred. Primary wound closure 
over multiple drains was performed. With this method 76.0% of deep SSIs were treated 
with a single surgical debridement. Further debridement procedures were performed if 
clinical evidence of uncontrolled infection continued.
Superficial SSI treatment is much less controversial. In our series of patients, aspirate 
cultures deep down into the fascia were performed and local wound care initiated. The 
reliability of these cultures was not as good as that of the deep cultures in the operating 
room. Only 51.2% of the wound cultures were positive; 85.7% of the positive wound 
cultures had evidence of S. aureus. Only 27.1% of the patients were taken to the operating 
room for formal debridement and wound closure. In all other patients, local wound care on 
an outpatient basis cured the superficial SSI. Antibiotic therapy was used in all cases, with 
most being adequately treated by a short course of oral medication.
All patients received antibiotic therapy as a part of the treatment of the SSI. In our 
cohort the patients with deep SSIs underwent a longer course of antibiotic treatment than 
patients with superficial SSIs (40.8 versus 19.6 days). Patients with s deep SSI were primarily 
treated with parenteral antibiotics, often followed by a short course of oral antibiotics. 
Initial antibiotic therapy included broad spectrum Gram-positive and Gram-negative 
coverage that was modified based on the culture results. Patients received on average of 
40.6 days of intravenous therapy, followed in the majority of the cases by a short course 
of oral therapy. Most superficial wound infections were only treated with oral antibiotics 
for an average of 14.5 days. Using these surgical and antibiotic treatment methods, there 
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were no cases of late recurrent infections after more than 1 year follow-up and no patient 
required long-term antibiotic suppression.
The most frequent causative organism for SSI following spine surgery was S. 
aureus.4,14,17,21,35 In the current series, S. aureus was present in 72.6% of all deep SSI isolates, 
with 17.8% demonstrating methicillin resistance. Most other cases of deep SSIs were caused 
by either E. Coli or E. Fecalis suggesting genito-urinary or faecal wound contamination. As 
opposed to reports in the literature, most of the SSIs in our series were caused by a single 
species of bacteria.25
Strengths and limitations: Several limitations of this study warrant consideration. Mainly 
due to its retrospective nature not all of the data could were obtained since not all of the 
physicians routinely put the same degree of detail into the medical records of each patient. 
For example, not all physicians routinely included the EBL in the operative notes for each 
surgical procedure. This resulted in incomplete clinical information for some patients and 
could have resulted in patients being excluded from a specific type of analysis.
The definition used for a SSI was “any postoperative wound that required treatment 
with oral or intravenous antibiotics or surgical debridement with a minimal follow-up of one 
year”. Using this definition and not the widely accepted US Center for Disease Control and 
Prevention and the American College of Surgeons (Appendix 1)20 definition makes this 
study less useful for inter-institutional comparison. However, since it is generally known 
that a SSI after spinal surgery can present itself many years after surgery10 one would miss 
cases of SSIs by using this definition.
Since the Johns Hopkins hospital functions as a tertiary referral hospital, it is possible 
that patients with minor superficial wound infections went to their primary care physician, 
or the in case of a tertiary referral, their more local spine specialist, resulting in a detection 
bias. The ESR, CRP and WBC values can often be elevated due to reasons other than a SSI, 
such as: urinary tract infection or a pulmonary infection, both of which are frequently seen. 
If one is only interested in the characteristics of ESR, CRP and WBC during a SSI, patients 
with an additional infection should be excluded. However, due to the retrospective nature 
of this study, we could not exclude these infections as a possible alternative cause of 
abnormal ESR, CRP and/ or WBC values. Another methodological difficulty in conducting 
retrospective studies for this topic was identification and documentation of SSIs, which 
was mainly done by the treating physician. Measurement bias is also possible, given the 
fact that the SSIs were identified by the last author. The last author was also one of the five 
treating orthopedic spine surgeons.
Conclusion: The most common causative organism in both superficial and deep SSIs 
following spinal surgery is S. aureus. The majority of superficial infections can be treated 
with local wound debridement, a short course of oral antibiotics and healing by secondary 
intent. Up to 76.0% of deep SSIs can be adequately treated by aggressive debridement of 
infected and necrotic tissues in the operating room, the retention of spinal instrumentation 
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(except in cases of instrumentation failure or loosening, where it is primarily replaced) and 
a course of culture-specific intravenous antibiotic therapy. Only a minority of cases will 
require a repeat debridement procedure, depending on a patient’s clinical course.
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Abstract
Study design: A retrospective cohort study to identify and analyse the rates and risk 
factors for postoperative spinal wound infection.
Objective: To determine significant risk factors for postoperative spinal wound 
infection.
Summary of background data: A surgical site infection (SSI) is a common complication 
after spinal surgery. SSIs lead to higher rates of morbidity and mortality and greater 
health-care costs. In order to develop strategies to reduce the risk of SSIs, independent 
risk factors for SSIs should be identified. 
Methods: The electronic patient records of all 3174 patients who underwent orthopaedic 
spinal surgery between 1996 and December 2005 at the Johns Hopkins hospital 
were abstracted. Individual patient and perioperative characteristics were stored in 
an electronic database. The statistical analysis was performed using the Statistical 
Packages for Social Sciences®.
Results: In total, 132 (4.2%) patients were found to have a SSI, with 84 having deep 
infections. Significant independent risk factors for SSIs were: estimated blood loss of 
more than 1 liter (p=0.017), a previous SSI (p=0.012) and diabetes (p=0.050). The risk of 
a superficial SSI was significantly increased by obesity (p=0.009), however the anterior 
spinal approach decreased the risk (p=0.010). Risk factors for deep SSI were: diabetes 
(p=0.033), obesity (p=0.047), a previous SSI (p=0.009) and surgeries of 2-5 hours 
(p=0.023) and 5 or more hours (p=0.009).
Conclusion: SSIs are commonly seen after spinal surgery. In our study we identified 
independent risk factors for both deep and superficial SSIs. The identification of 
these risk factors should enable us to design protocols that are specifically aimed at 
decreasing the risk of SSIs in future patients.
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Introduction
Surgical Site Infections (SSI) following adult spinal surgery have been reported to occur in 0.7 
to 12.0% of patients and can result in higher rates of postoperative morbidity and mortality 
and greater health-care costs.1,3,17,22,25,27,34,40,49 It has been estimated that SSIs following 
spinal surgery can increase health-care costs up to four-fold.9 Due to the increasing rates of 
spinal surgery and the high rate of morbidity due to a SSI, understanding the risks factors 
for SSIs and preventing them is an important field of research.11
A variety of risk factors for SSIs have previously been identified by several authors 
(Appendix 2). However, most of these studies were limited by a small sample size and failed 
to include potential confounding risk factors, thus their findings are difficult to interpret.
In recent years, the case-control method has been used to investigate spinal SSIs. Fang 
et al.16 identified 61 cases of SSI among 1629 surgeries (4.4%) and used a case-control 
analysis to identify age >60 years, smoking, diabetes, a previous SSI, increased body mass 
index, alcohol abuse, a combined anterior/posterior procedure as factors that significantly 
increased the odds for SSI. Olsen et al.35 identified 46 cases of SSI among 2316 patients 
(2.0%) and found that obesity, diabetes, inappropriate timing of prophylactic antibiotic 
therapy, elevated preoperative or postoperative serum glucose and more than two resident 
physicians participating in the surgery increased the odds of a SSI. 
In this study we performed a retrospective cohort analysis of all adult orthopaedic 
spinal patients (N=3174) who underwent surgical spinal procedures for all diagnoses other 
than infection, with at least 1 year of follow-up in the Johns Hopkins hospital, a tertiary 
care university-affiliated medical institution. We compared preoperative patient and 
disease characteristics, and the intraoperative surgical factors of patients who had a SSI 
with patients who did not have a SSI. This has resulted in the identification of those factors 
that modify the risk of SSI. The complete cohort of patients were analysed in order to 
obtain enough power to investigate previously reported risk factors for SSIs in an attempt 
to identify new risk factors for SSIs and to determine the absolute level of risk that patients 
face when undergoing spinal surgery.
Materials and Methods
Patients: After approval from the hospitals institutional review board an administrative 
database was used to identify all consecutive admissions for surgical treatment in the adult 
orthopedic spine service of the Johns Hopkins hospital between June 1996 and December 
2005. During this time period all types of surgical procedures ranging from discectomy to 
osteotomy for all indications were included. All surgical procedures were performed by one 
of five fellowship trained orthopedic spine surgeons. The electronic patient records for each 
patient, which includes all inpatient and outpatient laboratory results, radiographic results, 
all clinical outpatient notes, all operative notes and discharge summaries was abstracted 
to an electronic database.
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Infection control: During the cohort period all infection control procedures remained 
unchanged. All surgical procedures were performed in the same block of operating rooms, 
in which the sterility and air handling characteristics were monitored by the institutional 
infection control department. Standard surgical site preparation using DuraPrep was 
performed in all cases. A clorhexidine scrub was used followed by an alcohol wash in the 
case of an iodine allergy. Electric clippers were used in cases that required hair removal. 
First generation cephalosporins were used in all cases except in the case of a penicillin or 
cephalosporin allergy. Antibiotic prophylaxis began at least 30 minutes prior to skin incision, 
was re-dosed every 4 hours or at every 1500 cc of blood loss during the procedure and 
was then dosed every 6 hours for 24 hours postoperatively. In cases of allergy, clindamycin 
was used when no metallic implants were placed and vancomycin was used when implant 
placement was planned.
Preoperative patient characteristics: Preoperative patient characteristics including age 
(in years and decade), gender, weight, body mass index (BMI), co morbidities as recorded 
in patient chart (diabetes type I and II, presence of obesity (BMI >30), high blood pressure, 
other cardiovascular pathology), current active tobacco usage, perioperative use of non-
steroidal anti-inflammatory drugs (NSAID), serum albumin level, serum protein level and 
serum white blood cell count were recorded. For later analysis, poor nutritional status was 
defined as a serum albumin level <35 g/dL or a serum protein level <60 g/dL.32,34 The total 
white blood cell count was deemed low if it was than 4500 / mm3. The number of previous 
spinal surgeries and the diagnosis of a previous postoperative SSI were determined from 
preoperative clinical notes and (previous-) operation notes. 
Operative characteristics: The indication for each surgical procedure was categorized 
as: removal of painful hardware, trauma/fracture, disc herniation, degenerative disk 
disease, spinal stenosis, tumor/cancer, inflammatory arthritis, spinal deformity (scoliosis or 
kyphosis) or pseudo-arthrosis. All cases with primary infection as an indication for surgery 
were excluded from this study. The surgical procedure was categorized by anatomal 
location (cervical, thoracic, lumbar and/or sacral). The surgical approach was categorized 
as anterior, posterior, or a combined anterior/posterior procedure on the same day or 
as staged procedures. The type of surgery performed was categorized into discectomy, 
decompression, fusion (rooted down into instrumented or un-instrumented), osteotomy, 
hardware removal, soft tissue procedure or debridement. The estimated surgical estimated 
blood loss (EBL), the number of levels fused and the operative time were recorded. 
Operative time was categorized as 0-2 hours, 2-5 hours and greater than 5 hours.
Definition and identification of SSI cases: The postoperative clinical notes, discharge 
summaries and re-admission summaries of all patients were reviewed for a minimum 
follow-up period of 1 year. All intraoperative and postoperative wound cultures were 
noted and their results were reviewed. A clinically significant SSI was defined as: “any 
postoperative wound that required treatment with oral or intravenous antibiotics or surgical 
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debridement”. Clinical findings indicating a wound infection were: fever, pain, erythema, 
swelling, warmth, tenderness to palpation and/or drainage. All SSIs were rooted down 
into deep or superficial. A deep SSI was defined as: “any SSI infection with a component 
beneath the fascia”. Superficial SSI was defined as: “any SSI infection with a component 
above the fascia”. Therefore, a SSI with a superficial and deep component was included in 
both groups. In cases of a suspected deep infection, routine deep aspiration cultures were 
performed. All cultures were characterized by bacterial Gram characteristics and culture 
results. The senior author (D.B. Cohen) reviewed all infection cases and classified them as 
deep and/ or superficial to the fascia. All data was stored in a Microsoft Excel® sheet.
Statistical analysis: All statistical analysis were performed using the Statistical Packages 
for Social Sciences® v15.0 (SPSS, Chicago, Illinois, USA). Binary logistic regression was used 
for continuous data and Cochran’s and Mantel-Haenszels chi-square tests were used in 
case of dichotomous data. A forward and reverse stepwise multivariate logistic regression 
analysis was performed using variables with p<0.20 in univariate analysis. p-values <0.05 
were considered significant. 
Results
A total of 3174 patients were included in the current study. The majority were female 
(n=1901: 59.9%) (Table 1), with a mean age of 55.6 (±15.5) years. Age was not found to be a 
significant risk factor when treated as either a continuous variable or a categorical variable 
by decade. Among these patients, 132 cases of postoperative surgical site infection (4.2%) 
were identified with 84 deep infections. SSI rates varied among subgroups of patients. The 
rates of SSIs rates ranged from 1.8% to 10% with the patients diagnosed with inflammatory 
arthritis having the highest risk of a SSI.
Individual patient general health characteristics and comorbidities are summarized 
in Table 1. The history of prior spinal surgery, history of a SSI, the patient’s preoperative 
nutritional status and preoperative surgical indications are also summarized. The 
characteristics of the surgical procedures are summarized in Table 2; 19.8% of the cases 
involved the cervical spine, 32.0% the thoracic spine, 74.0% the lumbar spine and 36.1% 
the sacrum. Regarding the surgical approach, 67% were posterior only, 20% were anterior 
only, 5% were anterior/posterior staged procedures and 7.3% had an anterior/posterior 
procedure done on the same day. The type of surgical procedure, the length of surgical 
procedure and the estimated blood loss are summarized as well.
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Table 1. Preoperative patient characteristics.
N1 N2
Gender 3174
-Male 1273 40.1 %
-Female 1901 59.9 %
Mean Age, (sd) 55.6 (±15.5)
Comorbidities 2629
-Diabetes (type I or II) 290 11.0 %
-Obesity (BMI >30) 235 8.9 %
-High blood pressure 989 37.6 %
-Other cardiovascular pathology 382 15.5 %
-Active tobacco use 511 19.4 %
-Perioperative usage of immunosuppressive drugs 427 16.2 %
Previous surgery 2826
- no 1308 46.3 %
-One surgery 727 25.7 %
-Multiple surgery’s 791 28.0 %
- Previous SSI 2688 97 3.6 %
Indication 3174
- Removal of painful hardware 144 4.5%
- Fracture 67 2.1 %
- Herniation 338 10.6 %
- Deformity 1116 35.1 %
- Degenerative Disk Disease 423 13.3 %
- Spinal Stenosis 1300 41.0 %
- Tumor/ Cancer 137 4.3 %
- Rheumatoid arthritis 86 2.7 %
- Pseudo-arthrosis 428 13.5 %
Preoperative laboratory results
- Low preoperative protein 1772 64 3.6 %
- Low preoperative albumin 1776 77 4.3 %
N1: Number of patients where presence of risk factor could be determined.
N2: Number of patients with potential risk factor.
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Table 2. Operative characteristics.
N1 N2
Surgical location 3174
- Cervical 628 19.8 %
- Thoracic 1016 32.0 %
- Lumbar 2349 74.0 %
- Sacral 1446 36.1 %
Approach 3174
- Anterior 641 20.2 %
- Posterior 2143 67.5 %
- A/ P, staged 157 4.9 %
- A/ P, same day 233 7.3 %
Procedure 3174
- Discectomy 436 13.7 %
- Decompression 1721 54.2 %
- Fusion 
  un-instrumented 49 1.5 %
- Fusion
 instrumented 2336 73.6 %
- Osteotomy 712 22.4 %
- Removal of hardware 345 10.9 %
- Soft Tissue 81 2.6 %
- Debridement 10 0.3 %
Fused levels 3174
-0-1 1235 38.9 %
-2-4 1272 40.1 %
->5 667 21.0 %
Surgery time: 3174
- 0-2h 1024 32.3 %
- 2-5 h 1297 40.9 %
- >5h 853 26.9 %
EBL 1871
- <1 liter 813 43.5 %
- >1 liter 1058 56.5 %
N1: Number of patients where presence of risk factor could be determined.
N2: Number of patients with potential risk factor.
SSI: The outcomes of the univariate analysis are presented in Table 3. Those who were not 
significant related to occurrence of SSI, are not presented in this table. Diabetic patients 
(p=0.005), patients with prior postoperative wound infections (p=0.002) and patients who 
were undergoing surgery for a spinal deformity (p=0.002) were all associated with an 
increased risk for a SSI. Surgeries performed for disc herniation had a significantly lower risk 
for a SSI (p=0.025). Analysis of perioperative characteristics, showed that a longer surgical 
time (p=0.000), increased EBL (p=0.001), multiple level fusion (2-4 levels: p=0.006; ≥5 levels: 
p=0.001), posterior surgical approach (p=0.002) or combined anterior/posterior surgical 
approach (staged: p=0.008, same day: p=0.000), un-instrumented fusions (p=0.040) and 
spinal osteotomies (p=0.047) were significantly more likely to suffer a SSI (Table 3). 
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Table 3. Univariate comparisons of individual Risk factors in Patients with superficial or deep 
surgical site infection after spinal surgery.
Preoperative Clinical infection (N=132) Superficial (N=70) Deep (N=84)
Characteristics N1 N2 (Rate) p-
Value
N1 N2 (Rate) p-
Value
N1 N2 (Rate) p-
Value
Gender 0.359 0.791 0.101
-Male 58 132 (43.9 %) 27 70 (38.5 %) 41 84 (48.8 %)
-Female 74 132 (56.1 %) 43 70 (61.4 %) 43 84 (51.2 %)
Diabetes 22 114 (19.3 %) 0.005 10 63 (15.9 %) 0.218 16 73 (21.9 %) 0.003
Obesity 15 114 (13.2 %) 0.128 12 63 (19.0 %) 0.006 12 73 (16.4 %) 0.026
High blood pressure 47 114 (41.2 %) 0.416 32 63 (50.8 %) 0.031 32 73 (43.8 %) 0.267
Previous SSI 10 108 (9.3 %) 0.002 5 62 (8.1 %) 0.065 7 68 (10.3 %) 0.005
Previous surgery
- no 45 117 (38.5 %) 26 63 (41.3 %) 26 76 (34.2 %)
-One surgery 34 117 (29.1 %) 0.168 21 63 (33.3 %) 0.956 20 76 (26.3 %) 0.269
-Multiple surgery’s 38 117 (32.5 %) 0.122 16 63 (25.4 %) 0.277 30 76 (3.8 %) 0.014
Indication
- Herniation 6 132 (4.5 %) 0.025 3 70 (4.3 %) 0.094 2 84 (39.5 %) 0.025
- Deformity 63 132 (47.7 %) 0.002 31 70 (44.3 %) 0.108 40 84 (52.6 %) 0.017
Fused levels
-0-1 33 132 (25.0 %) 18 70 (25.7 %) 21 84 (25.0 %)
-2-4 61 132 (46.2 %) 0.006 35 70 (50.0 %) 0.027 36 84 (42.9 %) 0.060
->5 38 132 (28.8 %) 0.001 17 70 (24.3 %) 0.095 27 84 (32.1 %) 0.003
Approach
- Anterior 11 132 (8.3 %) 5 70 (7.1 %) 6 84 (7.1 %)
- Posterior 95 132 (72.0 %) 0.002 50 70 (71.4 %) 0.018 64 84 (76.2 %) 0.006
- A/ P, staged 14 132 (10.6 %) 0.008 7 70 (10.0 %) 0.003 10 84 (11.9 %) 0.000
- A/ P, same day 12 132 (9.1 %) 0.000 8 70 (11.4 %) 0.009 4 84 (4.8 %) 0.345
Procedure
- Discectomy 11 132 (8.3 %) 0.069 6 70 (8.6 %) 0.210 5 84 (6.0 %) 0.043
- Fusion 
  un-instrumented
5 132 (3.8 %) 0.040 1 70 (1.4 %) 0.937 4 84 (4.8 %) 0.022
- Osteotomy 39 132 (29.5 %) 0.047 20 70 (28.6 %) 0.215 28 84 (33.3 %) 0.016
Surgery time 
- 0-2 h 20 132 (15.2 %) 12 70 (17.1 %) 11 84 (13.1 %)
- 2-5 h 62 132 (45.5 %) 0.000 34 70 (48.6 %) 0.015 40 84 (47.6 %) 0.002
- >5h 50 132 (37.9 %) 0.270 24 70 (34.3 %) 0.012 33 84 (39.3 %) 0.000
EBL
- <1 liter 20 79 (25.3 %) 14 70 (20.0 %) 10 84 (11.9 %)
- >1 liter 59 79 (74.7 %) 0.001 29 70 (41.4 %) 0.148 35 84 (41.7%) 0.005
N1: Number of patients with clinical-, superficial- or deep infection and cited characteristics.
N2: Number of patients with clinical-, superficial- or deep clinical infection with and without cited 
characteristics.
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A forward and reverse stepwise multivariate regression analysis was performed in order to 
identify independent significant risk factors for a SSI. Analysis showed than an EBL greater 
than 1 liter (p=0.017), a previous wound infection (p=0.012), and diabetes (p=0.050) were 
significant independent risk factors for SSI (Table 4).
Table 4. Multivariate logistic regression for postoperative wound infection.
Risk factor Odds Ratio 
(95% confidence interval)
p-Value
EBL > 1liter 2.151 (1.150-4.024) 0.017
Previous SSI 3.196 (1.289-7.922) 0.012
Diabetes 2.050 (1.001-4.198) 0.050
Anterior 0.320 (0.098-1.051) 0.060
Superficial SSI; In our study group 70 patients (2.2%) had a superficial SSI. Multiple risk 
factors including obesity (BMI >30) (p=0.006), hypertension (p=0.031), multiple level fusion 
(p=0.027), surgical approach (posterior: p=0.018, anterior/posterior staged: p=0.003 and 
anterior/posterior same day: p=0.009), and longer surgical time (2-5 hours: p=0.015, ≥5 
hours: p=0.012) were linked to an increased risk of a superficial infection (Table 3). However, 
the multivariate analysis showed that only obesity (p=0.009) significantly increased patient 
risk, whereas an anterior surgical approach (p=0.010) decreased the rate of a superficial SSI 
(Table 5).
Table 5. Multivariate logistic regression for Superficial postoperative wound infection.
Risk factor Odds Ratio 
(95% confidence interval)
p-value
Obesity 2.359 (1.237-4.497) 0.009
Anterior approach 0.264 (0.096-0.732) 0.010
Deep SSI; A total of 84 patients (2,6%) in our study group had a postoperative wound 
infection deep to the fascia. Univariate analysis showed that multiple risk factors including: 
diabetes (p=0.003), obesity (p=0.026), prior SSI (p=0.005) surgery for a spinal deformity 
(p=0.017), multiple level fusions (p=0.060), the type of surgical approach (posterior: p=0.006, 
anterior/posterior staged: p=0.000), spinal un-instrumented fusion (p=0.022), osteotomy 
(p=0.016), a longer surgical time (2-5 hours (p=0.002), ≥ 5 hours (p=0.000)), and increased 
EBL (p=0.005) were linked with increased rates of infection. Meanwhile simple discectomy 
(p=0.043) and anterior surgical approaches (p=0.006) were linked with lower rates of deep 
infection (Table 3). During multivariate analysis we found that diabetes (p=0.033), obesity 
(p=0.047), history of prior wound infection (p=0.009), and longer surgical time (2-5 hours 
(p=0.023) and > 5 hours (p=0.009)) were independent risk factors for increased rates of 
deep SSIs (Table 6).
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Table 6. Multivariate logistic regression for Deep postoperative wound infection.
Risk factor Odds Ratio 
(95% confidence interval)
p-value
Diabetes 2.017 (1.508-3.847) 0.033
Obesity 2.003 (1.010-3.970) 0.047
Previous SSI 3.049 (1.321-7.036) 0.009
Length of surgery: 2-5h 2.401 (1.127-5.118) 0.023
Length of surgery: >5h 2.850 (1.296-6.268) 0.009
Discussion
Postoperative wound infections are major complications of surgical procedures that 
result in increased rates of patient morbidity and mortality, and fewer satisfactory 
outcome.1,9,26,41,51 Following spinal surgery the reported rate of SSI in the literature ranges 
from 0.7 to 12%.1,3,17,22,25,27,34,40,49 In our patient population the overall rate of clinically 
significant SSI following adult spinal surgery was 4.2% which is consistent with reports in 
the literature; it ranged from 1.8% to 10%. The frequent use of immune modulating drugs 
in the high risk group (inflammatory arthritis) can result in impaired wound healing and an 
increased risk of SSIs.8
A wide variety of risk factors for spinal SSI were previously identified in the 
literature.5,12,13,16,20,21,23,31,34,36,37,39,43,44,50 However most of these potential risk factors were 
identified in relatively small patient groups and potential confounding factors were not 
looked into. In our retrospective cohort study of 3174 patients we were able to investigate 
multiple potential confounding variables for SSIs and to determine the risk of SSIs for 
different patient subgroups.
In our analysis of clinically significant SSIs we identified more than 10 risk factors 
that seemed to influence the risk of a SSI in the univariate analysis. With the subsequent 
multivariate analysis we were able to identify four independent factors that influenced a 
patient’s risk of a SSI. EBL greater than 1 liter, a history of diabetes, and a history of SSI all 
increased the risk of SSI whereas an anterior surgical approach had a lower risk.
Our finding of an increased risk of SSI with an EBL of more than 1 liter is consistent with 
the results of previous studies on spinal trauma patients6 and elective spinal surgeries.51 This 
finding is also consistent with several studies in the field of cardiovascular surgery.4,47 Non-
autologous blood transfusions result in a relative immune suppression in the recipient38 
and result in an increased risk of infections of all types.4,33,46 Therefore, one should attempt 
to minimize the EBL in any surgical procedure and the need for non-autologous blood 
transfusions. Unfortunately, in reconstructive spine surgeries for deformities or spinal 
osteotomies it may not be possible to reduce the EBL to these levels. In our study, the 
EBL and the length of surgery were correlated with each other (p<0.001). However, when 
incorporated in the forward and reverse stepwise multiple regression analysis the inclusion 
of EBL > 1 liter as a variate in the model eliminated the significance of length of surgery as 
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a variable. Some surgeons intentionally stage different portions of a patient’s surgery over 
several days to minimize the magnitude of any individual procedure. However, when we 
look at our patient group, the highest rates of SSI occurred in patients having procedures 
staged on different days.
A history of a prior SSI significantly increases the risk of SSI; this finding has previously 
been observed by other authors.2,51 Although a patient may not have any signs, symptoms, 
or laboratory findings consistent with an active wound infection; individual bacteria can 
remain encapsulated in the scarred tissue. In this state bacteria can lie dormant until a new 
surgery releases the bacteria, allowing it to contaminate the wound. Unfortunately, one 
cannot change this risk factor for an individual. However, one should attempt to determine 
the organism that caused the prior SSI and its antibiotic sensitivities. It is possible to modify 
the prophylactic antibiotic regimen for an individual case in order to minimize the SSI risk.
Diabetes mellitus as a co-morbid condition was found to be an independent risk 
factor for SSI in our population, which is consistent with the results of many previous 
studies.16,34,43,51 Diabetes impairs wound healing because micro-angiopathic changes lead 
to local tissue ischemia18 and lower tissue concentrations of the antibiotics administrated. 
In addition, granulocyte function is impaired in diabetic patients,45 leading to a relative 
immune suppression, and impaired platelet-derived growth factor functioning28 can further 
impair wound healing. In this study we did not quantify the severity of a patient’s diabetes 
nor did we attempt to quantify the blood sugar levels during the perioperative period. 
Other authors found that tight perioperative regulation of blood sugar may decrease the 
risk of a SSI.13
In our patients the risk of a SSI was directly related to the surgical approach taken 
to the spine. Isolated anterior surgical approaches were associated with a 1.7% risk of a 
SSI whereas any surgery that included a posterior spinal approach was associated with a 
minimum 4.4% risk of SSI. This finding is consistent with the results of Levi et al. who did not 
find a SSI after anterior spinal surgery.26 The improved vascularity and lymphatic drainage 
of the anterior spine may enhance the clearance of incidental bacterial contamination of an 
anterior spinal surgery. Hence, consideration should be made to address spinal pathologies 
through an anterior procedure if equivalent patient outcome can be obtained via either an 
anterior or posterior approach.
When we analysed the superficial SSIs, an anterior surgical approach was found 
to decrease the risk of a superficial infection whereas obesity was found to be the only 
independent risk factor that increased the rate of SSI. In other small patient series, Patel 
et al.36 and Andreshak et al.2 found a similar linkage between obesity and superficial wound 
infections. In obesity the subcutaneous adipose layer can be quite thick. During closure of 
the surgical wound, areas of dead space can easily be created. Local fat necrosis can occur 
and result in a localized wound problem superficial to the fascia. Strategies to prevent this 
can include the use of subcutaneous drains to prevent dead space or recommending weight 
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loss prior to elective surgical treatment. One should recommend a balanced weight loss 
programme as many fad or starvation diets can result in mal-nutrition (a well documented 
risk factor for SSI).
When the deep SSIs were investigated, we found that, similar to the total group of 
infections, co-morbid diabetes and a prior SSI were independent risk factors for deep 
SSIs. Similar to the superficial infections, obesity was also found to increase the risk of 
a deep SSI. Finally longer surgical procedures were found to have a higher risk for deep 
SSI (operative time 2-5 hours, OR=2.4: >5 hours, OR=2.9). Longer operative times resulted 
in longer periods of tissue retraction, with the resulting tissue ischemia, necrosis and 
dessication. This can increase the risk of wound contamination. In longer procedures, 
frequently releasing the tension on self-retractors42 and frequent irrigation of the wound 
with saline7 can minimize tissue necrosis and help prevent wound infections.
Strength and limitations: Several limitations of this study warrant consideration. 
Mainly due to its retrospective nature not all of the data were obtained since not all of 
the physicians routinely put the same degree of detail in the medical records of each 
patient. For example, not all physicians routinely included the EBL in the operative notes 
for each surgical procedure. This resulted in incomplete clinical information for some 
patients and could have resulted in a patient being excluded from a specific regression 
model. Fortunately, since there were 3174 patients in our cohort, we had enough power to 
overcome some of these deficiencies and to discover some significant findings. 
The definition used for a SSI was “any postoperative wound that required treatment 
with oral or intravenous antibiotics or surgical debridement with a minimal follow-up of 1 
year”. Using this definition and not the widely accepted US Center for Disease Control and 
Prevention and the American College of Surgeons29 definition makes this study less useful 
for inter-institutional comparisons (Appendix 1). However, since it is generally known that 
a SSI after spinal surgery can present itself many years after surgery14 one would miss cases 
of SSI by using this definition.
SSIs were rooted down into deep and superficial. However, in this study a patient could 
have classified as having both a superficial and a deep SSI. Although not considered during 
the design of the current study, one could argue that when a deep SSI has been determined, 
the presence or absence of signs indicating a superficial SSI is not relevant for the clinical 
decision-making. In fact, there is a lack of evidence regarding the relationship between 
these two entities. Re-classifying patients as having both a deep and superficial SSI to the 
deep SSI group, would resulted in a decrease in the number of patients with a superficial 
SSI (from 70 to 48 (-31%). Such an alternative approach would have resulted in a potentially 
different outcome. For example, obesity was found to be a significant risk factor during 
both the univariate and multivariate analysis for deep- and superficial SSIs. It is remarkable 
that obesity was not found to be a significant risk factor for a SSI in general. This might 
be explained by the fact that patients with a superficial and deep wound infection were 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Risk factors for surgical site infections following adult spinal surgery
45
analysed in both deep and superficial categories. If during the analysis the definition of a 
superficial SSI was defined as isolated above the fascia, only 48 patients would have been 
included, which would probably have resulted in a different outcome.
Since the Johns Hopkins hospital functions as a tertiary referral hospital, it is possible 
that patients with minor superficial wound infections went to their primary care physician 
or in the case of a tertiary referral their more local spine specialist resulting in a detection 
bias. Because of the tertiary referral centre function, a selection bias may have resulted in 
a more complex, and perhaps more infection prone, study population. 
Another methodological difficulty in conducting retrospective studies in this area of 
research is the identification and documentation of SSI, which is manly done by the treating 
physician. Observation bias is also possible, given the fact that SSIs were identified by the 
last author. The last author was also one of the five treating orthopedic spine surgeons. 
However, as shown, we also evaluated the influence of the treating physician in the 
analysis. This factor was not significantly related to the occurrence of SSIs. 
In summary, a retrospective cohort analysis of 3174 patients undergoing all types of 
spinal surgery were found to have an overall clinical SSI rate of 4.2%, with subgroups 
showing rates ranging from 1.4 to 10.3%. A prior SSI, diabetes and obesity all increased 
the risk of a SSI. Higher EBL and longer operative times also increased the risk of different 
types of SSI while an anterior surgical approach to the spine was associated with the lowest 
risk of a SSI.
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-Chapter 4-
Influence of perioperative resuscitation status on 
postoperative spine surgery complications 
Based on: Influence of perioperative resuscitation status on postoperative spine surgery 
complications. A. Pull ter Gunne, R. Skolasky, H. Ross, C. van Laarhoven, D. Cohen. 
The Spine Journal 2010 Feb; 10(2):129-35.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 4
50
Abstract
Background: Restrictive transfusion criteria have led to decreased rates of morbidity 
and mortality in critically ill patients. Their use has been extended to other patient 
groups. In adult spine surgery, ongoing postoperative blood losses and soft-tissue 
trauma might make these patients unsuitable for restrictive transfusion practices.
Purpose: To assess the influence of the postoperative hemoglobin level (HGB) and the 
use of packed red blood cells (pRBC) or fresh frozen plasma (FFP) on postoperative 
patient morbidity and mortality rates and hospital length of stay (LOS).
Study design: Retrospective case series.
Patient sample: Three hundred consecutive patients who underwent spinal surgeries 
with blood losses greater than 2 liters.
Outcome measures: Postoperative patient morbidity and mortality rates and length of 
stay (LOS).
Methods: Patient records of adult spine patients who had ≥2 liters of blood loss were 
abstracted to obtain patient characteristics, operative characteristics, transfusion, 
and HGB levels over time. The ICU, ward and hospital LOS, discharge location, death, 
pulmonary embolism (PE), stroke, seizures, surgical site infections (SSI) and myocardial 
infarctions (MI) were also noted. Logistic regression analyses (SAS software version 
9.2) were used.
Results: Eleven (3.7%) patients had a postoperative HGB<8 g/dL, 152 (50.6%) ≥8 and 
<10 g/dL and 137 (45.7%) ≥10 g/dL. No significant difference was found in morbidity 
or mortality rates between the two higher HGB groups. Multiple regression analysis 
revealed that patients with an initial postoperative HGB of <8 g/dL were six times more 
likely to develop a SSI (6.37/ 1.15-35.28). The rates of deep SSI increased with greater 
postoperative pRBC use (p=0.002). FFP use in the operation room was lower in cases 
that developed a SSI (1.50 versus 2.69, p=0.042). ICU and ward LOS were longer with 
increased postoperative blood product use.
Conclusion: Patients who lost a larger amount of bloods (>2 liters) during spine surgery 
and who were under resuscitated (HGB<8 g/dL), might have a significantly increased 
risk of a SSI. However due to confounding factors due to the retrospective study 
design, further research should be performed before new guidelines or protocols are 
drawn up. 
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Introduction
In the United States more than 13.8 million pRBC are used for in-hospital transfusions, 
annually, costing billions of dollars. For patients undergoing spinal surgery, the use of 
transfusion services can lead to health-care costs ranging from $312.24 to $2,520.00 per 
patient.4 With an aging population and increasing numbers of surgeries the demand for 
blood products is steadily increasing.29 The use of pRBC for in-hospital transfusion is not 
without risk. Bacterial contamination,33 acute immune mediated hemolytic reactions or 
gastrointestinal complaints can also occur following transfusion.15 The use of perioperative 
pRBC transfusions is known to be an independent risk factor for prolonged mechanical 
ventilation,37 morbidity9,13,19,23,35,36 and mortality6,9,19,20,23,27 in different patient settings, while 
the use of FFP in critically ill surgical patients has also been associated with an increased 
risk of infection.28
Over the last decade, the risk associated with blood product 
transfusion led researchers to trial restrictive transfusion criteria 
in critically ill patients. It was found that restricting transfusions 
in critically ill patients without heart disease led to lower rates 
of patient morbidity and mortality.8,12 By decreasing the target 
HGB level of transfusion from > 10 g/dL to 7-9 g/dL patients suffered fewer complications 
and death. These findings resulted in the use of restrictive transfusion criteria in many 
health-care settings for most patients. However, in daily practice it seems that patients 
with hip fractures, perioperative anaemia leads to a prolonged length of stay and increased 
morbidity, mortality and readmission rates.11 Thus, extending restrictive transfusion criteria 
to other patient settings and patient groups might not have the intended effect.
To the best of our knowledge, no research has been performed to assess the influence 
of perioperative hemoglobin levels, the number of transfused red blood cells and the use 
of fresh frozen plasma on the operative outcome in patients who undergo spinal surgery. 
Adult spinal reconstructive surgery frequently entails blood losses greater than 1-2 liters 
and necessitates intraoperative pRBC transfusions. Due to the nature of spinal surgery, 
there is a large amount of soft tissue and muscular trauma associated (except in minimal 
invasive surgery) with it, which could make these tissues susceptible to hypoxia and death 
if anaemia restricts oxygen delivery to the tissues. During the first 24-48 hours following 
spinal surgery there can often be ongoing blood losses of up to a liter or more as the spinal 
fusion bed continues to lose blood out through the surgical drains. These factors suggest 
that adult spinal reconstruction cases may not be appropriate for the use of restrictive 
transfusion criteria. 
In the current study we retrospectively reviewed a series of patients having adult spinal 
surgery who lost at least 2 liters of blood intraoperatively. We looked at the postoperative 
HGB level and pRBC or FFP usage and evaluated the influence of each of these variables on 
postoperative rates of patient morbidity and mortality and hospital length of stay.
Hemoglobin levels
g/dL mMol/L
8 4.97
10 6.21
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Materials and Methods
Patients: All adult patients who underwent orthopaedic spinal surgery and who lost at 
least 2 liters of intra-operative blood loss were identified from the previously formed 
database as discussed in Chapter 2. We selected patients who lost at least 2 liters of blood 
preoperatively, so that any significant differences in the results of laboratory tests for HGB-
levels and transfusion requirements might appear. In contrast to the previous two chapters 
we used a timeframe between January 2000 and December 2005, since the information on 
used FFP and pRBC was not available before January 2000. After approval from the hospital 
institutional review board, the electronic patient records were reviewed for additional 
outcomes of laboratory tests, postoperative admission and complications. The electronic 
transfusion medicine database was also abstracted to confirm the exact number and type 
of blood products used for each patient. 
Reviewed variables: General patient demographics (age, gender, diabetes, weight, 
BMI, presence of obesity (BMI >30), high blood pressure, other vascular pathology, noted 
active tobacco usage, usage of immunosuppressive drugs, previous surgery, indication 
for surgery) were noted. Perioperative HGB-levels, the use of blood products (pRBC and 
FFP)28 and outcome measures including: the duration of intensive care stay31, the duration 
of non-ICU stay32, discharge destination, myocardial infarction (MI), cerebral infarction or 
seizure21 (CVA), pulmonary embolism (PE), surgical site infection (SSI)3,5,30 and mortality25,31 
were also noted. A clinically significant SSI was defined as: “any postoperative wound that 
required treatment with oral or intravenous antibiotics or surgical debridement”. All SSIs were 
rooted down into deep or superficial. A deep SSI was defined as; “any SSI infection with a 
component beneath the fascia”. A superficial SSI was defined as; “any SSI located above the 
fascia with or without a deep component”. 
Statistical analyses: The analysis was undertaken by the second (RLS) and last (DBC) 
author. All analyses were calculated using the SAS software version 9.2 (SAS Institute, Cary 
NC). Differences in outcomes were compared between patients with low-level hemoglobin 
(<8 g/dL), mid-level hemoglobin (>8 g/dL but <10 g/dL), and high level hemoglobin (≥10 g/
dL) immediately following surgery, 24 hours after surgery and just prior to discharge. Chi-
square test was used for dichotomous variables and Student’s t-test was carried out for 
continuous variables. Logistic regression analyses were used to determine which factors 
could predict the different outcomes. A statistical significance of p<.05 was used.
Results
A total of 300 patients were included in the present study. The majority of the patients 
were female (N=195, 65.0%) and the mean age was 55.1 years (±15.2). The general patient 
characteristics are summarized in Table 1. 
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Table 1. Patient characteristics.
N1 N2
Gender 300
-Male 105
-Female 195
Mean Age, (SD) 300 55.0 (15.2)
SSI 300 14 (4.7 %)
-Isolated superficial 6 (2.0 %)
-Isolated deep 6 (2.0 %)
-Superficial and deep 2 (0.7 %)
Co morbidities 263
-Diabetes 26 (9.9 %)
-Obesity (BMI >30) 26 (8.7 %)
-High blood pressure 100 (38.0 %)
-Other vascular pathology 43 (14.3 %)
-Active tobacco use 49 (16.3 %)
-Immunosupressive drugs 43 (14.3%)
Previous surgery 288
-none 96 (33.3 %)
-One surgery 86 (29.9 %)
-Multiple surgeries 106 (36.8 %)
Indication for surgery* 300
-Herniated Disc 9 (3.0 %)
-Deformity 195 (65 %)
-Degenerative disk disease 36 (12.0 %)
-Spinal stenosis 122 (40.7%)
-Tumor/ cancer 18 (6.0 %)
-Arthitis 2 (0.7 %)
-Pseudoarthosis 76 (25.3 %)
N1: Number of patients where the presence characteristic could be determined. 
N2: Number of patient with the characteristic.
*every surgery could have multiple indications.
The mean surgical blood loss was 3.6 liters (±2.0, range 2 to 20 liters). Post-operatively, the 
patients averaged 1.9 (±2.2) days in the ICU followed by 5.7 (± 2.9) days in the ward (Table 
2). The surgical characteristics are summarized in Table 2. Each surgery could consist out of 
multiple performed procedures.
Outcomes: MI, PE, CVA and deaths were all infrequent in our patient group (Table 2). 
The infrequent nature of these complications meant that no significant differences were 
found in the rates of these complications between the different HGB groups given our 
study population.
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Table 2. Per- and post- operative characteristics.
N1 N2 Mean (SD)
Surgical localisation 300
-Cervical 9 (3.0 %)
-Thoracic 187 (62.3 %)
-Lumbar 278 (92.7 %)
-Sacral 198 (66.0 %)
Operative approach
-Anterior 0
-Posterior 229 (76.3 %)
-Anterior/ posterior, same day 71 (23.7 %)
-Anterior/ posterior, staged 0
Procedure 300
-Discectomy 8 (2.7 %)
-Decompression 166 (55.3%)
-Fusion, instrumented 293 (97.7 %)
-Fusion, un-instrumented 1 (0.3 %)
-Osteotomy 136 (45.3 %)
-Removal of hardware 23 (7.7 %)
-Soft tissue 9 (3.0 %)
-Debridement 1 (0.3 %)
Number of fused levels
-0-1 21 (7.0 %)
-2-5 110 (36.7 %)
->5 169 (56.3 %)
Surgical time 300
0-2 h 5 (1.7 %)
-2-5h 86 (28.7 %)
->5h 209 (69.7 %)
Mean units pRBC (SD) 300 5.35 (±3.4)
-Intraoperative 286 (95.3 %) 1.09 (±2.1)
-First 24 hours post-operative 129 (43.0 %) 1.88 (±1.7)
->24 hours postoperative 224 (74.7 %)
Mean FFP use (SD) 300
-Intraoperative 164 (54.7 %) 2.61 (±3.5)
-First 24 hours post-operative 52 (17.3 %) 0.74 (±2.2)
->24 hours postoperative 16 (5.3 %) 0.24 (±1.3)
Mean ICU-stay (SD) 300 291 (97.0 %) 1.9 (±2.2)
Mean Ward-stay (SD) 300 298 (99.3 %) 5.7 (±2.9)
Myocardial infarction 300 3 (1.0 %)
Death 300 2 (0.7 %)
Pulmonary Embolism 300 4 (1.3 %)
Cerebral infarction/ seizures 300 2 (0.7 %)
N1: Number of patients where the presence characteristic could be determined. 
N2: Number of patient with the characteristic.
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SSI: In our study, 14 cases of SSIs were identified; 6 isolated superficial, 6 isolated 
deep and 2 combined. During further analysis we included 8 SSIs in the superficial group 
(6 isolated superficial and 2 combined) and 8 in the deep group (6 isolated deep and 2 
combined). No significant difference was found in risk of a SSI between the upper two 
HGB groups (p=0.564). In addition, the initial postoperative HGB level of <8 g/dL did not 
significantly increase the risk of a clinical SSI (18,1% versus 4,2%, p=0.087). pRBC use after 
surgery was increased among those with clinical infection (2.79 versus 1.85, p=0.049), 
whereas FFP use during surgery was lower among those with clinical a SSI (1.50 versus 2.69, 
p=0.042) (Table 3). Further exploration revealed that patients with an initial postoperative 
HGB level of <8 g/dL, had an increased use of pRBC during surgery (p=0.024), during the 
first 24 hours after surgery (p=0.003), during the entire period of hospitalization (p=0.001), 
increased use of FFP during the first 24 hours after surgery (p=0.012), and during the total 
hospitalization (p=0.032). However, we performed a multi-variate analysis and found that 
an initial postoperative HGB level of <8 g/dL was a significant factor to be included in 
further analysis. We included variables of interest found during the univariate analysis in 
the multivariate analysis. After multivariate analysis the initial post-operative HGB level of 
<8 g/dL was identified as being an independent significant risk factor for a SSI (OR: 6.37, 
95% CI: 1.15, 35.28) (Table 4). The use of pRBC and FFP was not associated with a significant 
change in the odds of clinical infection (pRBC: OR 1.22, 95% CI: 0.98, 1.52 and FFP: OR 0.86, 
95% CI: 0.68, 1.08). 
Table 3. Analysis of SSI.
SSI
Present Not present p-value
HGB < 8 g/dL 2 (18.1 %) 9 (81.8 %) 0.087
HGB > 8 g/dL 12 (4.2 %) 277 (95.8 %)
Mean units (SD) pRBC use after surgery till discharge 2.79 (2.12) 1.85 (1.70) 0.049
Units of FFP use during surgery 1.50 (1.87) 2.69 (3.61) 0.042
* Fisher exact test.
When the SSIs were stratified into superficial or deep, the univariate analysis showed a 
significant relationship between increased pRBC use after surgery untill discharge (3.75 
versus 1.85, p=.002) and deep SSI. Because only one significant risk factor was found during 
univariate analysis, no multivariate analysis was performed. No risk factors were identified 
during the analysis for superficial postoperative wound infection (Table 5).
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ICU-stay: The use of both pRBC (r=0.25, p<0.001) and FFP (r=0.18, p=0.002) during the 
first 24 postoperative hours was positively correlated with days in the ICU (Table 6). During 
the multivariate analysis an initial postoperative HGB level of <8, pRBC, and FFP use during 
the first 24 hours following surgery were included. Only pRBC use during the first 24 hours 
following surgery was positively associated with increased length of ICU stay (an increase 
of 0.25 days per unit increase in pRBC, p<0.001) (Table 4).
Ward stay: No significant difference was found in the length of ward stay between 
patients with an HGB level of < 8 g/dL or > 8 g/dL (p=0.351), pRBC use during the first 24 
hours after surgery (r=0.16, p=0.008) was positively correlated with days on the ward, and 
FFP use during surgery (r=0.15, p=0.008) and during the first 24 postoperative hours (r=0.19, 
p<0.001) were positively correlated with days on the ward (Table 6). The multivariate 
analysis included an initial post-operative HGB level of <8, pRBC use after surgery until 
discharge, and FFP use during surgery, only pRBC use after surgery until discharge was 
positively associated with increased length of ward stay (an increase of 0.36 days per unit 
increase in pRBC, p<0.001) (Table 4).
Table 6. Hospital admission.
ICU p-value Ward p-value
HGB < 8 g/dL days(sd) 2.00 (1.67) 0.940 7.18 (3.69) 0.351
HGB > 8 g/dL days(sd) 1.95 (2.25) 5.64 (5.32)
Units pRBC use first 24 hours after surgery* 0.25 0.001 0.16 0.008
Mean units (SD) pRBC use after surgery till discharge* Excluded 0.21 <0.001
Units of FFP use during surgery Excluded 0.15 0.008
Units of FFP use during first 24 hours following surgery* 0.18 0.002 0.19 <0.001
* Pearson’s correlation.
Discharge destination: During the univariate analysis no significant association was 
found between discharge destination (home versus inpatient rehabilitation and any of the 
risk factors measured in this study (Table 7).
Table 7. Discharge destination.
Home Other p-value
HGB < 8 g/dL (N) 6 (54.5 %) 5 (45.5 %) 0.239
HGB > 8 g/dL (N) 107 (37.0 %) 182 (63.0 %)
Mean units (SD) pRBC use after surgery till discharge* 1.81 (1.55) 1.95 (1.67) 0.521
Units of FFP use during surgery* 2.16 (3.01) 2.92 (3.82) 0.072
*Student T-test.
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Discussion
Over the last 10 years a significant body of information has been developed regarding the 
risks and benefits of non-autologous transfusions of packed red blood cells and fresh frozen 
plasma in patients with a variety of medical conditions. Investigators have found that both 
pRBC and FFP transfusions seem to increase the risk of patient morbidity, surgical site 
infection and mortality in critically ill patients26, cardiovascular surgery patients3 and many 
groups of general surgical patients30. This has led to the development of more restrictive 
transfusion criteria which have been shown to decrease morbidity and mortality in critical 
care patients12. 
However, this idea of restrictive transfusion criteria has since been extended across 
care settings and across patient groups whom were never included in the clinical trials. 
Some authors have found that in certain patient groups (i.e. those with hip fractures), 
lower HGB levels are linked to longer hospital stays, increased re-admission rates, and 
increased patient mortality11. To the best of our knowledge, we are not aware of any study 
that has looked at the effect of HGB levels, pRBC, and FFP transfusions on rates of patient 
morbidity and mortality following adult reconstructive spinal surgeries. 
In our study we retrospectively stratified patients based upon their initial postoperative 
HGB level, their 24 hour post-operative hemoglobin levels and their final pre-discharge 
hemoglobin level as anaemic (HGB <8.0 g/dL), meeting the restricted criteria ( 8.0≤ HGB < 
10.0 g/dL) or liberal criteria (HGB ≥10.0 g/dL) and we tracked them for multiple measures of 
patient morbidity and mortality. Fortunately, patient morbidity and mortality (not including 
SSIs) were rare in our study population and contrary to the findings in other populations12, 
a more restrictive HGB level did not lead to a decrease in morbidity or mortality. Within our 
selected patient group, the infection rate was 4.7% which is consistent with that seen in the 
literature1,2,10,14,16,17,22,24,34, however, we expected to have a higher rate of SSIs since our study 
only included patients with an increased blood loss. When we analysed these infections, 
the patients who were initially anaemic following surgery (HGB < 8.0) had an increased risk 
of developing a wound infection when controlling for postoperative transfusions (pRBC).
In reconstructive spine procedures, surgical exposure frequently requires a great deal 
of soft-tissue dissection, stripping and retraction during the procedure. This can lead to 
relatively poorly vascularized soft-tissues following the procedure which may be susceptible 
to hypoxia and resulting necrosis if oxygen delivery is inadequate. A decreased HGB level 
leads to a decreased oxygen carrying capacity and tissue delivery placing tissues at risk 
of necrosis. In restrictive transfusion practices the use of general plasma expanders to 
increase the intra-vascular volume might increase the problem by causing micro-vascular 
collapse that further limits oxygen delivery to the tissues.26 In our patient population a low 
postoperative HGB level (<8.0 g/dL) seemed to have a significantly increased the risk of a 
SSI as did the use of postoperative pRBC (for deep SSI). Thus, our findings would suggest 
that adequate intraoperative patient resuscitation with pRBC to prevent anaemia could 
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lead to a decrease in the risk of a SSI. Perhaps a more liberal HGB goal intraoperatively 
might limit the need for postoperative pRBC transfusions which did increase the risk of a 
SSI. 
When we tried to analyse the ICU length of stay (LOS), the ward length of stay and 
information regarding discharge destinations for our patient group we found no relationship 
between discharge destination and any of the measures followed in the study. However, 
we did find that ICU length of stay was not correlated with the postoperative HGB level, but 
it was related to the use of pRBC in the first 24 hours post-operative. Furthermore, length 
of stay on the ward was not correlated with the initial postoperative HGB level, but it was 
correlated with the increased need of postoperative pRBC and FFP transfusions following 
the surgery. 
Strength and limitations: To the best of our knowledge, no previous research has been 
undertaken to assess the influence of perioperative the HGB level or the use of pRBC and 
FFP on the operative outcome in patients who undergo spinal surgery. The definition of a 
SSI was “any postoperative wound that required treatment with oral or intravenous antibiotics 
or surgical debridement with a minimal follow-up of 1 year”. Using this definition and not the 
widely accepted US Center for Disease Control and Prevention and the American College 
of Surgeons (Appendix 1)18 definition makes this study less useful for inter-institutional 
comparisons. However, since it is generally known that a SSI after spinal surgery can present 
itself many years after surgery7 one would miss cases of SSI by using this definition. SSIs 
were rooted down into deep and superficial; however, in this study a patient could have 
classified as having both a superficial and a deep SSI. Although not considered during the 
design of the current study, one could argue that when a deep SSI has been determined, 
the presence or absence of signs indicating a superficial SSI is not relevant for clinical 
decision making. In fact, there is a lack of evidence regarding the relation between these 
two entities. Re-classifying patients as having both a deep and superficial SSI to the deep 
SSI group, would have resulted in a decrease in the number of patients with a superficial 
SSI. Such an alternative approach would have resulted in a potentially different outcome. 
One of the main limitations of this study is that it represents a retrospective analysis of 
clinical practice in the Johns Hopkins hospital over a period of several years. Within this time 
period there were no standardised transfusion criteria in place and therefore we cannot 
make any comment on whether instituting a more liberal or restrictive transfusion criteria 
in this patient population would change their clinical course. Another limitation of our 
study is that we did not include the preoperative HGB status of the patient. If one includes 
this factor, the influence of HGB changes could be assed. In this study we also only included 
patients who lost more than 2 liters of blood. Thereby, we excluded potential patients who 
received transfusions due to a low preoperative level of HGB. By excluding previously 
identified risk factors for SSIs (for example the duration of surgery), an incomplete 
multivariate analysis was performed. Therefore, the results of this study cannot be used 
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as a firm foundation for further protocol development. However, an important question is 
raised for future research.
During the analysis of discharge destination one might expect that the extent of the 
surgical procedure performed might influence the discharge destination. As previously 
mentioned, the exclusion of potential risk factors in this study may have resulted in the 
incorrect conclusion that there are no factors that significantly influencing the discharge 
destination.
Conclusion: Due to confounding factors the results of this study cannot be used as a 
foundation for future protocols but it does raises a points of interest for further (prospective) 
research. In patients undergoing adult reconstructive spinal surgeries with blood losses 
greater than 2 liters, patients with HGB levels in the “liberal” transfusion range (≥10.0 g/
dL) were not at risk of increased rates of morbidity or mortality compared to patients with 
HGB levels in the “restrictive” range (8.0≤ HGB <10.0 g/dL). “Anaemic” (HGB <8.0) were 
associated with an increased risk of SSIs. Intraoperative transfusion with pRBC or FFP 
did not increase the risk of a SSI or a longer LOS, but the increased use of postoperative 
transfusions did increase risk of SSIs and longer LOS.
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Incidence of surgical site infection following adult spinal 
deformity surgery: an analysis of patient risk 
 
 
 
Based on: Incidence of surgical site infection following adult spinal deformity surgery: an 
analysis of patient risk. A. Pull ter Gunne, C. van Laarhoven, D. Cohen. European Spine 
journal 2010 Jun;19(6):1982-8.
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Abstract
Surgical site infection (SSI) following spinal surgery is a frequent complication that 
results in higher rates of morbidity and mortality and greater healthcare costs. Patients 
undergoing surgery for spinal deformity (scoliosis/ kyphosis) require longer surgeries 
that, involve more spinal levels and larger blood losses than typical spinal procedures. 
Previous research identified risk factors for SSIs in spinal surgery, but few studies have 
looked at adult deformity surgeries. We retrospectively analysed a large case cohort 
of adult patients who underwent surgery for kyphosis or scoliosis between June 1996 
and December 2005, in the adult spine division in an academic institution to assess 
the incidence and to identify the risk factors for SSIs. We reviewed the electronic 
patient records of 830 adult patients. SSI were classified as deep or superficial to the 
fascia; 46 (5.5 %) patients were found to have a SSI with 29 patients (3.5 %) having 
deep infections. Obesity was found to be an independent risk factor for all SSIs and 
superficial SSIs (p=0.014 and p=0.013, respectively). A history of a prior SSI was a found 
to be a risk factor for SSI (p=0.041). Both patient obesity and history of prior SSI were 
found to lead to an increased risk of infection. Since obesity was related to an increased 
risk of both superficial and deep SSIs, counselling and treatment for obesity should be 
considered before elective deformity surgery.
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Introduction
Surgical site infection (SSI) following adult spinal surgery is a frequent complication 
that has been reported to occur in 0.7 to 12.0% of patients and results in higher rates of 
postoperative morbidity and mortality and greater health-care costs.1,3,12,14,17,19,24,30,35 SSIs 
following spinal surgery has been estimated to increase health-care costs by four-fold.5 
Over the last 30 years the rates of spinal surgery have increased significantly, with a 
corresponding increase in the number in of cases of SSIs.8 As a result, SSIs following spinal 
surgery are increasing the cost burden on society, making it important that we understand 
the risk factors for SSIs so that the risk of infection can be minimized. Within the literature, 
different patient characteristics (age,16,34 obesity,2,6,21,24,25,36 diabetes,31,36 presence of more 
than three co-morbid diseases,24 urinary incontinence,24 tobacco use,36 poor nutritional 
status,15,16,23 complete neurological deficit,28 non-steroidal anti-inflammatory drugs 
use,7 operative characteristics ( revision surgery2,36, posterior surgical approach24, tumor 
resection24, increased estimated blood loss23,36, prolonged surgical time36, multilevel fusion 
surgery extending to the sacrum26) have been identified as risk factors for SSI. 
It is known that general complication rates in cases of deformity surgery can be 
as high as 40%.4,22 Ganocy et al.11 reviewed 145 consecutive adult deformity patients 
who underwent combined anterior and posterior surgery. They found a relatively high 
incidence of early surgical site infections of 11,1% in revision surgery patients. However, 
few researchers have looked at this high risk group to identify the risk factors for SSI. Rihn 
et al.29 reviewed 236 adolescent patients who underwent spinal surgery for adolescent 
idiopathic scoliosis in order to identify specific risk factors for SSI; they found 7 (3%) cases 
of SSIs and described the treatment of these infections but did not identify specific risk 
factors for developing SSIs. Ho et al.13 also reviewed adolescent idiopathic scoliosis patients 
and identified “significant medical history”, receipt of blood transfusions and failure to use 
a postoperative drain as factors that increased risk of SSI but this study was limited by its 
population size. Other small studies in the literature were not able to identify the patient or 
surgical characteristics that result in a significantly increased risk of SSI.18,32,33
In this study we performed a retrospective cohort analysis of all adult kyphosis and 
scoliosis patients (N=830) who underwent surgery at the Johns Hopkins hospital. The 
patient preoperative characteristics, intraoperative surgical factors and postoperative 
outcome of the patients were reviewed. We compared the patients with SSI to the rest of 
the cohort and identified risk factors for SSI. 
Material and Methods
Patients: After approval from the hospitals institutional review board, we used an 
administrative database to identify all consecutive admissions to the spine division of 
the adult orthopaedic department in the Johns Hopkins hospital between June 1996 and 
December 2005. All surgeries for the diagnosis of spinal deformity (kyphosis or scoliosis) 
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were included. As shown in our previous publication this resulted in the selection of 1116 
patients.27 For this project we reviewed all 1116 patient charts again and selected patients 
who underwent spinal surgery with deformity as the primary indication or a significant 
secondary indication. This resulted in 830 patients who had surgery performed by one of 
the five fellowship trained orthopaedic spine surgeons. The electronic patient record for 
each patient, which includes all inpatient and outpatient laboratory results, radiographic 
results, all clinical outpatient notes, all operative notes and discharge summaries was 
reviewed and abstracted into an electronic database. All cases of possible SSIs were re-
reviewed by the senior author (DBC) to confirm case identification and classification as 
superficial or deep.
Patient characteristics: Preoperative patient characteristics including age (in years and 
decade), gender, weight, body mass index (BMI), co morbidities (diabetes (presence of 
obesity (BMI >30), type I and II as recorded in the patient charts), high blood pressure (as 
recorded in the charts), other cardiovascular pathologies, current active tobacco usage 
(as recorded in the charts), perioperative use of non-steroidal anti-inflammatory (NSAID) 
drugs), serum albumin level, serum protein level and serum white blood cell count were 
recorded. For later analysis poor nutritional status was defined as a serum albumin level of 
<35 g/dL or serum protein level <60 g/dL.23,24 The total white blood cell count was deemed 
low if less than 4500 / mm3. The number of previous spinal surgeries and the diagnosis 
of a previous spinal SSI were determined from preoperative clinical notes and notes from 
previous operations. 
Operative characteristics: During the inclusion period for our cohort all surgical 
procedures were performed in the same block of operating rooms. Sterility and air handling 
characteristics remained unchanged and were monitored by the institutional infection 
control department. Standard surgical site preparation using DuraPrep was performed 
in all cases. In the case of iodine allergy, a chlorhexidine scrub was used followed by an 
alcohol wash. In cases requiring hair removal, electric clippers were used. First generation 
cephalosporins were used in all cases except in the case of penicillin or cephalosporin 
allergies. Antibiotic prophylaxis began at least 30 minutes prior to skin incision, was re-
dosed every 4 hours or 1500 cc of blood loss during the procedure and was dosed every 6 
hours for 24 hours postoperatively. In the case of an allergy, clindamycin was used when 
no metallic implants were placed and vancomycin was used when implant placement 
was planned. During the review of the patient records the following characteristics of the 
surgery were noted: anatomical location (cervical, thoracic, lumbar and/or sacral), surgical 
approach (anterior, posterior or a combined anterior/posterior procedure on the same day 
or staged), type of surgery (decompression, fusion (instrumented or un-instrumented), 
osteotomy), estimated blood loss (EBL) during surgery, number of levels fused and 
operative time. The operative time was categorized as 0-2 hours, 2-5 hours and greater 
than 5 hours.
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Outcome measurement: In our study the primary outcome measure was SSI. In order 
to identify such cases the clinical notes, discharge summaries, re-admission summaries, 
all obtained cultures (intraoperative and postoperative) and culture outcomes (Gram 
characteristics and culture results) of all 830 included patients were reviewed. The minimum 
follow-up period was 1 year. A clinically significant SSI was defined as: “any postoperative 
wound that required treatment with oral or intravenous antibiotics or surgical debridement”. 
All SSIs were rooted down into deep or superficial. A deep SSI was defined as: “any SSI 
infection with a component beneath the fascia”. Superficial SSI was defined as: “any SSI 
infection with a component above the fascia”.
Statistical analysis: All analyses were performed using the Statistical Packages for 
Social Sciences® v15.0 (SPSS, Chicago, Illinois, USA). Binary logistic regression was used 
for continuous data and Cochran’s and Mantel-Haenszels chi-square tests were used in 
case of dichotomous data. Multivariate logistic regression was performed using variables 
with p<0.20 in univariate analysis. p-values were considered significant at p<0.05. During 
multivariate analysis of SSI including variables found during univariate analysis created a 
weak model. Therefore we replaced the variable “age” for surgical approach. The approach 
served as an indirect surrogate of age, since within the Johns Hopkins hospital anterior/ 
posterior same day procedures were performed in patients less than 60 years old, while 
staged procedures were performed in older patients. This created a stronger model.
Results
A total of 830 patients were eligible for inclusion in the current study. The mean age was 
55.4 (±16.1) years, and the majority of patients were female (N=610) (Table 1). Statistical 
analysis showed that age as a continuous variable was not a significant risk factor (p=0.523). 
However, when age was categorized by decade it showed significant variability between 
decades (Table 2). Within our study group 46 patients were identified as having a SSI 
and 29 patients had infections that extended deep to the fascia. The surgical procedures 
performed and their characteristics are summarized in Table 3. The lumbar (84%) and 
thoracic (75%) spinal regions were most frequently involved and the posterior surgical 
approach was included in most cases (89.4%). 
SSI: Univariate analysis of this group showed that obesity (p=0.035) and history of prior 
SSI (p=0.045) significantly increased the risk of SSI. When age was categorized by decade, 
different decades were identified as significant risk factors for postoperative wound 
infection (Table 2). Univariate analysis of the operative characteristics did not show any 
significant factors (Table 4). The multivariate analysis, included obesity, history of prior SSI 
and surgical approach (as previously explained). Forward and reverse stepwise regression 
showed obesity (p=0.014), and history of SSI (p=0.041) to be independent significant risk 
factors for SSI. Surgeries performed on the anterior and posterior spine on separate days 
(p=0.068) had a tendency to be independent significant risk factor (Table 5).
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Table 1. Preoperative patient characteristics.
N1 N2
Gender 830
-Male 220 26.5 %
-Female 610 73.5 %
Mean Age, (sd) 55.4 (±16.1)
Comorbidities 683
-Diabetes 55  8.1 %
-Obesity 54  7.9 %
-High blood pressure in chart 259  37.9 %
-Other cardiovascular pathology 105  15.4 %
-Active tobacco use in chart 128  18.7 %
-Perioperative NSAID use 117  17.1 %
Previous surgery 734
- no 263  35.8 %
-One surgery 183  24.9 %
-Multiple surgery’s 288  39.2 %
Previous SSI 695 38 5.5 %
Preoperative laboratory results
- Low preoperative protein (<35 g/dL) 546 24  4.4 %
- Low preoperative albumin (<60 g/dL) 546 24  4.4 %
N1: Number of patients where presence of patient characteristic could be determined.
N2: Number of patients characteristic.
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Table 2. Univariate comparisons of individual Risk factors in Patients with superficial or deep surgical site 
infection after spinal surgery.
N with surgical site infection 
Preoperative Clinical infection Superficial Deep
Characteristics N (Rate) p-Value N (Rate) p-Value N (Rate) p-Value
Gender 0.864 0.645 1.000
-Male 11 (5.0 %) 5 (2.3 %) 7 (3.2 %)
-Female 35 (5.7 %) 20 (3.3 %) 22 (3.6 %)
Mean Age 54.0 (sd ±16.1) 55.8 (sd±16.2) 55.8 (sd±16.3)
Age in decades (N)
-2 (13) 3 (23.1 %) 2 (15.4 %) 1 (7.7 %)
-3 (55) 1 (1.8 %) 0.021 0 (0.0 %) 0.997 1 (1.8 %) 0.300
-4 (65) 2 (3.1 %) 0.021 0 (0.0 %) 0.997 2 (3.1 %) 0.445
-5 (150) 9 (6.0 %) 0.037 5 (3.3 %) 0.063 4 (2.7 %) 0.337
-6 (182) 16 (8.8 %) 0.109 8 (4.4 %) 0.106 10 (5.5 %) 0.741
-7 (179) 7 (3.9 %) 0.009 5 (2.8 %) 0.039 5 (2.8 %) 0.348
-8 (160) 6 (3.8 %) 0.009 4 (2.5 %) 0.033 4 (2.5 %) 0.309
-9 (26) 2 (7.7 %) 0.195 1 (3.8 %) 0.236 2 (7.7 %) 1.000
Diabetes 5 (9.1 %) 0.366 2 (3.6 %) 0.707 3 (5.5 %) 0.458
Obesity 7 (13.0 %) 0.035 5 (9.3 %) 0.029 4 (7.4 %) 0.142
NSAID 7 (6.0 %) 1.000 4 (3.4 %) 1.000 5 (4.3 %) 0.790
High blood pressure 17 (6.6 %) 0.623 12 (4.6 %) 0.189 11 (4.2 %) 0.682
Other cardiovascular pathology 7 (6.7 %) 0.823 5 (4.8 %) 0.378 4 (3.8 %) 1.000
Active tobacco usage 8 (6.3 %) 0.838 4 (3.1 %) 1.000 5 (3.9 %) 1.000
- Low preoperative protein 2 (8.3 %) 0.650 2 (8.3 %) 0.234 1 (4.2 %) 0.581
- Low preoperative albumin 2 (8.3 %) 0.651 2 (8.3 %) 0.236 1 (4.2 %) 0.582
Previous SSI 5 (13.2 %) 0.045 3 (7.9 %) 0.101 3 (7.9 %) 0.138
Previous surgery
-None 12 (4.6 %) 6 (2.3 %) 7 (2.7 %)
-One surgery 11 (6.0 %) 0.498 6 (3.3 %) 0.524 8 (4.4 %) 0.952
-Multiple surgery’s 18 (6.3 %) 0.385 10 (3.5 %) 0.409 12 (4.2 %) 0.920
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Table 3. Operative characteristics.
N1 N2
Surgical location 830
- Cervical 69 8.3 %
- Thoracic 625 75.3 %
- Lumbar 698 84.1 %
- Sacral 466 56.1 %
Approach 830
- Anterior 88 10.6 %
- Posterior 441 53.1 %
- A/ P, staged 133 16.0 %
- A/ P, same day 168 20.2 %
Procedure 830
- Decompression 324 39.0 %
- Fusion instrumented 816 98.3 %
- Osteotomy 494 59.5 %
Fused levels 830
-0-1 28 3.4 %
-2-4 242 29.2 %
->5 560 67.5 %
Surgery time: 830
- 0-2h 24 2.9 %
- 2-5 h 186 22.4 %
- >5h 620 74.7 %
EBL 606
- <1 liter 79 13.0 %
- >1 liter 527 87.0 %
Attending surgeon 830
-1 11 1.3 %
-2 443 53.4 %
-3 75 9.0 %
-4 172 20.7 %
-5 129 15.5 %
N1: Number of patients where presence of patient characteristic could be determined.
N2: Number of patients characteristic.
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Table 4. Univariate comparisons of operative Risk factors in Patients with superficial or deep 
surgical site infection after spinal surgery.
Preoperative 
Characteristics
N with surgical site infection
Clinical infection Superficial Deep
N (Rate) p-Value N (Rate) p-Value N (Rate) p-Value
Fused levels
-0-1 2 (7.1 %) 1 (3.6 %) 1 (3.6 %)
-2-4 12 (5.0 %) 0.537 10 (4.1 %) 0.887 9 (3.7 %) 0.969
->5 32 (5.7 %) 0.708 14 (2.5 %) 0.727 19 (3.4 %) 0.959
Approach
- Anterior 3 (3.4 %) 1 (1.1 %) 2 (2.3 %)
- Posterior 25 (5.7 %) 0.393 13 (2.9 %) 0.352 17 (3.9 %) 0.472
- A/ P, staged 11 (8.3 %) 0.159 7 (5.3 %) 0.144 7 (5.3 %) 0.285
- A/ P, same day 7 (4.2 %) 0.767 4 (2.4 %) 0.504 3 (1.8 %) 0.790
Procedure
- Osteotomy 29 (5.9 %) 0.647 17 (3.4 %) 0.416 19 (3.8 %) 0.567
- Decompression 15 (4.6 %) 0.437 11 (3.4 %) 0.679 9 (2.8 %) 0.441
Localisation of Surgery
- Cervical 4 (5.8 %) 0.788 1 (1.4 %) 0.714 3 (4.3 %) 0.727
- Thoracic 33 (5.3 %) 0.598 17 (2.7 %) 0.479 21 (3.4 %) 0.667
- Lumbar 40 (5.7 %) 0.683 23 (3.3 %) 0.406 24 (3.5 %) 0.797
- Sacrum 25 (5.4 %) 0.879 15 (3.2 %) 0.838 16 (3.4 %) 1.000
Surgery time 
- 0-2 h 2 (8.3 %) 0 (0.0 %) 2 (8.3 %)
- 2-5 h 12 (6.5 %) 0.759 7 (3.8 %) 0.998 6 (3.2 %) 0.236
- >5h 32 (5.2 %) 0.599 18 (2.9 %) 0.998 21 (3.4 %) 0.217
EBL
- <1 liter 2 (2.5 %) 2 (2.5 %) 2 (2.5 %)
- >1 liter 26 (4.9 %) 0.352 13 (2.5 %) 0.972 15 (2.8 %) 0.857
Attending surgeon
-1 1 (9.1 %) 1 (9.1 %) 0 (0.0 %)
-2 27 (6.1 %) 0.686 12 (2.7 %) 0.240 17 (3.8 %) 0.999
-3 3 (4.0 %) 0.467 1 (1.3 %) 0.169 2 (2.7 %) 0.999
-4 6 (3.5 %) 0.367 4 (2.3 %) 0.218 4 (2.3 %) 0.999
-5 9 (7.0 %) 0.794 7 (5.4 %) 0.619 6 (4.7 %) 0.999
Table 5. Multivariate logistic regression for postoperative wound infection.
Risk factor Odds Ratio(95% confidence interval) p-Value
Obesity 3.13 (1.26-7.75) 0.014
History of SSI 2.98 (1.05-8.50) 0.041
Staged, AP 2.07 (0.95-4.52) 0.068
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Superficial SSI; Sub-analysis showed that 25 patients (3.0 %) had a superficial SSI and 17 
patients (2.0%) had an isolated superficial SSI. Univariate analysis showed that obesity was 
a significant (p=0.029) risk factor for superficial SSI. Also patients of 60-69 years (p=0.039) 
and 70-79 years (p=0.033) had a significantly higher risk for postoperative wound infection. 
However, multivariate analysis showed that only obesity (p=0.013) was an independent 
significant risk factor for SSI (Table 6).
Deep SSI; Twenty-nine patients (3.5 %) had a deep postoperative wound infection. 
No significant risk factors were identified during the univariate analysis. However, we 
performed a multivariate analysis using forward and reverse stepwise regression. During 
this analysis we found that obesity (p=0.064) and procedures performed anterior and 
posterior on separate days (p=0.063) had a tendency to be independent significant risk 
factors (Table 7).
Table 6. Multivariate logistic regression for Superficial postoperative wound infection.
Risk factor Odds Ratio(95% confidence interval) p-value
Obesity 3.82 (1.33-10.97) 0.013
Table 7. Multivariate logistic regression for Deep postoperative wound infection.
Risk factor Odds Ratio (95% confidence interval) p-value
Staged, AP 2.42(0.95-6.18) 0.064
Obesity 2.93(0.94-9.15) 0.063
Discussion
The prevalence of SSI infection within our patients undergoing spinal deformity surgery was 
46/830 (5.0%), which is consistent with the results in published literature,1,3,12,14,17,19,24,30,35 17 
patients (2.0%) had isolated superficial SSIs, and 29 patients (3.5 %) had SSI that extended 
deep into the fascia. As shown in Table 1 only a limited number of patients received their 
primary surgery at the Johns Hopkins hospital, this can be explained since the hospital 
functions as a tertiary care university-affiliated medical centre.
Multiple risk factors for SSI are previously identified. However, most studies included 
a wide variety of patient diagnoses and relatively small numbers of patients. A limited 
sample size often limits the ability of these studies to analyse subgroups or to identify 
potential confounding factors. We previously reported the risk factors for SSIs in a large 
patient cohort (N=3174).27 The univariate analysis showed that the diagnosis of deformity 
was one of the higher risks of SSI. However, this was not confirmed as an independent risk 
factor during the multivariate analysis. As discussed in the Introduction there is a tendency 
for patients with a spinal deformity have a significantly higher incidence of SSI. Therefore, 
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the identification of risk factors would be interesting. In our previous study, we did not 
perform a separate sub-analysis of this group. In our current patient population, patient 
obesity, a prior SSI and same day anterior/ posterior surgery significantly increased the risk 
of SSI while obesity played a key role in predicting superficial SSI.
The finding that obesity is an independent risk factor for SSI was previously described 
in studies of spinal surgery patients.2,6,24,25,36 However it had not been previously described 
within a population of patients with spinal deformity. None of our analyses showed patient 
weight or BMI to be a significant predictor of SSI. Only when patients were categorized as 
being obese (BMI>30) did the risk of SSI increase. In obesity, the subcutaneous fat layer 
increases in thickness. This can result in the need for increased retraction forces during 
surgery to provide exposure. This increased force could lead to increased tissue necrosis 
and thereby an increased risk of SSI. Because of an increased thickness of subcutaneous 
tissue the obese patient is also at risk of the creation of dead space between the fascia and 
the stitches in the skin. This can be controlled by the use of a separate drain in this layer 
to prevent the development of dead space. Preoperative weight loss can also modify a 
patient’s level of obesity but weight loss should be achieved in a balanced matter in order 
to prevent malnutrition which can increase the risk of SSI.15,16,23
Having had a previous surgical site infection was also identified as an independent risk 
factor for SSIs. This is consistent with findings in the literature for general spinal surgery.2,36 
In our study, no significant relationship was found between the history of prior spinal 
surgery and SSI. Therefore, it is not the presence of old scar tissue alone that is responsible 
for the increased risk for SSI. Only the cases with a prior infection in the surgical field 
showed an increased risk of SSI. In theory, bacteria can lie dormant and encapsulated 
in the scar tissue following a SSI. Incising the scar tissue in a previously infected wound 
could release the dormant bacteria and seed into the new wound and lead to a greater 
risk of a SSI. In cases of a prior SSI, perioperative antibiotics should be modified to cover 
any organism previously present and treatment beyond the standard 24 hour prophylaxis 
should be considered.
During the analysis of deep wound infections, no risk factors were identified during the 
univariate analysis; however during the multivariate analysis, surgeries performed anterior 
and posterior on separate days, and obesity were found to show a tendency towards 
being independent significant risk factors. When surgeries performed on the anterior and 
posterior spine, are performed on separate days, the duration of each operative session will 
be shorter than if both surgeries are performed on the same day. Hypothetically, one could 
argue that since each session is shorter then the risk of a SSI would decrease as studies in 
the literature report that a longer operating time results in a significantly increased risk of 
SSI.27 However it is unclear whether the two surgical times in a staged procedure should 
be evaluated separately or combined. When surgery is performed in a staged manner the 
cases are typically performed 5-7 days apart and the patient is exposed to two rounds of 
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anaesthetics and a recovery period between the two surgeries. During this recovery period 
it is typical for the patient to become mal-nourished which has been shown by other authors 
to significantly increase the risk of infection in these staged procedures.10,15 In addition, in 
the Johns Hopkins hospital, spinal surgeries were typically staged when the patients who 
required anterior/ posterior surgery were older than 60 years old or were younger and had 
multiple co-morbid conditions. Hence, an increased risk of infection in this group could 
be expected not only because of the known effect caused by staging a procedure but also 
because the staging procedure was most frequently used in older patients with co-morbid 
conditions. In these high risk patients, staging procedures over a longer period (several 
weeks) to allow nutritional recovery or the use of parenteral hyper-alimentation between 
the procedures might decrease the risk of SSI.
Strength and limitations: Several limitations of this study warrant consideration. Mainly 
due to its (retrospective) nature not all of the data could be obtained since not all of the 
physicians routinely put the same degree of detail in the medical records of each patient. It 
is remarkable that only a limited number of previously identified risk factors were confirmed 
in our study. However since the analysis is performed for patients having a deformity and 
it is performed within a large study group, the outcomes of our study should be applied to 
this patient group.
The definition of SSI was “any postoperative wound that required treatment with oral or 
intravenous antibiotics or surgical debridement with a minimal follow-up of one year”. Using 
this definition and not the widely accepted US Center for Disease Control and Prevention 
and the American College of Surgeons20 definition makes this study less useful for inter-
institutional comparisons (Appendix 1). However, since it is generally known that a SSI 
after spinal surgery can present itself many years after surgery9 one would miss cases of SSI 
by applying this definition.
SSIs were rooted down into deep and superficial. However, in this study a patient could 
have been classified as having both a superficial and a deep SSI. Although not considered 
during the design of the current study, one could argue that when a deep SSI has been 
determined, the presence or absence of signs indicating a superficial SSI is not relevant for 
the clinical decision-making. In fact, there is a lack of evidence regarding the relationship 
between these two entities. Re-classifying patients having both a deep and superficial SSI 
to the deep SSI group, would have resulted in a decrease in the number of patients with a 
superficial SSI (from 25 to 19 (-24%)). Such an alternative approach would have resulted in 
a potentially different outcome.
Another methodological difficulty in conducting retrospective studies in this area 
of research is the identification and documentation of SSI, which is mostly done by the 
treating physician. Measurement bias is possible given the fact that the SSIs were identified 
by the last author. The last author was also one of the five treating orthopaedic spine 
surgeons. However, as shown, we also evaluated the influence of the treating physician in 
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the analysis. This factor was not significantly related to the occurrence of SSIs. This study 
was conducted in a tertiary referral center; therefore, selection bias may have resulted in a 
more complex, and perhaps more infection prone, study population. On the contrary, the 
high volume of patients in this study may have reduced the effects of bias and confounding 
factors. 
Conclusion: In this retrospective cohort analysis of 830 adult patients who underwent 
surgery for a spinal deformity (kyphosis/ scoliosis) 46 patients (5.5%) developed a SSI, 
17 patients (2.0%) had an isolated superficial SSI, and 29 patients (3.5 %) had a deep SSI. 
Obese patients had an increased risk of all types of SSI, while patients who had a prior SSI 
had an increased risk of a recurrent SSI. Anterior/ posterior procedures on the same day 
have a tendency to increase the risk of SSIs. By understanding these findings, protocols can 
be developed to decrease the rate of SSIs in this high-risk population.
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-Chapter 6-
Surgical site infection following osteotomy of the adult 
spine: does the type of osteotomy matter? 
 
 
 
 
Based on: Surgical site infection following osteotomy of the adult spine: does type of 
osteotomy matter? A. Pull ter Gunne, C. van Laarhoven, D. Cohen. The Spine Journal 2010 
May;10(5):410-6.
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Abstract
Study design: Retrospective review of all adult patients who underwent spinal 
osteotomy surgery for deformity by an orthopaedic surgeon in the Johns Hopkins 
hospital.
Objective: To assess the incidence and to indentify significant risk factors for surgical 
site infection (SSI) after spinal osteotomy.
Summary of background data: Surgical site infections (SSI) after spinal surgery is 
frequently seen. It occurs between 0.7 and 12% of patients, leading to higher rates 
of morbidity and mortality and greater health-care costs. Osteotomy procedures are 
known to involve greater blood loss and longer surgical times compared to other spinal 
surgeries. Both of these factors were previously identified as significant risk factors for 
SSI. We performed a cohort study of this high-risk population to identify risk factors 
and rates of SSI after spinal osteotomy surgery and to identify any differences in risk 
between the different types of osteotomy.
Methods: All electronic records of adult orthopaedic patients who underwent a spinal 
osteotomy procedure at the orthopaedic spinal surgery department between January 
1998 and December 2005 (N=363) were abstracted. During surgery a pedicle subtraction 
osteotomy (PSO) (transpedicular wedge resection), an anterior spine osteotomy (ASO) 
(resection of anterior and middle column), a posterior Smith-Peterson osteotomy 
(SPO) (resection of a portion of the superior and inferior lamina, ligamentum flavum 
and the inferior and superior articular process), or a combined anterior and posterior 
osteotomy (VCR) (circumferential resection of the vertebrae via either a combined 
anterior/posterior or a posterior-only approach) was performed. The primary outcome 
measure was SSI. A sub-analysis of deep and superficial SSIs was performed.
Results: A total of 20 (5.5%) patients were found to have a SSI with 9 (2.5%) having deep 
SSIs. The analysis showed that patients undergoing VCR (p=0.042) had a significantly 
greater risk of a deep SSI (11.1%). Obese patients had a significantly greater risk 
(p=0.045) of a superficial SSI. 
Conclusions: The VCR was found to have a significantly greater risk of SSI (11.1%) 
compared to the other types of osteotomy (4.1%) studied. When possible, osteotomy 
techniques that involve less extensive exposures and soft tissue dissection should 
be chosen in order to minimize the risk of a deep SSI risk. Obese patients should be 
counselled on weight loss to try to minimize their risk of a superficial SSI.
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Introduction
Surgical site infection (SSI) is frequently seen after spinal surgery. It can occur in 0.7 to 
12% of patients and leads to higher rates of morbidity and mortality and greater health-
care costs.1,5,13,18-20,26,32,38 During spinal osteotomy procedures bone is taken out to correct 
a deformity of the spine in order to restore sagittal and coronal alignment. Osteotomy 
procedures are known to involve greater blood loss and longer surgical times compared 
to other spinal surgeries. Both of these factors were previously identified as significant 
risk factors for SSI.24,30,39 Over the years, several types of spinal osteotomies have been 
described and currently four principal types of osteotomy are performed in the Johns 
Hopkins hospital.
Smith-Petersen osteotomy (SPO; Figure A): The SPO 
was first described in 1945 by Smith-Petersen.34 During 
this procedure a portion of the superior and inferior 
lamina, the ligamentum flavum, and the inferior and 
superior articular processes are removed bilaterally to 
create a chevron shaped posterior resection. Compression 
is then placed across the posterior spine to shorten the 
posterior column and re-appose the bone surfaces. This is 
only possible if the anterior disc space is mobile and one 
can gain up to 10º of lordosis per level of osteotomy.
Pedicle subtraction osteotomy (PSO; Figure B): This type of osteotomy was first described 
by Thamasen in 1985.36 During this procedure a transpedicular wedge resection of the 
vertebral body is performed. After resection of the bone wedge, the cut bone surfaces are 
re-apposed resulting in shortening of the middle and posterior column. The length of the 
anterior column remains unchanged. This can result in up to 30 to 40º of increased lordosis 
at the level of the osteotomy.
Anterior spinal osteotomy (ASO; Figure C): The ASO is a resection of the anterior and 
middle column of the vertebrae via an anterior approach of the spine (normally trans-
thoracic or retroperitoneal). The ASO is most frequently performed to correct kyphotic 
deformities from either healed burst fractures or compression fractures. Once the 
deformed vertebral body is resected the anterior spine is distracted and reconstructed with 
a structural graft and instrumentation.
Vertebral column resection (VCR; Figure D): The VCR is an osteotomy technique 
during which one resects the anterior, middle and posterior columns of the vertebrae. 
This completely disassociates the spine cranial and caudal to the osteotomy and allows 
sharp angular coronal and sagittal deformities to be corrected. Following correction of 
the deformity the spine is reconstructed using structural grafts and instrumentation. In 
order to safely perform a VCR the circumference of the spine must be exposed via either a 
combined anterior and posterior approach or via a wide posterior exposure with bilateral 
resection of 5-7 cm of ribs over two or more levels.
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In a previous work we identified multiple risk factors for SSI following spinal surgeries. 
During the univariate analysis we found that patients undergoing spinal osteotomy were 
at high risk of (deep-) SSIs.30 However, marked differences in the amount of bleeding and 
soft tissue dissection were found for the different types of spinal osteotomy. The purpose 
of this study was to identify any significant risk factors for SSI in this high-risk population. 
If specific risk factors for SSI can be identified then strategies can be developed to try to 
minimize the risk of infection in this population.
Materials and Methods
After approval from the institutional review board we used an administrative database 
to identify all adult patients who were admitted for adult orthopaedic spine surgery and 
who underwent a PSO, ASO, SPO or VCR osteotomy procedure between January 1998 
and December 2005 in our tertiary care university-affiliated medical centre. The minimal 
follow-up period was 1 year. All patients with infection as their primary diagnosis were 
excluded. All surgeries were performed by one of five fellowship-trained orthopaedic 
spine surgeons. Electronic patient (outpatient and inpatient) records were reviewed to 
identify patient demographics. Operative notes were reviewed to identify the type of 
osteotomy and operative characteristics. Discharge and follow-up notes were reviewed in 
order to identify cases of SSI. During the review of these notes the outcome of all cultures 
(intraoperative and postoperative) was reviewed. A clinically significant SSI was defined 
as: “any postoperative wound that required treatment with oral or intravenous antibiotics or 
surgical debridement”. All of the SSIs were rooted down into deep or superficial. A deep SSI 
was defined as: “any SSI infection with a component beneath the fascia”. Superficial SSI was 
defined as: “any SSI infection with a component above the fascia”. All data were abstracted 
in an electronic database.
During the review of patient demographics and characteristics (age, gender, weight, 
presence of obesity (BMI >30) co morbidities (diabetes (type I and II recorded in patient 
chart), high blood pressure (as recorded in chart), other cardiovascular pathology, current 
active tobacco usage (as recorded in chart), perioperative use of non-steroidal anti-
inflammatory (NSAID) drugs), serum albumin level, serum protein level and serum white 
blood cell count, number of previous spinal surgeries, previous SSI) were recorded. The 
serum albumin level and serum protein level was used to determine nutritional status. 
Where the serum albumin level was <35 g/dL or the serum protein level was <60 g/dL a 
patient was considered to have a poor nutritional status.24,26 The white blood cell count was 
categorized as normal or low. If the total white blood cell count was less than 4500 / mm3 
the patient was considered to have a low white blood cell count. 
The operative notes were reviewed for anatomical location (cervical, thoracic, lumbar 
and/or sacral), surgical approach (anterior, posterior, a combined anterior/posterior 
procedure on the same day, or staged), the type of osteotomy performed (ASO, PSO, SPO, 
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or VCR), estimated blood loss (EBL) categorized into less than or more than 1 liter, number 
of levels fused, and operative time. The operative time was categorized as 0-2 hours, 2-5 
hours and more than 5 hours.
All surgical procedures were performed in the same block of operating room. Sterility and 
air handling characteristics remained unchanged and were monitored by the institutional 
infection control department. The standard surgical site preparation remained unchanged 
during this time frame. The standard surgical site preparation DuraPrep was used. In case 
of iodine allergy, DuraPrepwas replaced by a clorhexidine scrub followed by an alcohol 
wash. Electric clippers were used if hair removal was needed. Antibiotic phrophylaxis 
began at least 30 minutes prior to skin incision. The antibiotics were re-dosed every 4 hours 
or 1500 cc of blood lost during the procedure. Postoperatively every 6 hours for 24 hours 
the antibiotic was re-dosed. First generation cephalosporins were used in all cases. In the 
case of a penicillin or cephalosporin allergy these were replaced by clindamycin when no 
metallic implants were placed and vancomycin when implant placement was planned. 
Statistical analysis: All analysis was performed using the Statistical Packages for Social 
Sciences® v15.0 (SPSS, Chicago, Illinois, USA). Binary logistic regression was used for 
continuous data and Cochran’s and Mantel-Haenszels chi-square tests were used in case 
of dichotomous data. Multivariate logistic regression was performed using significant 
variables found during univariate analysis. Where no significant variables were found 
during univariate analysis those with p<0.10 were included in the multivariate model. 
p-values were considered significant at p<0.05. 
Results
A total of 363 patients were included in this study. The mean age was 55.8 years (±14.9, range 
18-86 years). The majority of patients were female (70.8%). The general characteristics of 
the cohort are summarized in Table 1. The most frequent surgical site was lumbar (89.5%) 
with the posterior approach (57.3%). The most frequently performed type of osteotomy 
was a PSO (272; 57.0 %); 72 VCR’s (18.8 %), 68 SPO’s (18.7 %) and 16 ASO’s (4.4 %) were 
performed. Table 2 summarizes the surgical characteristics. In our cohort, 20 patients 
(5.5%) had a SSI. Sub-analysis showed that 5 patients (1.4%) had an isolated superficial 
SSI, 11 patients (3.0%) had an isolated deep SSI, and 4 patients (1.1%) had a SSI involving 
both the superficial and deep to the fascia.
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Table 1. Preoperative patient characteristics.
N1 N2
Gender 363
-Male 106 (29.2 %)
-Female 257 (70.8 %)
Mean Age, (sd) 55.8 (±14.9%)
Comorbidities 305
-Diabetes 30 (8.3 %)
-Obesity 32 (8.8 %)
-High blood pressure 128 (35.3 %)
-Other cardiovascular pathology 63 (17.4 %)
-Active tobacco use 50 (13.8 %)
-Arthritis 1 (0.3 %)
-Immunosuppressive drugs 39 (10.7 %)
Previous surgery 321
- no 65 (20.2 %)
- One surgery 85 (26.2 %)
-Multiple surgery’s 172 (53.6 %)
Previous SSI 295 29 (9.8 %)
Preoperative laboratory results
- Low preoperative protein 241 10 (2.8 %)
- Low preoperative albumin 241 9 (2.5 %)
N1: Number of patients where presence of risk factor could be determined.
N2: Number of patients with risk factor.
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Table 2. Operative characteristics.
N1 N2
Surgical location 363
- Thoracic 277 (76.3 %)
- Lumbar 325 (89.5 %)
- Sacral 223 (61.4 %)
Approach 363
- Anterior 22 (6.1 %)
- Posterior 208 (57.3 %)
- A/ P, staged 61 (16.8 %)
- A/ P, same day 72 (19.8 %)
Procedure 363
- PSO 207 (57.0 %)
- VCR 72 (19.8 %)
- SPO 68 (18.7 %)
- ASO 16 (4.4 %)
Fused levels 363
-0-1 29 (8.0 %)
-2-4 103 (28.4 %)
->5 231 (63.6 %)
Surgery time: 363
-0-2 h 0
- 2-5 h 54 (14.9 %)
- >5 h 309 (85.1 %)
EBL 261
-Not reported 102
- <1 liter 19 (7.3 %)
- >1 liter 242 (92.7 %)
N1: Number of patients where presence of risk factor could be determined.
N2: Number of patients with risk factor.
SSI: No risk factors were identified during the univariate analysis. Since no significant 
risk factors were identified, diabetes and VCR (both having p<0.10) were included in the 
multivariate model. No significant risk factors were found.
Superficial SSI: During the subsequent sub-analysis of superficial SSIs, obesity (p=0.041) 
and high blood pressure (p=0.011) were identified as being significant risk factors (Table 
3). Multivariate analysis of this finding showed that obesity (p=0.045) was an independent 
significant risk factor for superficial SSI. Within this model, hypertension (p=0.064) was not 
found to be a significant independent risk factor (Table 4). 
Deep SSI: Univariate analysis of the deep SSIs showed that patients who underwent a 
VCR (p=0.042) were at an increased risk of a SSI compared to the other types of osteotomy 
studied. In order to evaluate whether or not VCR was a more difficult type of surgery, we 
analysed whether or not there was any correlation between the amount of blood lost and 
the length of surgery and VCR. However, no correlation was found (p=0.269 and p=0.090). 
Since only one risk factor was found during the univariate analysis no multivariate analysis 
was performed.
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Table 3. Univariate comparisons of individual Risk factors in Patients with SSI, superficial SSI, or deep 
SSI.
Preoperative SSI Superficial SSI Deep SSI
Characteristics N (Rate) p-Value N (Rate) p-Value N (Rate) p-Value
Gender 0.117
-Male 9 (8.5 %) 4 (3.8 %) 7 (6.6 %)
-Female 11 (4.3 %) 5 (1.9 %) 8 (3.1 %)
Comorbidities
-Diabetes 4 (13.3 %) 0.087 2 (6.7 %) 0.180 3 (10.0 %) 0.149
-Obesity 4 (12.5 %) 0.106 3 (9.4 %) 0.041 3 (9.4 %) 0.172
-High blood pressure 10 (7.8 %) 0.325 7 (5.5 %) 0.011 7 (5.5 %) 0.586
-Other cardiovascular pathology 2 (3.2 %) 0.384 1 (1.6 %) 1.000 2 (3.2 %) 0.742
-Active tobacco use 4 (8.0 %) 0.510 3 (6.0 %) 0.622 3 (6.0 %) 0.709
-Arthritis 0 (0.0 %) 1.000 0 (0.0%) 1.000 0 (0.0 %) 1.000
-Immunosuppressive drugs 3 (7.7 %) 0.713 2 (5.1 %) 0.272 3 (7.7 %) 0.401
Previous SSI 3 (10.3 %) 0.173 1 (3.4 %) 0.568 3 (10.3 %) 0.082
Previous surgery
- no 3 (4.6 %) 2 (3.1 %) 1 (1.5 %)
-One surgery 4 (4.7 %) 0.967 3 (3.5 %) 0.868 3 (3.5 %) 0.459
-Multiple surgery’s 10 (5.8 %) 0.718 3 (1.7 %) 0.530 9 (5.2 %) 0.236
Preoperative laboratory results
- Low preoperative protein 0 (0.0 %) 1.000 0 (0.0 %) 1.000 0 (0.0 %) 1.000
- Low preoperative albumin 0 (0.0 %) 1.000 0 (0.0 %) 1.000 0 (0.0 %) 1.000
Surgical location
- Thoracic 18 (6.5 %) 0.180 8 (2.9 %) 0.692 13 (4.7 %) 0.536
- Lumbar 18 (5.5 %) 1.000 8 (2.5 %) 1.000 13 (4.0 %) 0.663
- Sacral 13 (5.8 %) 0.817 7 (3.1 %) 0.491 9 (4.0 %) 1.000
Approach
- Anterior 0 (0.0 %) 0.998 0 (0.0 %) 0.998 0 (0.0 %) 0.998
- Posterior 12 (5.8 %) 0.269 6 (2.9 %) 0.443 9 (4.3 %) 0.479
- A/ P, staged 6 (9.8 %) 0.109 3 (4.9 %) 0.997 4 (6.6 %) 0.310
- A/ P, same day 2 (2.8 %) 0 (0.0 %) 2 (2.8 %)
Procedure
- PSO 10 (4.9 %) 4 (2.0 %) 7 (3.4 %)
- VCR 8 (11.1 %) 0.069 3 (4.2 %) 0.308 7 (9.7 %) 0.042
- SPO 2 (2.9 %) 0.512 2 (2.9 %) 0.624 1 (1.5 %) 0.429
- ASO 0 (0.0 %) 0.999 0 (0.0 %) 0.999 0 (0.0 %) 0.999
Fused levels
-0-1 0 (0.0 %) 0.998 0 (0.0 %) 0.998 0 (0.0 %) 0.998
-2-4 6 (5.8 %) 0.993 2 (1.9 %) 0.574 6 (5.8 %) 0.435
->5 14 (6.1 %) 7 (3.0 %) 9 (3.9 %)
Surgery time: 
- <5h 3 (5.6 %) 0.987 0 (0.0 %) 0.997 3 (5.6 %) 0.571
- >5h 17 (5.5 %) 9 (2.9 %) 12 (3.9 %)
EBL
- <1 liter 1 (5.3 %) 1 (5.3 %) 1 (5.3 %)
- >1 liter 9 (3.7 %) 0.695 3 (1.2 %) 0.208 8 (3.3 %) 0.615
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Table 4. Multivariate logistic regression for Superficial SSI.
Risk factor Odds Ratio(95% confidence interval) p-value
Hypertension 4.18( 0.9-19.0) 0.064
Obesity 8.78 (1.1-13.3) 0.045
Discussion
SSI after spinal surgery is frequently seen. In the literature, the reported incidence of SSI 
ranges from 0.7 to 12%.1,5,13,17-20,26,31,32,38 In the current study we found that our osteotomy 
group had an overall SSI rate of 5.5% varying from 0 to 11.1% depending on the type of 
osteotomy performed. In general, during spine surgery retractors must be placed on 
overlying soft tissues to gain exposure to the underlying spine. Tissue retraction leads to 
decreased blood flow to the surrounding tissue and it can result in foci of tissue necrosis. 
Spinal osteotomy procedures tend to have prolonged surgical times, the prolonged surgical 
retraction can result in increased tissue necrosis and risk of a SSI. A previous study showed 
that prolonged surgical time was an independent risk factor for SSI.39 However, since the 
majority of the osteotomies had surgical times longer than 5 hours we could not determine 
whether or not the length of surgery affected the risk of SSI.
In general, because of the extensive amount of bone work and prolonged surgical time 
osteotomy procedures involve greater blood loss compared to other spinal surgeries. 
These blood losses result in an increased need for blood transfusions. The increased risk 
of SSI with blood transfusions has been seen in both orthopaedic29 and non-orthopaedic 
procedures.6,7,25,35 However, since obligatory blood loss is associated with the resection of 
bone during an osteotomy, it may not be possible to modify this risk factor unless different 
types of osteotomies are associated with different amounts of blood loss.
During the univariate analysis the incidence of deep SSIs was greater in cases of VCR 
than in any of the other types of spinal osteotomy performed in the current series. Each type 
of osteotomy requires a different amount of exposure of the spine with varying degrees of 
soft-tissue dissection. In our ASO group we found no occurrence of SSI. Although the ASO 
group comprised a small cohort (N=16), we previously reported that anterior-only spinal 
surgery showed a much lower risk of SSI than other approaches.30 In the current study 
no SSIs were found in the ASO group and these patients also had a significantly shorter 
operative time and lower blood loss than the other types of osteotomy (Table 5). All of 
the other types of osteotomy performed (PSO, SPO and VCR) included a posterior surgical 
approach to the spine but differed greatly in the amount of exposure required. In the SPO’s 
procedure one only needs to expose lateral to the edge of the facet which is normally already 
exposed for the placement of instrumentation. In the PSO, the bone resection includes 
the posterolateral fusion mass, transverse processes and the lateral walls of the vertebral 
body. This requires lateral exposure, at least to the lips of the transverse processes. In 
order to safely perform a VCR, circumferential exposure of the spine is required via either a 
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combined anterior/ posterior approach or a posterior exposure that includes a wide enough 
exposure so that 5-7 cm of ribs can be resected on both sides to enable the anterior body 
to be safely resected. In this series, the rate of deep SSIs appeared to be correlated with 
the degree of exposure required: ASO (0.0%), SPO (1.5%), PSO (3.4%), and VCR (9.7%) 
(Table 5). We were concerned that the VCR procedure was the most difficult type of surgery 
requiring a longer operation time, and larger blood losses. However, neither blood loss nor 
the length of surgery was correlated with type of osteotomy when VCR was compared 
to all of the other types of osteotomy. Given our findings during the univariate analysis, 
perhaps a more liberal use of PSO’s and SPO’s should be considered than VCR’s for more 
severe deformity corrections.
Table 5. Patient demographics divided into osteotomy type.
ASO SPO PSO VCR
Mean age (SD) 47.9 (±18.4) 60.8 (±15.1) 55.8 (±14.4) 53.0 (±13.9)
Gender
-Male 6 (37.5%) 18 (26.5%) 60 (29.0%) 22 (30.6%)
-Female 10 (62.5%) 50 (73.5%) 147 (71.0%) 50 (69.4%)
SSI (N) 0 2 (2.9%) 10 (4.8%) 8 (11.1%)
Superficial SSI (N) 0 2 (2.9%) 4 (1.9%) 3 (4.2%)
Deep SSI (N) 0 1 (1.5%) 7 (3.4%) 7 (9.7%)
EBL >1 liter* 9 (60.0%) 34 (87.2%) 147 (71.0%) 52 (96.3%)
Surgical time >5 hours 0 58 (85.3%) 185 (89.4%) 66 (91.7%)
*Not in all cases the EBL was known, therefore the percentage is calculated using the total number 
of cases with known EBL.
During the analysis to identify independent risk factors for superficial SSIs, obesity was 
found to be a significant factor. The World Health Organization estimated that there were 
at least 400 million obese adults worldwide in 2005, and this number will increase to 700 
million in 2015.40 Obesity is a known risk factor for SSIs in general spine surgery.4,8,23,26,27,39 
It also leads to increased morbidity or adverse outcomes in other patient groups,28,33 and 
it increases the risk of SSIs after non-spinal surgery.10,21 In general, obese patients have 
a thicker subcutaneous tissue layer with a greater need for retraction in order to expose 
the spine. Surgical times can also be prolonged because of difficulties in dealing with the 
soft tissue. The duration of surgery and thus the length of time that retractors are used is 
also significantly increased in obese patients, which results in an increased risk of tissue 
necrosis.37 Careful debridement and irrigation of soft tissue may help to modify this risk. 
The thick subcutaneous layer can increase the risk of a large dead space when closed. 
Separate drainage of this layer may help to prevent the development of a dead space and 
it has been shown to decrease the risk of late SSIs.14 Obesity should be taken into account 
during a patient’s evaluation before surgery. It should be discussed with the patient that 
he or she has a significantly higher risk of superficial SSI. It is known within gastric bypass 
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surgery that preoperative weight loss does not decrease complication rates.2,3 However, 
it is important that weight is lost in a balanced manner since malnutrition has also been 
previously described as a risk factor for SSI. Therefore, delaying spinal surgery until weight 
has been lost may be preliminary on these results
Limitation of this study: The main limitation of this study is that it was a retrospective 
cohort study. The design of the study meant that incomplete patient data were included, 
even though electronic patient records were used. The utilized definition of a SSI was 
“any postoperative wound that required treatment with oral or intravenous antibiotics or 
surgical debridement with a minimal follow-up of 1 year”. Using this definition and not the 
widely accepted US Center for Disease Control and Prevention and the American College 
of Surgeons (Appendix 1)22 definition makes this study less useful for inter-institutional 
comparisons. However, since it is generally known that a SSI after spinal surgery can present 
itself many years after surgery11 one would miss cases of SSI by using this definition.
SSIs were rooted down into deep and superficial. However, in this study a patient 
could have classified as having both a superficial and a deep SSI. Although not considered 
during the design of the current study, one could argue that when a deep SSI has been 
determined, the presence or absence of signs indicating a superficial SSI is not relevant 
for clinical decision-making. In fact, there is a lack of evidence regarding the relationship 
between these two entities. Re-classifying patients having both a deep and superficial 
SSI to the deep SSI group, would have resulted in a decrease in the number of patients 
with a superficial SSI (from 9 to 5). Such an alternative approach would have resulted in a 
potentially different outcome.
Within this study four types of osteotomy were compared in terms of their infection 
rate. During the univariate analysis for a deep SSI the VCR was found to be a significant risk 
factor for deep SSIs. However no multivariate analysis was performed. Previous research 
studies (Appendix 2) identified multiple risk factors for SSI. After publication the authors 
considered that the results of this study might be biased. By performing a stepwise forward 
and backward logistic regression analysis one might find that the factor identified during 
univariate analysis (VCR) might not be the true risk factor. For example, there could be 
a correlation between a VCR and the approach since it is known that a staged anterior/ 
posterior procedure has a significantly increased risk of SSI than an anterior/ posterior 
procedure performed on the same day.9,12,16 As stated in the Introduction and a published 
supplementary commentary by Hu15 the different types of osteotomy have different 
characteristics. For example, patients with a lower amount of deformity are usually treated 
by PSO compared to patients with major deformities who are treated with VCR. In some 
cases, VCR can be replaced by PSO’s and SPO’s. Therefore, one might consider this change 
in osteotomy, performing PSO’s or SPO’s at multiple sites instead of one VCR. However, by 
performing multiple PSO or SPO, previously identified risk factors may arise (for example 
longer surgical time and greater blood loss) and therefore decrease the advantage of 
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osteotomy change, resulting in the same risk of SSI as one VCR was performed. In our 
study it was possible for one patient to have more than one osteotomy performed during 
surgery. However we did not include the number of osteotomies performed. By not 
including this variable in a multivariate analysis a different factor than the true risk factor 
might be identified. Blood loss and surgery time was analyzed dichotomous, during sub-
division the majority of the patients were divided in one group. During the subsequent sub-
analysis we did not found any correlation between the type of osteotomy and estimated 
blood loss or length of surgery. If continuous data or more sub-divided data were used, a 
more equal distribution of patients might have resulted, leading to different associations. 
Conclusion: The risk of SSI following spinal osteotomy is significant (5.5%), but it is 
also directly related to the type of osteotomy performed, with VCR having a significantly 
higher risk of infection than ASO, PSO, or SPO. As in all spinal surgeries, obesity increases 
the risk of superficial SSIs. Care should be taken to encourage preoperative weight loss 
and to choose the best type of osteotomy that will correct a deformity correction while 
minimizing the risk of SSI for each patient.
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Abstract
Study design. Methodological systematic review.
Objective. To critically appraise the validity of risk factors for surgical site infection (SSI) 
following spinal surgery.
Summary of background data. Surgical site infections (SSIs) lead to higher morbidity, 
mortality and increased health-care costs. Understanding which factors lead to an 
increased risk of SSI is important for the development of prophylactic protocols to 
counter this risk. To date, however, no review appraising the methodological quality of 
studies evaluating risk factors for spinal SSIs has been published. 
Methods. Contemporary studies identifying risk factors for SSI following spinal 
surgery were searched through the Medline and EMBASE databases (January 2001 
to December 2010). References were retrieved and bias-prone study features were 
abstracted individually and independently by 2 authors.
Results. Twenty-four eligible studies were identified, including 9 (nested) case-control 
studies and 15 case series. Included studies covered wide variations of indications 
and surgical procedures. A total of 73 different types of factors were evaluated for the 
risk of a SSI of which 34 (47%) were reported to be significantly related in at least one 
study. Only the following risk factors: diabetes mellitus, obesity and previous SSI were 
confirmed more often (n=11, 8, 3, respectively) as a significant risk factor for SSI than 
they were disproved (n=7, 6, 1, respectively). Various sources of heterogeneity were 
observed, including patient selection, selection and analysis of putative risk factors 
and definitions of SSI outcomes.
Conclusion. There is an abundance of conflicting data on risk factors for SSI following 
spinal surgery. Given various sources of heterogeneity observed in observational 
literature, there is a paucity of solid evidence for the proof of robust risk factors. The 
authors recommend the introduction, validation and use of a standardised set of 
strongly justified eligibility criteria and well-defined candidate risk factors and spinal 
SSI outcomes.
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Introduction
Spinal surgery can be complicated due to the occurrence of a surgical site infection (SSI). 
A SSI occurs between 0.7 to 12% of spinal surgery patients and leads to higher morbidity, 
mortality, and increased health-care costs.4,7,19,23,24,28,34,42,53 To decrease the risk of a SSI, 
disinfected surgical equipment is utilized and antibiotics are administered perioperatively.43 
In addition to these prophylactic strategies, studies have been performed to identify pre-, 
per-, and postoperative factors for their risk on the occurrence of a SSI following spinal 
surgery. These efforts led to the identification of a variety of risk factors (Appendix 3).
Schuster and colleagues46 recently published a systematic review on risk factors for SSI 
after spinal surgery. Risk factors were listed and the levels of evidence (LoE) of included 
studies were presented.55 Despite the fact that all included studies that evaluated risk 
factors for SSI were based on retrospective data collection, eight studies were rated as 
LoE grade II and three studies were rated LoE grade III as they did not control for putative 
confounders.46
Although adjustment for confounders is crucial in observational studies evaluating risk 
factors for SSI, other methodological study features may also impose a profound impact 
on a study’s validity. Details such as indications for surgery, types of surgical procedures 
and applied definitions of candidate risk factors and SSI outcomes may all interfere with 
the risk attributed to the variables under study. Although the LoE grading system gives 
the reader a prompt understanding of the applied study design, it does not provide the 
necessary details for the judgment of a study’s validity.36 Therefore, also the conduct and 
reporting of applied methodological safeguards require assessment.
For such a purpose, the ‘Strengthening the Reporting of Observational Studies in 
Epidemiology’ (STROBE) statement offers valuable guidance.52 The STROBE statement 
was introduced to improve the quality of reporting in observational studies. Moreover, as 
an intended side-effect, the STROBE committee aimed to increase doctors’ awareness of 
the importance of methodological study features for the judgment of a study’s validity. This 
awareness would not only lead to an increased quality of reporting, but also to an improved 
quality of observational studies’ design and conduct. Eventually, such improvements 
may lead to an increased homogeneity (i.e., comparability) and validity of similar future 
prognostic, non-randomized studies
Along with Schuster et al.,46 a number of literature reviews on risk factors for spinal 
SSIs have been published previously.11,15,35,44,56 However, none of these reviews performed 
an extensive critical appraisal of studies’ overall quality and validity. The aim of the current 
systematic review of contemporary literature was to critically appraise the validity of 
previously identified risk factors for SSI following spinal surgery.
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Materials and methods
Search Strategy & Study Eligibility Criteria; In order to identify contemporary and relevant 
articles on risk factors for SSI following spinal surgery, we conducted a computerized 
search using the Medline and EMBASE (January 2001 to December 2010) databases. 
The syntax used for Medline, PubMed interface was: (surgery[text word] OR surgical[text 
word] OR prevention[text word] OR prophylaxis[text word] OR antibiotic*[text word]) AND 
(spine[text word] OR spinal[text word]) AND infection[text word] AND (“2001/01/01”[PDAT] : 
“2010/12/31”[PDAT]). The syntax used for EMBASE was: (surgery OR surgical OR prevention 
OR prophylaxis OR antibiotic$) AND (spine or spinal) AND infection AND 2001:2010.(sa_
year). The initial screening for eligibility included the following two criteria. The study 
had to consist of a clearly defined group of adult patients who underwent spinal surgery. 
In addition, the study’s objective had to be identification of risk factors for SSI. Studies 
including pediatric patients (<18 years old) were excluded. Articles published in languages 
other than English and articles without an abstract were also excluded.
Data Abstraction; Titles and abstracts were first screened, potentially relevant articles 
and reports were then retrieved and evaluated individually and independently by 2 authors 
(JJvM, AFPtG) using Endnote X2 software (Thompson Reuters, Carlsbad, CA, USA). A 
manual cross-reference search of the citations of each included and relevant literature 
review was performed to ensure no relevant studies were missed by the database search. 
In each phase, and in all cases, disagreement concerning inclusion of articles was resolved 
by discussion and consensus agreement. To counter review bias, an independent third 
observer (AJFH) - who had not published in the field of SSI before - was consulted to 
evaluate manuscripts published by co-authors of this manuscript. Data were entered into 
Excel 2007 (Microsoft, Redmonds, WA, USA) and reviewed for errors prior to analysis.
Critical Appraisal; Critical appraisal of included articles was performed to examine 
studies’ validity. The following standard study characteristics were recorded: study 
design, method of data collection, level of spinal surgery covered by a study, intervention 
details, number of patients and age of study population. Based on items covered by the 
STROBE statement52 we abstracted the reporting of following bias-prone features from 
the included studies: study setting, period of investigation, eligibility criteria, method of 
patient/case identification, evaluated risk factors and their definition, method of data 
retrieval, indications for spinal surgery, applied surgical approaches, the use of prophylactic 
strategies, applied SSI definition, and reporting of patient follow-up details. More 
specifically, statistical approaches were abstracted. Special attention was paid to the use 
and reporting of multivariate regression techniques and the consideration and selection of 
putative confounders in these analyses. 
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Results
Search and Screening Results; The computerized search strategy resulted in 6739 citations; 
Medline 2157/ EMBASE 4582 (Appendix 5). After screening of titles and abstracts, 106 
studies were reviewed for full-text screening. 65 articles were excluded during full-
text screening. The most frequent reasons for exclusion were: no effect evaluation of 
prognostic or therapeutic factors, inclusion of pediatric patients, and combined analysis 
of SSI with other infections. No additional references were identified by cross-reference 
checks. Finally, 17 studies specifically evaluated the efficacy of prophylactic treatments for 
SSI instead of risk factors and were therefore included in the second part of this literature 
review project.1 This resulted in a total number of 24 included articles in the current 
review.5,8,9,12,13,17,18,22,25-27,30,32,34,37-41,45,47,51,54
Study characteristics; 21 out of the 24 studies (88%) were based on retrospective data 
collection and included 6 case-control studies (25%), 13 case series (54%) and 2 nested 
case-control series (8%). The remaining 3 studies (13%) were prospective; 2 case-series 
(8%) and 1 case-control study (4%). Fourteen studies (58%) reported the spinal levels under 
study: the cervical spine was operated on in 8 studies, thoracic spine in 13, lumbar spine in 
13 and the sacral spine was operated on in 8 studies. The number of total study subjects 
ranged from 45 to 24,774. A detailed description of age characteristics (mean and range) 
was provided in 8 studies (33%, Table 1).
Reporting of general bias-prone issues; The setting (i.e. type of hospital (e.g. university 
hospital, referral centre) and/or population details) and timeframe in which the study 
took place were described in 12 (50%) and 24 studies (100%), respectively (Table 2). The 
method of patient/case identification was reported in 17 studies (71%). The hospital’s 
infection control surveillance records were used as case identification method in 7 out 
of 17 studies.5,8,9,18,30,34,47 Review of all patient records was performed in the remaining 12 
studies (50%).13,17,25,32,37-41,45 The method of data retrieval was reported in 19 studies (79%). 
Surveillance records, patient records, questionnaires and the veterans affairs’ national 
surgical quality improvement program database were the applied and reported methods 
of data retrieval in prospective studies.18,51 Medical chart review was performed in all 
retrospective studies.
Eligibility criteria were reported in 20 studies (83%, Table 3). Surgical characteristics, 
including elective and emergency surgery, type of surgical procedure, anatomic location 
and the amount of blood loss during surgery were applied as eligibility criteria in 12 out 
of 20 studies. Age was applied as an eligibility criterion in 7 studies. Four out of 20 studies 
included patients with a prior SSI,17,37,39,40 one study applied previous spinal infection as an 
exclusion criterion (Table 3).13
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Table 1: Study characteristics (24 studies).
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Apisarnthanarak et al.5 CCS Retro NR 13 64 (30–85)* 47 56 (24-84)*
Banco et al.8 CS Pro NR 72 NR 1324 NR
Boston et al.9 CCS Retro NR 55 44 (31–73)* 179 45 (22–77)*
Chen et al.13 CS Retro ThL 27 NR 168 NR
Chen et al.12 CS Retro S 16 49.6 (18-78) † 29 49.6 (18-78) †
Demura et al.16 CS Retro C,T,L 8 56 (32–72)*, † 105 56 (32–72)*, †
Fang et al.17 CCS Retro NR 43 47.8 (NR) 77 40.0 (NR)
Friedman et al.18 CCS Pro C,T,L,S 41 53 (30-85) 82 51 (21-85)
Kanafani et al.22 NCCS Retro NR 27 59 (19-80) 54 47 (17-77)‡
Kuo et al.25 CS Retro NR 30 64.1 (NR) 3200 59 (NR)
Lee et al.26 CS Retro NR 15 72.1 (65-NR)† 340 72.1 (65-NR) †
Liao et al.27 CS Retro NR 6 NR§ 331 NR§
Maragakis et al.30 CCS Retro NR 104 59.4 (NR)* 104 50.6 (NR)*
Mastronardi et al.32 CS Retro C,T,L 9 NR 964 NR
Olsen et al.34 CCS Retro C,T,L,S 41 54.3 (17-84)‡ 178 52.9 (18-83)
Pull ter Gunne et al.37 CS Retro C,T,L,S 132 55.6 (NR) † 3042 55.6 (NR) †
Pull ter Gunne et al.39 CS Retro C,T,L,S 46 55.4 (NR) † 784 55.4 (NR) †
Pull ter Gunne et al.38 CS Retro C,T,L,S 14 55.1 (NR) † 286 55.1 (NR) †
Pull ter Gunne et al.40 CS Retro T,L,S 20 55.8 (NR) † 343 55.8 (NR) †
Rechtine et al.41 CS Retro T,L 12 36 (18-64) 105 NR
Schimmel et al.45 NCCS Retro T,L,S 36 51 (NR) 135 48 (NR)
Schwarzkopf et al.47 CCS Retro T,L 61 56 (NR) 71 53 (NR)
Veeravagu et al.51 CS Pro NR 752 NR§ 23992 NR§
Willems et al.54 CS Retro C,T,L 17 46.1 (21-82) † 98 46.1 (21-82) †
Abbreviations and Symbols.
CS: Case series, CCS: Case-control study, NCCS: Nested case-control study, Pro: Prospective, 
Retro: Retrospective, NR: Not reported, C: Cervical, T: Thoracic, L: Lumbar, S: Sacral, Y: Yes, N: No, 
*: Median age, †: No subgroup details were provided, ‡: study was included despite minimum age 
of 17 years, §: Other values than mean or median age were reported.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
A methodological systematic review on surgical site infections following spinal surgery. Part 1
99
Table 2: Reporting of bias prone issues for the evaluation of risk factors for SSIs after spinal surgery 
(24 studies).
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Apisarnthanarak et al.5 + + + + - - + + + -
Banco et al.8 + + + - + - - + + + 30/-/-
Boston et al.9 + + + + + - + + + -
Chen et al.13 - + + + + - + + + + 12/30/60
Chen et al.12 - + - + + + + + + + -/-/-
Demura et al.16 - + - - - + + - + -
Fang et al.17 - + + + + - - - + -
Friedman et al.18 + + + + + - + + + -
Kanafani et al.22 + + - - - - - + + -
Kuo et al.25 + + + - + + + - - -
Lee et al.26 - + - - + - + + + -
Liao et al.27 - + - + + + + + + + 12/33/68
Maragakis et al.30 + + + + + - + + + -
Mastronardi et al.32 - + + + + + - + + + 12/-/-
Olsen et al.34 + + + + + - + + + -
Pull ter Gunne et al.37 - + + + + + + + + + 12/-/-
Pull ter Gunne et al.39 + + + + + + + + + + 12/-/-
Pull ter Gunne et al.38 + + + + + + + - + -
Pull ter Gunne et al.40 - + + + + - + + + + 12/-/-
Rechtine et al.41 - + + + + + + - - -
Schimmel et al.45 + + + + - + + + + -
Schwarzkopf et al.47 - + + + + - + + + -
Veeravagu et al.51 + + - + + + + - + + -/-/1
Willems et al.54 - + - + + + + - - + -/-/12
Abbreviations and Symbols.
Y: Yes, N: No, +: Reported, -: Not reported, *: Includes type of hospital (eg. University hospital, 
referral centre) and/or population details (eg. hospital service area), †: Methods include use of 
administrative database, evaluation of consecutive series, etc., ‡: Methods include chart review, 
use of case report forms, etc.., §: See Table 3, ||: See Table 4, ¶: See Table 5 & Web table 1.
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Table 3: Reporting of eligibility criteria for the evaluation of risk factors for SSIs after spinal 
surgery.
Study Cr
it
er
ia
 re
po
rt
ed
Pa
tie
nt
 a
ge
Pa
tie
nt
 c
ha
ra
ct
er
is
tic
s
Pr
im
ar
y 
su
rg
er
y 
pe
rf
or
m
ed
 e
ls
ew
he
re
Pr
ev
io
us
 s
pi
na
l s
ur
ge
ry
Pr
ev
io
us
 s
pi
na
l S
SI
In
di
ca
tio
n 
su
rg
er
y
Su
rg
ic
al
 c
ha
ra
ct
er
is
tic
s 
*
Tr
ea
ti
ng
 s
ur
gi
ca
l t
ea
m
/ d
ep
ar
tm
en
t †
N
o 
ac
tiv
e 
no
n 
sp
in
al
 in
fe
ct
io
n 
pr
es
en
t
Ty
pe
 o
f A
B
P
 re
gi
m
e 
‡
M
is
si
ng
 d
at
a/
 lo
ss
 to
 fo
llo
w
-u
p
O
th
er
Apisarnthanarak et al.5 N
Banco et al.8 Y - - - - - - - + - - - -
Boston et al.9 Y - - - - - - + - - - + -
Chen et al.13 Y + - - + + + + - - + + -
Chen et al.12 Y - § - - - + + - - - - -
Demura et al.16 N
Fang et al.17 Y + - - - - - - - - - - -
Friedman et al.18 Y - - - - - - + - - - - -
Kanafani et al.22 N
Kuo et al.25 Y - - - - - + - - - - - -
Lee et al.26 Y + ||,¶, **, Ω - - - - - - + - - +
Liao et al.27 Y - - - - - - + + - - + -
Maragakis et al.30 Y + - - - - + + - - - - -
Mastronardi et al.32 Y - ∞ - - - + - - - - - -
Olsen et al.34 Y - - - - - + + - - - + -
Pull ter Gunne et al.37 Y - - - - - - - + - - + -
Pull ter Gunne et al.39 Y + - - - - + - - - - - -
Pull ter Gunne et al.38 Y + - - - - - + - - - - -
Pull ter Gunne et al.40 Y + - - - - + + - - - - -
Rechtine et al.41 Y - - - - - + + - - - - -
Schimmel et al.45 N
Schwarzkopf et al.47 Y - - + + - - + - + - - -
Veeravagu et al.51 Y - α - - - - - - - - - -
Willems et al.54 Y - - - - - + + - - - - -
Abbreviations and Symbols.
Y: Yes, N: No, +: Reported and applied as eligibility criterion, -: Not reported/applied as eligibility 
criterion, *: Type of surgical procedure (elective and emergency surgery), anatomical location, 
amount of blood lost during surgery. †: orthopaedics/ neurosurgery/ specific surgeon, ‡: ABP: 
Antibiotic prophylaxis, §; Pre-operative embolisation of arteries, ||: Gender, ¶: Use of preoperative 
Indwelling bladder catheter, **: Mental status, Ω: Symptoms of UTI, ∞: Allergies to antibiotics, α: 
Veteran status.
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Reporting of surgical indications and procedures; Indications for surgery and performed 
surgical procedures were reported in 12 (50%) and 20 (83%) studies, respectively. 
Degenerative stenosis and tumor, both reported in 6 studies, were the most frequent 
indication for spinal surgery. The most frequently performed surgical procedures were 
spinal fusion in 14 out of 20 studies and spinal decompression/laminectomy in 12 out of 
20 studies. Surgical decompression, fusion and spinal instrumentation were all reported as 
standalone as well as combined procedures (Table 4).
Reporting of applied SSI definition; Applied definitions and/or features of SSI were 
reported in 17 studies (71%, Table 5). 12 studies (50%) reported a distinction between 
superficial and deep SSI. 10 out of 17 studies reported the use of the Centers of Disease 
Control and Prevention (CDC) definition of a SSI (Appendix 1).29. Other reported criteria 
of a SSI included findings from anamnesis, physical examination, additional tests (blood, 
cultures and/or radiographic) and applied treatment. Seven studies reported one or more 
criteria that were required to be present for the diagnosis of SSI; pus and/or purulent 
discharge from the wound were present in SSI cases in 3 studies; a positive wound culture 
combined with positive MRI findings were present in cases in 2 studies, and antibiotic or 
surgical treatment was applied as a required criterion for SSI in 4 studies (Table 5).
Reporting of applied statistical techniques and follow-up; Applied statistical techniques 
were reported in 21 studies (88%, Table 2). Univariate analysis was performed in 20 studies, 
multivariate analysis was performed in 16 out of 21 studies. In 15 out of 16 studies the 
multivariate analysis was performed following univariate analysis.8,9,12,13,16,18,30,34,37-40,45,47,51 
Criteria for candidate variables to enter multivariate analysis were presented in 12 out of 16 
studies.8,9,12,13,16,18,30,34,37,39,40,45 Nine out of these studies reported variables that were found to 
be significantly related to the occurrence of a SSI in univariate analysis were entered in the 
multivariate model.9,16,18,30,34,37,39,40,45 In one study9 p<0.25 was applied as an entry criterion, 
in 6 studies16,34,37,39,40,45 p<0.20 and in 2 studies18,30 p<0.10 was applied as an entry criterion. 
In addition to significant variables from the univariate analyses, 3 studies also entered 
variables that were identified in literature and/or guidelines to the multivariate analysis.9,34,45 
Entry criteria for the multivariate analysis were not reported in 7 studies.8,12,13,26,38,47,51
Follow-up details were presented in 10 studies (42%) and in 2 studies (8%) a complete 
description of the minimum, mean and maximum follow-up period was reported (Table 
2).13,27 
Reporting of analyzed potential risk factors and their definition; All candidate risk factors 
for SSI that were evaluated in the included studies were abstracted. Table 6 represents a 
categorized overview of all variables. A complete table of all specific risk factors that have 
been evaluated for the risk of developing a SSI is presented in Appendix 7. In the included 
studies, 73 different types of variables were evaluated for the risk of a SSI. In total, 34 
variables (47%) were reported to be significantly related in one or more studies, of which 11 
variables (15%) were confirmed in two or more studies (Table 6).
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Table 4: Reported indications for spinal surgery and types of surgical procedures.
Indications spinal surgery Surgical procedures
Study
R
ep
or
te
d?
Tr
au
m
a
D
ef
or
m
ity
D
eg
en
er
at
iv
e 
st
en
os
is
Sp
on
dy
lo
lis
th
es
is
D
is
c 
di
se
as
e
Tu
m
or
A
nk
yl
os
in
g 
sp
on
dy
lit
is
O
th
er
R
ep
or
te
d?
D
ec
om
pr
es
si
on
/ 
La
m
in
ec
to
m
y
Fu
si
on
In
st
ru
m
en
ta
tio
n
D
is
ce
ct
om
y
O
st
eo
to
m
y
Tu
m
or
 re
se
ct
io
n
O
th
er
Apisarnthanarak et al.5 N Y +S, +C +C +C - - - -
Banco et al.8 N N
Boston et al.9 N Y +S +S - - - - NOS
Chen et al.13 N Y - +S - - - - -
Chen et al.12 Y - - - - - + - - Y - - - - - + +
Demura et al.16 Y - - - - - + - - Y - - - - - + +
Fang et al.17 N N
Friedman et al.18 N Y +S - - - - - -
Kanafani et al.22 N N
Kuo et al.25 Y + + + + - - - + Y +S, +C - - - - - +
Lee et al.26 N Y +S +C +C +S - - -
Liao et al.27 Y - - + + - - - - Y - +S - - - - -
Maragakis et al.30 N Y +S, +C +S, +C - - - - -
Mastronardi et al.32 Y + - + - + + - - N
Olsen et al.34 N Y +S, +C +S, +C - - - - -
Pull ter Gunne et al.37 Y + + + - + + + + Y +S +S, +C +C +S + - +
Pull ter Gunne et al.39 Y - + - - - - - - Y +S +S - - + - -
Pull ter Gunne et al.38 Y - + + - + + - + Y +S +S, +C +C +S + - +
Pull ter Gunne et al.40 N Y - - - - + - -
Rechtine et al.41 Y + - - - - - - - Y - +C +C - - - -
Schimmel et al.45 Y - + + + - + - + Y - +S, +C +C - - - -
Schwarzkopf et al.47 N Y +S, +C +S, +C - +S, +C - - NOS
Veeravagu et al.51 Y - - - - - - - +* Y +S, +C +S, +C +S, +C - - - -
Willems et al.54 Y - - - - - - + Y - - - - + - -
Abbreviations and Symbols.
Y: Yes, N: No, +: Reported, +S: Standalone treatment, +C: Part of combined treatment, NOS: Not 
otherwise specified. *: A list of 21 ICD-9 codes was reported, †: No subgroup details were provided, 
‡: Other values than mean or median were reported.
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Table 5: Applied SSI definitions.
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Apisarnthanarak et al.5 Y N Y
Banco et al.8 Y N Y
Boston et al.9 Y N Y
Chen et al.13 Y Y N D,S Y
Chen et al.12 Y N N - - - - - - - - - - - + - + -
Demura et al.16 N Y N D -
Fang et al.17 N N
Friedman et al.18 Y N Y
Kanafani et al.22 Y N Y
Kuo et al.25 N Y Y D
Lee et al.26 Y N N + - - + - + - +† + - + - - - -
Liao et al.27 Y N N - - + - + + - - - - - + - - -
Maragakis et al.30 Y N Y
Mastronardi et al.32 Y Y N D,S N - + - - - + + +‡ + + - + + - -
Olsen et al.34 Y N Y
Pull ter Gunne et al.37 Y Y Y D,S N - - - - - - - - - - - - - + +
Pull ter Gunne et al.39 Y Y Y D,S N - - - - - - - - - - - - - + +
Pull ter Gunne et al.38 N Y N D,S
Pull ter Gunne et al.40 Y Y Y D,S N - - - - - - - - - - - - - + +
Rechtine et al.41 N N
Schimmel et al.45 Y Y Y D Y§
Schwarzkopf et al.47 Y Y Y D,S Y
Veeravagu et al.51 N Y N D,S
Willems et al.54 N Y N D,S
Abbreviations and Symbols.
Y: Yes, N: No, D; Deep, S; Superficial, *: See Panel 2 CDC SSI definition, †: Persistent elevation or 
second rise of CRP about a week after the surgery, ‡: ESS (not further specified), §: CDC definition 
and the Dutch national PREZIES guidelines.
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Table 6: Categorized variables assessed for the risk for SSIs after spinal surgery.
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Patient characteristics
Age† U - M M M M U M U NR - - M - M M M - - - M - M -
Gender U - M M M M U M U - - - M - M M M - M - M M M -
Race† U - - - - - - M - - - - M - - - - - - - - - M -
Workers compensation - - M - - - - - - - - - - - - - - - - - - - - -
Height - - - - - - - - - - - - - - - - - - - - M - - -
Previous spinal surgery† U - M - - M U M U - M - M - - M M - U - M - - -
Previous non-spinal surgery - - - - - - - - - - - - - - - - - - - - - M - -
Previous surgery (NOS) - - - - M - - - - - - - - - - - - - - - - - - -
Previous spinal infection/ ssi - - - - - - U - - - - - - - - M M - M - - - - -
Smoking† U - M M M - U - - - M - M - M - M - M - M M M -
Alcohol use/ abuse† - - - - M - U - - - - - - - - - - - - - - M M -
Immunosuppressive drugs† U - - - - M U - - - M - - - M - M - M - - M M -
Co-morbidities
Co-morbidities† - - M - - - - - - - - - - - - - - - - - M - - -
Obesity/ BMI/ weight† U - M M M - U M - - - - M - M M M - M - M M - NR
Diabetes Mellitus† U - M M M M U M U NR M U M - - M M - M - M M M -
(Rheumatoid) arthritis - - - - - - - - - - - - - - - - - - M - M - - -
Cardiovascular disease † - - - - - - - - - - - - M - - M M - M - M M - -
Pulmonary disease† - - - - - - - - - - - - - - - - - - - - M - - -
(Asymptomatic) Urinary tract 
infection
- - - - - - - - - - M - - - - - - - - - - - - -
Urinary incontinence - - M - - - - - - - - - - - M - - - - - - - - -
(In-)Complete neurological deficit† U - - - - M - - - - - - - - M - - - - NR - - - -
Functional status - - - - - - - - - - - - - - - - - - - - - - M -
Karnofsky score - - - - - - - - - - - - M - - - - - - - - - - -
ASA risk class U - M M - M - M - - - - M - M - - - - - - - M -
NNIS risk index score - - - - - - - M - - - - - - - - - - - - - - - -
Malignancy U - - - - - - M - - - - - - - - - - - - - - M -
Neoadjuvant therapy 0 - - - M M - - - - - - - - M - - - - - - - - -
Tumor size - - - - M - - - - - - - - - - - - - - - - - - -
History of weight loss - - - - - - - - - - - - - - - - - - - - - - M -
Other - - - - - - - - - - - - - - - - - - - - - - M -
Anesthesiology variables
Use of Propofol U - - - - - - - - - - - - - M - - - - - - - - -
Ventilation and oxygenation 
characteristics†
- - - - - - - - - - - - M - - - - - - - - - - -
Body temperature† U - M - - - - - - - - - M - M - - - - - - - - -
Intraoperative fluid infusion rate - - - - - - - - - - - - M - - - - - - - - - - -
Use of clotting agents U - - - - - - - - - - - - - - - - - - - - - - -
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
A methodological systematic review on surgical site infections following spinal surgery. Part 1
105
Surgical variables
Indication for surgery† - - - - - - - - U - - - U - M - - - - - - - -
Date of surgery - M - - - - - - - - - - - - - - - - - - - - - -
Operating room personnel† U U M - M - - M - - - - - - - - M - - - - - - -
Specific operating room - - M - - - - - - - - - - - - - - - - - - - - -
Timing of surgery - - - - - M - - - - - - M - - - - - - - - - M -
Hair removal† U - M - - - - - - - - - M - - - - - - - - - - -
Use of anti-sepsis† U - M - - - - - - - - - - - - - - - - - - - -
Prophylactic antibiotics† U - M M - - - M U - - - M - M - - - - - - - - -
Anatomical approach surgery† - - - - - - - - - - - - M - M M M - M - M - - -
Type of surgery procedure† U - M - M M U M U NR M - M - M M M - M - - - - -
No. of surgeries performed - - M - - - - - - - - - - - - - - - - - - - - -
Duration surgery† U - M M M M U M U - - - M - M M M - M - M - - -
Estimated blood loss† - - - M M M U - - - - - - - - M M - M - - - - -
Spinal level of surgery† U - - - - - U M - NR M - M - M - M - M - M - - -
No. of spinal levels operated† - - - - - - - - - - - - - - M M M - M - - - - -
Type of graft usage U - - M - - U - - - - - - - - - - - - - M - - -
Dural tear /CSF leak/use of glue U - - - - - - - - - - - M - - - - - - - - - - -
Use of operation microscope - - - - - - - - - - - - - - M - - - - - - - - -
Closed-suction drains U - - M - - - - - - - - - - - - - - - - - - - -
Postoperative variables
Postoperative steroids usage - - - - - - - - - - - - - - M - - - - - - - - -
Postoperative bed bath - - - - - - - - - - - - - - M - - - - - - - - -
Postoperative incontinence - - - - - - - - - - - - - - M - - - - - - - - -
Any incontinence pre or 
postoperative†
- - - - - - - - - - - - - - M
-
- -
-
- - - - -
Laboratory results
Pre-operative:
Evidence of malnutrition U - - - - - - - - - - - - - - - - - - - - - - -
Serum albumin level† - - M - M M - - - - - - - - - - M - M - - - - -
Serum protein level - - - - - - - - - - - - - - - - M - M - - - - -
Serum white blood cell count† - - - - - - - - - - - - - - - - - - - - - - M -
Creatinine level - - - - - - - - - - - - - - - - - - - - - - M -
Hematocrit level - - - - - - - - - - - - - - - - - - - - - - M -
Glucose level† U - M - - - - M - - - - U - - - - - - - - - - -
Post-operative:
Glucose level - - - - - - - - - - - - - - M - - - - - - - - -
Hemoglobin level - - - - - - - - - - - - - - - - - M - - - - - -
Transfusion
Transfusion U - - - - - - - - - - - M - M - - - - - - M - -
pRBC usage after surgery till 
discharge
- - - - - - -
- - - - - -
- -
-
- M
-
- - - - -
FFP usage during surgery - - - - - - - - - - - - - - - - - M - - - - - -
Hospitalization
Pre-operative hospitalization† U - M - - - - M U - - - - - M - - - - - - - - -
Postoperative location U - - - - - - - - - - - - - - - - - - - - - - -
Length of stay U - M - - - - - U - - - - - - - - - - - - - - -
Abbreviations and Symbols.
U: Variable considered for univariate analysis, not for multi-variate regression analysis, M: Variable considered for 
multi-variate regression analysis, 0: no SSI therefore no analysis performed, NR: Statistical approach not reported 
variable is significant however no description of analysis given, NOS: Not otherwise specified, *: Subanalysis to SSI, 
Deep SSI, Superficial SSI merged together, †: This variable is generated out of multiple sub-variables these cited in 
Webtable 1. Symbols printed in bold and underlined indicate variable reported as a significant risk factor for SSI.
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Four studies evaluated the risk for SSI of one single variable; diabetes mellitus,27 
obesity,54 indication for surgery (i.e. spinal tumor)32 and complete neurologic injury.41 In 
all of these four studies the variable under study was found to be significantly related to 
the occurrence of SSI. Apisarnthanarak et al.5 performed and reported the largest series 
of univariate analyses on 36 specific candidate risk factors; five of them were significantly 
related to SSI. The number of candidate risk factors in studies that applied multivariate 
regression analyses ranged from 58 to 4034 (Appendix 7).
The following variables were evaluated in more than half of the studies: diabetes mellitus 
(n=18; 75%), gender (n=16; 67%), age (n=15; 63%), obesity, type of procedure, duration of 
surgery (n=14; 58%) and smoking (n=13; 54%). Out of these variables only two were found 
to be significantly related to SSI in more than half of the studies: diabetes mellitus in 11 
out of 18 studies (61%) and obesity in 8 out of 14 studies (57%). Also, a history of a spinal 
infection was confirmed more often (n=3) as a significant risk factor for SSI than it was 
disproved (n=1; Table 6). In contrast to common perception, smoking was demonstrated as 
a risk factor for SSI in only 2 out of 11 studies that performed multivariate analyses (18%).
Reporting of prophylactic strategies; Fourteen studies (58%) reported details of standard 
prophylactic strategies applied to the whole population or a subgroup under study. Not 
all of these standardised prophylactic treatments were considered as potential effect 
modifiers during analysis. All 14 studies reported the use of antibiotics. Other reported 
prophylactic strategies included the use of skin-antisepsis (5 studies), hair removal (6 
studies), air ventilation (1 study), no change of operating room personnel during surgery 
(1 study), description of surgical clothing (1 study) and the use of closed-suction drains (4 
studies) (Table 7). Whereas not all prophylactic treatments were considered as potential 
effect modifiers in studies that did report the standard use of these strategies, other 
studies considered such confounders in their analysis without reporting to what extent a 
prophylactic strategy was applied to the population under study. For instance, Chen et al.13 
analysed the risk (or preventive effect) of drain placement for SSI without reporting any 
details about the standard use or indications for this prophylactic strategy.
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Table 7: Reporting of prophylactic regimens in the evaluation of risk factors for SSIs after 
spinal surgery.
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Apisarnthanarak et al.5 Y +* +* +* + + + +*
Banco et al.8 N
Boston et al.9 N† +* +* +* - - - -
Chen et al.13 N† +* - - - - - +*
Chen et al.12 N
Demura et al.16 Y + - - - - - -
Fang et al.17 Y + - - - - - +
Friedman et al.18 N† +* - - - - - -
Kanafani et al.22 N
Kuo et al.25 N
Lee et al.26 Y + - - - - - +
Liao et al.27 Y + - - - - - -
Mastronardi et al.32 Y + - - - - - -
Maragakis et al.30 N† +* - +* - - - -
Olsen et al.34 Y +* - - - - - -
Pull ter Gunne et al.37 Y + + +
Pull ter Gunne et al.39 Y + + + - - - -
Pull ter Gunne et al.38 N
Pull ter Gunne et al.40 Y + + + - - - -
Rechtine et al.41 N
Schimmel et al.45 N
Schwarzkopf et al.47 N
Veeravagu et al.51 N
Willems et al.54 N
Abbreviations and Symbols.
Y: Yes, N: No, +: Reported, not considered for analysis, -: Not reported, not considered for 
analysis, *: This prophylactic strategy was also considered in the risk factor evaluation for SSI, 
see Table 6, †: Despite no details of this prophylactic regimen were reported, this prophylactic 
variable was entered in the risk analysis.
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Discussion
As in other fields of research, clinical research generates both answers and new questions 
to be answered. The difference between research of high and low quality is, however, 
that high quality research results in new questions that lead clinicians to new frontiers in 
research, whereas low quality research results in questions that not only stop clinicians 
from moving forward but also hinders any advancement in the knowledge base of the 
existing scientific field. This systematic review of the literature clearly indicates where we 
currently stand in our search for risk factors for SSI after spinal surgery: new frontiers are 
way out of sight…
This rather pessimistic point of view can mainly be attributed to the concept of 
heterogeneity, resulting in a number of conflicting findings as presented in this review. 
Heterogeneity deteriorates prognostic research to valueless bits and pieces, whereas 
standardization increases homogeneity which eventually results in invariable and 
reproducible findings. In this review the following sources of heterogeneity were identified: 
patient selection, selection and analysis of putative risk factors and definitions of SSI 
outcomes.
Patient selection has a profound impact on both the internal and external validity of 
prognostic studies. In most of the included studies the selection of patients was based on 
indications for surgery and applied surgical procedures. By applying these selection criteria, 
a study population could range from young patients with a herniated disc undergoing 
minimally invasive procedures to elderly co-morbid patients with spinal metastasis requiring 
an extensive en bloc spondylectomy. In this review, a similar variety of surgical indications 
and procedures was observed among included studies. This type of heterogeneity leads to 
incomparable distributions of observed and non-observed confounders between studies. 
The inter-study differences in these spectra of patient characteristics are probably the 
main reason for the contradicting findings demonstrated in this review.
Other selection criteria than surgical indications and procedures were reported 
less often. One previously identified risk factor requires special attention in this regard: 
a history of spinal SSI. Only one study excluded patients with a previous SSI and only 4 
studies observed, or measured, and analysed this risk factor. This means that in the other 
19 studies (79%) a history of spinal SSI can be considered as an ‘unobserved’, though 
evident, risk factor. Although statistical techniques have been introduced to adjust for 
unobserved prognostic factors in observational studies, such adjustments require a well-
defined high-volume cohort of patients.20 The exclusion of patients with a history of SSI 
is strongly justified and enables researchers to identify other risk factors for SSI following 
spinal surgery. The introduction of strongly justified eligibility criteria in the field spinal SSI 
research may lead to increased homogeneity, and thus less variability, between studies.21,50 
Another source of heterogeneity is the variability of applied definitions and selection of 
candidate risk factors for a spinal SSI. Although Table 6 is extensive, it clearly demonstrates 
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which variable has been examined in how many studies and which study considered how 
many variables for the risk assessment. From this table it can be seen that only 8 out of 
73 (categorized) variables (11%) have been considered for analysis in more than half of 
the studies. This means that only a small selection of factors are generally believed, or 
hypothesized, to be related to the occurrence of a SSI by the majority of researchers. 
Interestingly, only two variables have been confirmed as a risk factor for spinal SSI by the 
majority of these studies: diabetes mellitus and obesity.
Although the exact underlying mechanism is not entirely understood, various studies 
in other fields of surgery have confirmed the predisposing role of diabetes mellitus in the 
occurrence of a SSI.48 In this review we identified 7 studies (39%) that did not confirm the risk 
attributed to diabetes mellitus for developing a SSI. Apart from earlier raised arguments, 
there is another possible explanation leading to this discrepancy. We recorded the applied 
and reported definitions of diabetes mellitus in each study, see Appendix 4. Surprisingly, 14 
out of 18 studies (78%) that examined the prognostic role of diabetes mellitus did not report 
the applied definition, or criteria, for the diagnosis of this medical condition. The 4 studies 
that did report diagnostic criteria for diabetes mellitus all reported a different approach. 
Obviously, applied diagnostic criteria for diabetes mellitus are hardly comparable between 
the studies and thus pooled risk estimates presented in a review should be interpreted 
with caution. Despite their complexity, the criteria for the diagnosis diabetes mellitus as 
introduced by the NIH (Appendix 4) may act as an initial standardised approach that can 
be applied in future studies.3 Standardization of definitions of putative risk factors and 
confounders is of imminent importance for the comparability of prognostic studies.
Obesity is the second-most confirmed risk factor for SSI in contemporary literature. 
In contrast to diabetes mellitus, the globally accepted definition of obesity, i.e. body 
mass index (BMI) ≥30, was applied consistently in included studies.2 However, Appendix 
7 demonstrates that various data processing techniques have been applied for the risk 
analysis of overweight, ranging from BMI applied as a continuous variable to categorical 
index groups with 5 points difference. Although each statistical approach comes with 
advantages and disadvantages, the categorical approach is commonly used and advocated 
for comparability between studies.14
Perhaps even more important than a standardised approach for defining and analysing 
potential risk factors is the use of a standardised outcome measure.31 The variety of applied 
criteria for the diagnosis of a SSI, as demonstrated in Table 5, indicates another important 
source of heterogeneity among included studies. The other, more positive, side of the coin 
is that a substantial number of studies applied the same CDC criteria for a SSI (Appendix 
1). However, only 3 out of the 10 studies that applied the CDC criteria specified whether 
the infection involved skin or subcutaneous tissue (superficial SSI), or the deeper fascia 
and muscle layers (deep SSI). Moreover, only 2 out of the 10 studies reported details on the 
follow-up of patients.8,13 Both studies followed patients for at least 12 months and not up to 
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30 day as recommended by the CDC guideline.29 Because of the short-term follow-up, the 
difficulty of distinguishing a deep from a superficial SSI and also the possibility of diagnosing 
a SSI merely by the judgment of the attending physician (Criterion C4, Appendix 1), one 
could argue the content validity, accuracy and reliability of the CDC guideline. However, 
the common use of a single, standardised outcome measure is a very valuable method for 
the evaluation of risk factors for a spinal SSI. To improve the clinical and scientific utility of 
this CDC SSI outcome measure, a validation process and, if necessary, further refinements 
of its criteria are recommended.6
Adjustment for confounding is crucial in observational studies evaluating risk factors for 
SSI. Researchers generally include patient characteristics (eg. pre-existent co-morbidities) 
and surgical attributes (eg. type and duration of surgery) as candidate risk factors. This 
review demonstrates that potentially serious confounding prophylactic strategies applied 
in the observational cohort(s) are rarely considered in this risk estimation. The majority 
of the included studies (67%) adjusted for confounding by using multivariate regression 
techniques in their risk assessments. The reader should be aware, however, that statistical 
adjustment in a single study does not necessarily lead to the generation of a list of causal 
factors for spinal SSI. In fact, a variable may appear, correctly, to be an independent risk 
factor for an outcome in one study, but may also appear, equally correctly, not to be so 
in another study.10 The explanation for this theoretical contradiction comes down to the 
overarching theme of this review: heterogeneity. For this reason we recommend readers 
– and researchers performing a review of the literature – not to focus on LoE grades and 
regression techniques alone, but also to critically appraise sources of heterogeneity and 
consider their impact on a study’s validity and clinical applicability.
The limited number of valid risk factors for SSI after spinal surgery found in this 
review illustrates the gap that currently exists between practice and research. No other 
specialty than orthopedic surgery is aware of the risk of post-interventional infections. In 
arthroplasty, various prophylactic strategies are commonly applied and, in case a surgeon 
classifies a patient as ‘high-risk’, additional pragmatic precautions are usually considered.49 
However, to our knowledge, no critical appraisal of previously identified risk factors for SSI, 
as performed in the current study, has been published in the field of arthroplasty before. 
The next step forward is to combine clinicians’ valuable pragmatic reasoning with adequate 
methodological research techniques. The quality and clinical relevance of future studies on 
SSI risk factors will mainly depend on the extent of collaboration between spine surgeons, 
infectious diseases specialists and clinical epidemiologists.
Our study is strengthened by a comprehensive search to identify all published studies 
on risk factors for SSI after spinal surgery. By including only references published in the 
last decade, we were able to assess the methodological quality of contemporary literature. 
Also, no exclusion criteria were applied for indications for spinal surgery or applied surgical 
procedures, enabling us to generalize current review’s findings to the entire spectrum 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
A methodological systematic review on surgical site infections following spinal surgery. Part 1
111
of spinal surgery. On the other hand, this review does not provide an overview of all 
previously identified risk factors, therefore, no recommendations, related to the influence 
of risk factors, can be made. As it is difficult to distinguish a badly conducted study that is 
well reported from a well conducted study that is poorly reported, we were limited in the 
judgment of the true methodological quality of a study.33 Finally, our critical appraisal was 
limited by the use of non-validated scoring items abstracted from the STROBE statement 
that was originally designed to provide guidance on how to report observational studies.52
Previous systematic and narrative reviews attributed the following factors to an 
increased risk of developing a spinal SSI: trauma, older age, malnutrition, higher 
American Society of Anesthesiologists (ASA) score, smoking, alcohol abuse, preoperative 
hospitalization, posterior surgical approach, blood transfusion, and duration of 
surgery.11,15,35,44,46,56 However, in the current systematic review of contemporary literature 
we found more studies disproving rather than confirming this list of risk factors. In fact, 
we showed that only 2 out of 11 multivariate analyses studies demonstrated smoking to 
be significantly related to the occurrence of a SSI. Does this mean that there is no true 
causal relationship between smoking and SSI? Supported by the paradoxical findings of 
this review, we honestly find it hard to believe so. But what this review does make very 
clear is that because of the various sources of heterogeneity in previous literature there is a 
paucity of valid evidence for the proof of true risk factors for SSI following spinal surgery. 
Therefore, we recommend the introduction, validation and use of a standardised set of 
strongly justified eligibility criteria and well-defined candidate risk factors and spinal SSI 
outcomes.
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Abstract
Study Design. Methodological systematic review.
Objective. To critically appraise the validity of preventive effects attributed to 
prophylactic treatments for surgical site infection (SSI) following spinal surgery.
Summary of Background Data. As a result of a rapidly increasing number of spinal 
procedures, healthcare expenditure is expected to increase substantially in the 
foreseeable future. Administration of effective prophylactic treatments may prevent 
occurrence of SSIs and may thus result in lower costs. To date, however, no review 
appraising the methodological quality of studies evaluating prophylactic treatments 
for spinal SSIs has been published. 
Methods. Contemporary studies evaluating the preventive effect of prophylactic 
interventions on the rate of SSI following spinal surgery were searched through the 
Medline and EMBASE databases (January 2001 to December 2010). References were 
retrieved and bias-prone study features were abstracted individually and independently 
by 2 authors.
Results. Eighteen eligible studies were identified, including 6 randomized controlled 
trials and 12 comparative cohort studies. Antibiotic prophylaxis administration was 
investigated most often (n=7). Included studies covered a wide variation of indications 
and surgical procedures. Except for five studies (28%), applied definitions of SSI 
outcomes were ambiguous. Although several important methodological aspects, 
including blinding of outcome assessors and attrition, were poorly reported in RCTs, 
these studies were far less susceptible to bias and confounding as observed in non-
randomized studies. None of the 12 cohort studies adjusted for confounding by either 
matching, stratification or multivariate regression techniques.
Conclusion. Given the plethora of previously hypothesized confounding risk factors 
for a spinal SSI, conduct of non-randomized comparative therapeutic studies are 
strongly discouraged. On the other hand methodological safeguards, including use of 
standardised definitions of putative confounders and outcomes, should be considered 
in more detail during the design phase of a randomized trial.
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Introduction
Surgical site infection (SSI) following spinal surgery is a commonly encountered 
complication resulting in increasing rates of morbidity, length of hospital stay, readmissions 
and healthcare expenditure.1, 2 Given the rapidly increasing number of spinal procedures 
performed on an increasingly older, co-morbid patient population, spinal surgery related 
costs are expected to increase substantially in the foreseeable future.3, 4 In order to maintain 
healthcare expenditure at a sustainable level, the true benefits of surgical interventions 
for specific spinal disorders warrant thorough investigation. Also, strategies to prevent the 
occurrence of costly complications including SSI are a high priority on the research agenda.
For the prevention of SSIs two different perspectives can be applied. The first perspective 
covers the identification – and, if possible, the elimination – of risk factors for SSIs. The 
second perspective covers the evaluation of prophylactic treatments, including the use 
of antibiotic prophylaxis (ABP), for their efficacy in reducing the rate of postoperative 
SSIs. Although these two preventive approaches have much in common, risk factors and 
prophylactic treatments traditionally have been evaluated separately.
In the first part of this systematic literature review project we critically appraised the 
validity of previously identified risk factors for SSIs.5 We found that risk factors and SSI 
outcomes have been investigated in a variety of study populations and were generally poorly 
defined. This resulted in the identification of only three risk factors that were confirmed 
more often as a significant risk factor for SSI than they were disproved, namely diabetes 
mellitus, obesity and a history of a SSI. The controversy around the SSI risk attributed to 
other factors, including smoking and duration of surgery, was mainly explained by the 
methodological differences between the studies.5 By applying a similar methodological 
approach, the aim of the current review was to critically appraise the validity of preventive 
effects attributed to prophylactic treatments for SSI following spinal surgery.
Material and Methods
Search Strategy & Study Eligibility Criteria; In order to identify contemporary and relevant 
articles on the preventive effect of prophylactic interventions on the rate of SSI following 
spinal surgery, we conducted a computerized search using the Medline and EMBASE 
(January 2001 to December 2010) databases. The syntax used for Medline, PubMed 
interface, was: (surgery[text word] OR surgical[text word] OR prevention[text word] OR 
prophylaxis[text word] OR antibiotic*[text word]) AND (spine[text word] OR spinal[text word]) 
AND infection[text word] AND (“2001/01/01”[PDAT] : “2010/12/31”[PDAT]). The syntax used 
for EMBASE was: (surgery OR surgical OR prevention OR prophylaxis OR antibiotic$) AND 
(spine or spinal) AND infection AND 2001:2010.(sa_year). The initial screening for eligibility 
included the following two criteria. The study had to consist of a clearly defined group 
of adult patients who underwent spinal surgery. In addition, the study’s objective had to 
cover a comparative evaluation of the preventative effect of one or more prophylactic 
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treatments for SSIs. Studies including pediatric patients (<18 years old) were excluded. 
Articles published in languages other than English and articles without an abstract were 
also excluded.
Data Abstraction; Titles and abstracts were first screened, potentially relevant articles 
and reports were then retrieved and evaluated individually and independently by 2 authors 
(JJvM, AFPtG) using Endnote X2 software (Thompson Reuters, Carlsbad, CA, USA). To 
ensure that no relevant studies were missed by the database searches, we also performed 
a manual cross-reference search of the citations of each included and relevant literature 
review to obtain further relevant studies. In each phase, and in all cases, disagreement 
concerning inclusion of articles was resolved by discussion and consensus agreement. Data 
were entered into Excel 2007 (Microsoft, Redmonds, WA, USA) and reviewed for errors 
prior to analysis.
Critical Appraisal; Critical appraisal of included articles was performed to examine 
studies’ validity. The following standard study characteristics were recorded: study 
design, method of data collection, level of spinal surgery covered by a study, intervention 
details, comparison details, number of patients and age of study population. Based on 
items covered by the CONSORT and STROBE statements we abstracted the reporting 
of following bias-prone features from the included studies:6, 7 study setting, period 
of investigation, eligibility criteria, method of patient/case identification, method of 
data retrieval, sample size calculation, indications for spinal surgery, applied surgical 
approaches, the use of other prophylactic strategies other than the treatment under 
investigation, applied SSI definition, blinding of SSI outcomes assessor and reporting of 
patient follow-up. More specifically, statistical approaches used for the effect evaluation of 
prophylactic treatments and putative confounders were abstracted. Special attention was 
paid to the use and reporting of multivariate regression techniques and the consideration 
and selection of putative confounders in these analyses. Especially for non-randomized 
studies, these details would illustrate authors’ awareness of the multi-etiological causes of 
SSIs following spinal surgery.
Results
Search and Screening Results; The computerized search strategy resulted in 6739 citations, 
see Appendix 6. After removal of duplicate references and screening of titles and abstracts, 
106 remaining potential eligible articles were obtained for full-text screening. 88 articles 
were excluded during full-text screening. The majority of the irrelevant articles did not 
present an effect evaluation of prognostic or therapeutic factors, combined SSIs with other 
infections in their analyses or included pediatric patients. Cross-referencing did not result 
in additional citations. Finally, 23 studies evaluated risk factors for SSI without comparing 
two or more prophylactic strategies and were therefore included in the first part of this 
literature review project.5 This resulted in a total number of 18 included articles in the 
current review.8-25
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Study Characteristics & Prophylactic strategies; Included studies consisted of 6 
randomized controlled trials (RCTs, 33%), 12 comparative cohort studies (67%; 3 
prospective, 7 retrospective, 1 ambidirectional, 1 unclear).26 Seven cohort studies applied 
historical controls, meaning that all patients ‘allocated’ to the comparison group received 
treatment in an earlier period than patients ‘allocated’ to the intervention group, or vice 
versa. Eight studies (44%) reported on the treatment of sole lumbar spine pathology, four 
studies (22%) evaluated more than 1 anatomic region of spinal pathology and 6 studies 
(33%) did not report the spinal levels under study (Table 1).
The evaluated SSI prophylactic strategies in the included studies were as follows: 
antibiotic prophylaxis (ABP) in 7 studies (39%), tailored prophylaxis protocol, povidone-
iodine wound irrigation and closed-suction wound drainage; all in 2 studies (11%) and shaving 
of surgical site, air flow system combined with body exhaust gowns, silver-impregnated 
dressings, tumor irradiation with prostaglandin E1 and autologous transfusion; all in 
one study (6%). Two studies evaluated the prophylactic effect of a ‘tailored prophylaxis 
protocol’. Christodoulou et al.12 evaluated the effect of the ‘Nine Ps Protocol’. This protocol 
effectively covered the following three elements: 1) frequent and aseptic changes of sheets 
and dressings; 2) addition of amikacin to the perioperative ABP scheme; and 3) scrutinizing 
patient characteristics with specific attention paid to factors amenable to ‘risk reducing 
interventions’ before surgery, especially in elective cases. The so-called ‘risk reducing 
interventions’ were not further specified by the authors.12 Meyer et al.21 neither specified 
the exact differences between the two (‘2006’ and ‘2007’) prophylactic regimens under 
investigation.
Intervention group sizes ranged from 21 to 887 patients and comparison group sizes 
ranged from 20 to 1133. The mean ages of the study intervention and comparison groups 
ranged from 41 to 67 years and 43 to 67 years, respectively. Four studies (22%) did not 
provide details about the mean or median age of the study population.
Reporting of general bias-prone issues; Table 2 provides an overview of the reporting 
of bias-prone issues in included studies. Being considered as a key component in the 
judgement of a study’s external validity,27 only two studies (11%) reported sufficient details 
about the setting the study was conducted in. In contrast, the time period the study was 
conducted in and applied eligibility criteria were reported in 15 (83%) and 14 (78%) studies, 
respectively. Related to selection and measurement bias, 8 (44%) and 10 (56%) studies 
reported the method of patient/case identification and data retrieval, respectively. Three 
RCTs (11%) reported a post hoc power analysis in the results or discussion section. Related 
to the assessment of attrition bias, 4 studies (22%) described the mean duration and range 
of follow-up in detail.28
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Table 2: Reporting of bias prone issues for the evaluation of risk factors for SSIs after spinal surgery 
(18 Studies).
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Hellbusch et al.17 - + + + + +§ + + + + - -
Petignat et al.24 + + + + + - + + - + Yes + 1.5/-/6
Kanayama et al.18 - + - + + - + - + + - + 6/6/6
Takahashi et al.25 + + + - - - - + - + - -
Khan et al.20 - + + - + - + + - + No + 1/-/>6
Ohtori et al.22 - - + - - - + + + - - -
Dobzyniak et al.14 - + - - + +§ + + - + No + 1.5/1.5/1.5
Christodoulou et al.12 - + + + + - + - - - - -
Meyer et al.21 - + + - - - - + - - - -
Chang et al.10 - + + + - - + + + + - + -/I: 19, II: 19/-
Cheng et al.11 - + + + + - + + + + - + 6/16/24
Brown et al.8 - - + + - +|| + + - - - + 12/-/-
Kanayama et al.19 - + + - + - - + + - - -
Celik et al.9 - + + + - - + - + + Yes -
Gruenberg et al.16 - + + - + - + + + + - + 6/I: 35, II: 28/67
Epstein et al.15 - - - - - - - + - + - -
Demura et al.13 - + - - - - + + + - - -
Park et al.23 - + + - + - + + - + - -
Abbreviations and Symbols.
+: Reported, -: Not reported, *: Includes type of hospital (eg. University hospital, referral centre) 
and/or population details (eg. hospital service area), †: Methods include use of administrative 
database, evaluation of consecutive series, etc., ‡: Methods include chart review, use of case 
report forms, etc., §: Post hoc sample size analysis, ||: Post hoc power analysis, ¶: When reported 
in original report, follow-up details presented for each subgroup, Note: Studies printed in bold 
indicate a randomized controlled trial.
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Reporting of surgical indications and procedures; The reported indications for spinal 
surgery and types of investigated surgical procedures are outlined in Table 3. 14 studies 
(78%) reported details about the indications for surgery. The indications ranged from 
one (disc herniation) to more than 11 in a single study. Patients undergoing surgery for 
degenerative stenosis was reported in 11 out of 14 studies. Oncological characteristics 
(eg. benign, malignant, metastasis) were documented in 2 out of 6 studies that reported 
the inclusion of tumor cases. The surgical procedures ranged from a single discectomy to 
an extensive en bloc spondylectomy. 15 studies (83%) reported details about the applied 
surgical procedures. Surgical decompression, fusion and spinal instrumentation were all 
reported as standalone as well as combined procedures.
Table 3: Reported indications for spinal surgery and types of surgical procedures (18 Studies).
Study
Indication spinal surgery Surgical procedure
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a
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 re
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Hellbusch et al.17 Y - - + - + - - Y - +C - +C -
Petignat et al.24 Y - - - - + - - Y +S, +C - - +S, +C -
Kanayama et al.18 Y - - + + - NOS + N
Takahashi et al.25 N Y +S +S, +C +C +S -
Khan et al.20 Y - - + - + - - Y +S - - - -
Ohtori et al.22 Y - + + + - - - Y - +C +C - -
Dobzyniak et al.14 Y - - - - - - - Y +S - - +S -
Christodoulou et al.12 Y + + + + - NOS + N
Meyer et al.21 N Y - - + - -
Chang et al.10 Y - - + - + NOS + N
Cheng et al.11 Y + + + - - +* - Y - +C +C - -
Brown et al.8 Y - + + + - - - Y - +C +C - -
Kanayama et al.19 Y + + + - + NOS - Y +S, +C - +S, +C +S +
Celik et al.9 Y - - + + + - - Y +S, +C +C +C - -
Gruenberg et al.16 N Y +S - - +S -
Epstein et al.15 Y - - + - + NOS + N
Demura et al.13 Y + + + - - +* - Y - +C +C - -
Park et al.23 N Y +C +C +C - -
Hellbusch et al.17 Y - - - - - +* - Y - - - - +
Petignat et al.24 Y - - + + - - - Y - +C +C - -
Abbreviations and Symbols.
Y: Yes, N: No, +: Reported, -: Not reported, +S: Standalone treatment, +C: Part of combined 
treatment, NOS: Not otherwise specified. *: Details such as benign, malignant, metastasis were 
(partly) reported, Note: Studies printed in bold indicate a randomized controlled trial.
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Reporting of applied SSI definition; Table 4 presents the SSI criteria applied and reported 
in included studies. Six studies (33%) did not provide any detail about applied criteria for, 
or features of, the diagnosis spinal SSI. Where 11 studies applied and reported a distinction 
between ‘deep’ and ‘superficial’ SSIs, only 6 studies reported related criteria. Five studies 
(28%) reported the occurrence of both deep and superficial SSIs in their study population, 
three studies (17%) the occurrence of sole deep SSIs and another three (17%) the occurrence 
of sole superficial SSIs. One out of the 5 studies where both deep and superficial SSIs were 
observed performed additional prophylactic effect analyses for both SSI subtypes.11
Two studies (11%) reported the use of Centers for Disease Control and Prevention (CDC) 
definition of the diagnosis SSI, see Appendix 1.29 Only three studies (17%) reported one 
or more criteria required to be present for the diagnosis SSI; positive wound cultures in 2 
studies (11%), positive blood testing and the requirement of a surgical washout, both in 
1 study (6%). Other reported signs and symptoms present in at least one of the studied 
subjects are listed in Table 4 and ranged from presence of fever to signs suggestive of SSI 
as discerned on magnetic resonance imaging.
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Table 4: Applied criteria and reported features for the diagnosis spinal SSI (18 Studies).
Study SS
I d
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ng
s
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rg
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n’
s 
im
pr
es
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M
RI
Hellbusch et al.17 Y Y Y S - + + + - - - - - - - - - - - -
Petignat et al.24 Y Y Y D,S + - - - - - - - - - - - - - - -
Kanayama et al.18 Y Y N D,S - + - + - + - - - + - + +† - - -
Takahashi et al.25 Y Y Y D,S + - - - - - - - - - - - - - - -
Khan et al.20 Y Y Y S - - - - - - - - - - - - - + - +
Ohtori et al.22 N N - -
Dobzyniak et al.14 Y N - - - + - + - + - - - + - - - - + -
Christodoulou et al.12 N N - -
Meyer et al.21 N Y N D
Chang et al.10 Y Y Y D - - - - - - - - - +† - +† - - - -
Cheng et al.11 Y Y Y D,S - + + + - - + - + + + + - - - -
Brown et al.8 N N - -
Kanayama et al.19 N N - -
Celik et al.9 Y Y N S - + - + - - - + - - + + - - - +
Gruenberg et al.16 Y N - - - - - + + - - - - + - - - - - -
Epstein et al.15 Y Y N D,S - - - - - - - - - +† - - - - - +
Demura et al.13 N Y N D
Park et al.23 Y N - - - - - + - - - - - + - - - - - -
Abbreviations and Symbols.
Y: Yes, N: No, D: Deep, S: Superficial, SSI: Surgical site infection, MRI: Magnetic resonance 
imaging, +: Described as a feature of SSI, -: Not described as a feature of SSI, *: See Panel 1, SSI, †: 
Feature had to be present for diagnosis, or was reported to be present in all SSI cases, 
Note: Studies printed in bold indicate a randomized controlled trial.
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Evaluated prophylactic treatments and consideration of putative confounders; Table 
5 provides an overview of all treatments and putative confounders considered in the 
effect evaluation of prophylactic treatments. 14 studies (78%) evaluated the effect of the 
prophylactic strategy under investigation with use of univariate statistical approaches. Nine 
out of these 14 studies found a statistically significant lower rate of SSIs in the intervention 
group, see Table 5. Two studies did not observe SSIs in either group and in two other studies 
statistical methods were not applied or reported.
Four studies (22%; 2 RCTs, 2 prospective comparative cohort studies) considered the 
role of confounding in their evaluation of prophylactic treatments. In their trials, Cheng et 
al.11 and Hellbusch et al.17 performed subgroup analyses to asses “effect heterogeneity”.30 
After the univariate analysis of the prophylactic effect of povidoneiodine solution wound 
irrigation on the rate of SSIs, Cheng et al.11 performed a multivariate regression analysis 
consisting of 14 putative confounders. The authors found that having a spinal injury as 
surgical indication was significantly related to a higher rate of SSIs when compared to 
other indications, see Table 5. Hellbusch et al.17 performed additional univariate analyses 
of 15 putative confounders in their RCT, no significant associations were found. Two 
comparative studies performed additional subgroup analyses. Demura et al.13 performed 
additional univariate analyses of 6 putative confounders, none were significantly related to 
the occurrence of SSI. Without specifying applied statistical approach, Kanayama et al.18 
reported that the use of instrumentation was not significantly related to an increased risk 
for SSI.
Reporting of prophylactic strategies other than the prophylactic treatment under study; 
Nine studies (50%) reported details of prophylactic strategies other than the treatment 
under study, see Table 6. The use of antibiotics was reported in 6 out of 11 studies that did 
not investigate the preventive effect of ABP. Closed-suction wound drains were used and 
reported in 4 out of 16 studies not primarily investigating this prophylactic treatment. Two 
studies explicitly stated that no advanced air ventilation systems, body-exhaust suits, or 
routine UV lights were used in the operation theatres,10, 11 see Table 6. Three prophylactic 
treatment being subject of investigations in three different studies were not reported in 
any of the other studies, including surgical site shaving and use of Silverlon dressings.9, 15
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Table 5: Evaluated prophylactic treatments and putative confounders for SSIs after spinal surgery.
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Prophylactic treatment
AB Regimen U U NR U* U† U U - - - - - - - - - - -
Prophylaxis protocol - - - - - - - U U - - - - - - - - -
Povidoneiodine solution - - - - - - - - - U U - - - - - - -
Closed-suction wound drains - - - - - - - - - - - 0 0 - - - - -
Shaving pre-op - - - - - - - - - - - - - U - - - -
Laminar airflow operating facility - - - - - - - - - - - - - - U - - -
Silverlon dressings - - - - - - - - - - - - - - - NS - -
PGE1 administration - - - - - - - - - - - - - - - - U -
Autologous transfusion - - - - - - - - - - - - - - - - - U
Putative confounders
Pre-operative factors
Age U - - - - - - - - - M - - - - - U -
Gender - - - - - - - - - - M - - - - - U -
Height U - - - - - - - - - - - - - - - - -
Weight U - - - - - - - - - - - - - - - - -
BMI U - - - - - - - - - - - - - - - - -
Tobacco use U - - - - - - - - - - - - - - - - -
Steroid use U - - - - - - - - - - - - - - - - -
Diabetes U - - - - - - - - - M - - - - - - -
Pre-op fasting sugar - - - - - - - - - - M - - - - - - -
Cardiovascular disease - - - - - - - - - - M - - - - - - -
Pre-op WBC count - - - - - - - - - - M - - - - - - -
Pre-op haemoglobin concentration - - - - - - - - - - M - - - - - - -
Previous spine surgery U - - - - - - - - - M - - - - - - -
Previous SSI U - - - - - - - - - - - - - - - - -
Radiation dose (pre-op) - - - - - - - - - - - - - - - - U -
Interval radiation & surgery - - - - - - - - - - - - - - - - U -
Indications spinal surgery
- Deg. scoliosis/stenosis - - - - - - - - - - M - - - - - - -
- Discectomy - - - - - - - - - - M - - - - - - -
- Fracture/injury - - - - - - - - - - M - - - - - - -
- Tumor/metastasis - - - - - - - - - - M - - - - - - -
Peri-operative factors
Blood transfusion intra-op U - - - - - - - - - - - - - - - - -
Operative time U - - - - - - - - - - - - - - - U -
Use of allograft U - - - - - - - - - - - - - - - - -
Use of cell saver U - - - - - - - - - - - - - - - - -
Treating surgeon U - - - - - - - - - - - - - - - - -
Treating hospital U - - - - - - - - - - - - - - - - -
Estimated blood loss - - - - - - - - - - - - - - - - U -
Use of instrumentation - - NR - - - - - - - M - - - - - - -
Level of surgery - - - - - - - - - - M - - - - - - -
Abbreviations and Symbols.
U: Variable considered for univariate analysis, not for multi-variate regression analysis, M: Variable considered for multi-variate 
regression analysis, NR: Statistical approach not reported, 0: No statistical tests was performed since no SSI was reported in 
either group, NS: No statistical test was performed, op: AB: Antibiotic prophylaxis, Operative, PGE1: Prostaglandin E1, Deg.: 
Degenerative, *: Group I vs. III, see Table 1, †: Group II vs. III, see Table 1, Note: Studies printed in bold indicate a randomized 
controlled trial, letters (eg. U,M) printed in bold and underlined indicate variable reported as a significant risk factor for SSI.
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Table 6: Reporting of prophylactic strategies in the evaluation of risk factors for SSIs after spinal 
surgery (18 Studies).
Prophylaxis No. Studies reported Part of intervention in no. 
studies
Antibiotic prophylaxis 69-11, 13, 16, 19 714, 17, 18, 20, 22, 24, 25
Closed-suction wound drains 410, 11, 18, 22 28, 19
Laminar airflow operating facility 310, 11, 18 116
Body-exhaust suits surgeons 210, 11 116
Routine ultraviolet lights in op-theatre 210, 11 0
Povidoneiodine solution wound irrigation 29, 17 210, 11
AB solution wound irrigation 217, 18 0
Chlorhexidine soap shower night before op 117 0
Frequency dressing changes 122 0
Debridement of nonviable tissue intra-op 111 0
Shaving before op 0 19
Silverlon dressings 0 115
Use of PGE1 0 1
13
Abbreviations and Symbols.
AB: Antibiotic prophylaxis, OP: Operation, PGE1: Prostaglandin E1, Note: In the bold references, 
the absence of this prophylactic strategy was reported.
Discussion
The aim of this review was to critically appraise the validity of preventive effects attributed 
to prophylactic treatments for SSIs following spinal surgery. In the last decade most of the 
prophylactic treatments evaluations focused on ABP administration and were conducted 
in patients undergoing surgery for lumbar spine pathology. However, indications and 
applied surgical procedures varied considerably among included studies. Except for five 
studies, applied definitions of SSI outcomes were ambiguous. Only four studies considered 
other putative confounders in the effect evaluation of the prophylactic treatment under 
investigation. Moreover, the use of (potentially confounding) prophylactic treatments 
other than the treatment under investigation was, except from ABP administration, rarely 
reported.
Covering the last decade in spinal SSI research, six out of 18 included studies (33%) were 
RCTs. It is well-known that, when properly conducted, RCTs are the most reliable method 
of determining the effect of a treatment.31 Proper randomization minimizes allocation bias 
and therefore maximizes the likelihood that both known and unknown prognostic factors 
are balanced in the different treatment groups being investigated. Particularly relevant for 
the field of spinal SSI research, where many risk factors have previously been hypothesized 
and tested,5, 32 high-volume RCTs allow researchers to isolate and evaluate the effect of a 
single intervention.
Subgroup analyses were performed and reported in two RCTs.11, 17 Since these analyses 
were neither justified, nor predefined in the authors’ report, they should be interpreted 
with caution. In his elucidating review on subgroup analysis, Dr. Rothwell draws the analogy 
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between selective reporting of post hoc subgroup observations and placing a bet on a 
horse after watching a race.33 Therefore, the association between the indication for spinal 
surgery (fixation for traumatic spinal fracture) and occurrence of SSI (Odds ratio: 7.091, (P= 
0.0371) reported by Cheng et al.11 is likely to be a false positive finding. Similarly, the absent 
association between diabetes mellitus and SSI in their study11 may well be another example 
of an underpowered false negative finding, see Table 5.33 Where Hellbusch et al.17 reported 
their study to be underpowered for the primary outcome (SSI), subgroup analyses must 
have been underpowered even more so.
Although the quality of reporting in included RCTs was better than in non-randomized 
studies in general, only two RCTs reported the blinding status of the outcome observer. 
Lack of blinding increases the likelihood of overestimating treatment effects.34 Moreover, 
SSI prophylaxes are one of the few interventions in surgery allowing straightforward 
blinding of outcome assessors.35 Only one RCT provided detailed information on patient 
follow-up.11 Due to loss to follow-up, characteristics of study groups may change during the 
study and may eventually result in attrition bias.28 Finally, differences in co-interventions 
(Table 6) between the study groups have not been ruled out by most authors and may have 
resulted in under- or overestimated treatment effects.36 Despite these and other outlined 
methodological shortcomings, included RCTs represent the best currently available 
evidence on prevention of SSI after spinal surgery.
As opposed to RCTs, observational comparative studies are particularly prone to 
confounding by indication (or by contraindication).37 Comparing a group of patients given 
a new treatment with a group previously treated with an alternative treatment (a historical 
comparison) may seem a reasonable solution to overcome non-randomized treatment 
allocation. Nothing could be further from the truth. Altman and Bland previously outlined 
that it is impossible to eliminate biases due to other factors (apart from treatment) that 
may have changed over time.38 Comparing randomized trials with historical comparative 
cohort studies on similar topics, Sacks et al.39 found historical comparative cohort studies 
tending to yield more favorable results than RCTs.
Remarkably enough, none of the 12 non-randomized comparative studies adjusted 
for confounding by either matching, stratification or multivariate regression techniques.40 
Awareness of the concept of confounding has been demonstrated to be low in observational 
study reports.41 In the first part of this literature review project we showed that more than 
70 potential risk factors for SSI following spinal surgery have been assessed over the last 
decade.5 Therefore, contemporary literature provides enough clues to define and justify the 
selection of putative confounders for the evaluation of new prophylactic treatments. Other 
methodological drawbacks observed in non-randomized comparative studies included five 
studies (42%) that did not report the definition of the primary SSI outcome and no study 
reported the blinding status of the outcome assessors.
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Our study is strengthened by a comprehensive search to identify published randomized 
and non-randomized controlled studies on the preventive effect of prophylactic treatments. 
By including only references published in the last decade we were able to assess the 
methodological quality of contemporary literature. Also, no exclusion criteria were applied 
for indications for spinal surgery or applied surgical procedures, enabling us to generalize 
current review’s findings to the entire spectrum of spinal surgery. On the other hand, this 
review does not provide an overview of all previously investigated prophylactic strategies. 
Therefore, recommendations related to the use of prophylactic treatments cannot be 
entirely based on our results. In accordance with the aim of this review our results do 
provide, however, clear information for researchers investigating novel prophylactic 
treatments in the future.
The assessment of the quality of a study is closely intertwined with the quality of 
reporting.42, 43 It is not always easy to distinguish a badly conducted trial that is well reported 
from a well conducted trial that is poorly reported.44 This limited us in the judgment of the 
true methodological quality of a study. Hence, investigators should strive for high quality 
of both the conduct and reporting of a study. This in turn allows the readership to interpret 
and apply studies’ findings adequately. This systematic review is limited by the use of non-
validated methodological scoring items. Items were based on key items reported in the 
consensus-derived CONSORT and STROBE statements6, 7 and were independently applied 
by two reviewers. Although no agreement values were calculated, agreement was notably 
high and consensus was reached in all cases.
Where several previous literature reviews presented a ‘quantitative’ overview of 
available prophylactic strategies for the prevention of SSI following spinal surgery,32, 45, 46 
we are the first authors presenting a ‘qualitative’ summary of contemporary prophylactic 
treatments. We showed that SSI prophylaxes have been investigated in a wide variation of 
indications and surgical procedures. Although several important methodological aspects, 
including blinding of outcome assessors and attrition, were poorly reported in RCTs, these 
studies were far less susceptible to bias and confounding as observed in non-randomized 
studies. Given the plethora of observed and non-observed confounders for a spinal SSI,5 
conduct of non-randomized comparative therapeutic studies are strongly discouraged. 
On the other hand methodological safeguards, including use of standardized definitions 
of putative confounders and outcomes, should be considered in more detail during the 
design phase of a randomized trial.
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The objective of this thesis was to identify significant risk factors for surgical site infection 
(SSI) after adult spinal surgery. To identify these risk factors, a retrospective analysis was 
performed of all adult patients who had spinal surgery at the Johns Hopkins hospital, 
USA, between June 1996 and December 2005. Sub-analysis was performed to identify risk 
factors in high-risk patient groups and surgical procedures. Besides these retrospective 
analyses, a systematic review was performed to evaluate the methodological quality of 
contemporary studies that identified risk factors of and prophylactic treatments for SSI 
after spinal surgery.
Diagnosing a SSI
The diagnosis of a SSI following spinal surgery is difficult to confirm. Patients can present 
with fever, local pain, erythema, swelling, warmth, tenderness upon palpation, and/-or 
postoperative wound drainage. However, in daily practice not all of these signs are always 
present. In this thesis we found that wound drainage was most frequently present during 
presentation of the SSI. Additional blood tests showed an elevated C-reactive protein level 
(CRP) and erythrocyte sedimentation rate (ESR). Due to the absence of a comparison with 
patients who did not have a SSI, the applicability of these findings for further guideline 
development is limited. Since it is known in the literature that CRP and ESR levels increase 
postoperatively even though no SSI is present, the finding that CRP and ESR were elevated 
in most of our cases may reflect the normal postoperative elevation.7,18 Moreover, the 
finding that the most frequently isolated micro-organism was Staphylococcus aureus is 
important. 
Evaluation of contradicting outcomes
Preoperative risk factors. In chapters 3 to 6 we evaluated risk factors for SSI. Table 1 
summarizes the identified significant risk factors. Three preoperative risk factors were 
found to be significant; previous SSI, obesity and diabetes mellitus.
Previous SSI was found to be a significant risk factor for SSI in chapters 3 and 5, and for 
deep SSI in chapter 3, though it was not significantly related to superficial SSI. Previous SSI 
has already been identified as a significant risk factor for SSI.3,19 Most frequently the presence 
of subcutaneous micro-organisms presents itself by erythema, swelling and drainage from 
the involved area. In the case of these symptoms therapy is generally started. However, 
symptoms of osteomyelitis as a sign of a (remnant) deep SSI can be less overt, and limited 
to minor bone pain after surgery.5 Due to the limited number of symptoms, undiagnosed 
osteomyelitis might be present during a re-operation. Due to the presence of an (remnant) 
infection during a re-operation increased (deep) SSI rates are expected. Besides the history 
and physical examination, plain films can be made and additional laboratory studies can be 
performed to detect remnant infections.
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Therefore, in future studies, preoperative laboratory tests should be noted (at least) 
to exclude any chronic infection in patients with a previous SSI. The contradicting finding 
that a previous SSI was a significant risk factor for SSI in one study and was not identified in 
another can be due to confounding. 
Obesity was also identified in several chapters as a significant risk factor for SSI. 
The significance of obesity for superficial SSI can be explained due to the thickness of 
subcutaneous tissues. During open spinal procedures, retractors are placed to expose the 
bony elements. The retractors’ force on subcutaneous tissues may lead to necrosis. This 
local area of necrosis is a perfect place for bacteria to grow since there is 1) an ideal local 
temperature, 2) a moist environment and 3) a limited local vascular supply and concomitant 
coverage of the immune system. Moreover, the thick subcutaneous layer may lead to the 
creation of ‘dead space’ during closure of the surgical wound which in turn may lead to 
wound healing problems. 
Brown et al.4 performed a study to assess the influence of drain placement on the SSI 
rate. They did not find any significant correlations. However, the drain was placed under 
the fascia, resulting in a limited suction in the subcutaneous space. In addition, Kanayama 
et al.12 performed a study to assess the influence of closed-suction drainage on the risk for 
SSI, and did not find any significant relationship between the two. Kanayama et al. only 
included single vertebral level surgeries making this finding difficult to apply to other types 
of surgeries.
Another possible approach of eliminating the risk factor itself is to reduce a patient’s 
body weight. However, this should be performed in a balanced manner since malnutrition 
is a known significant risk factor for SSIs. Nonetheless, findings from the Center of Disease 
Control and Prevention (CDC) indicate that the prevalence of obesity is still increasing.2 
As discussed in our literature review (Chapter 7), obesity was found to be a significant risk 
factor in 4 studies, however, 3 studies did not confirm a significant relationship. During 
comparison of Chapter 3, 5 and 6, similar contradicting findings were found. A possible 
explanation for this could be that patients were counted twice in the risk factor evaluation 
since patients with both deep and superficial SSI components were counted in both sub-
groups. If we limited superficial SSI to only those patients with an isolated SSI, this would 
have resulted in a lower number of obese patients; 75% less in chapter 3, 40% in chapter 
5 and 67% in chapter 6. In retrospect, this would have resulted in the absence of any 
significant relationship between superficial SSI and obesity. In the future, further analysis 
should be performed by evaluating possible effect modifiers including the thickness of the 
subcutaneous tissue at the surgical site, the usage of closed suction drains, and whether a 
closure of the sub-cutaneous tissue is performed.
Another disorder that is increasing in prevalence is diabetes mellitus.1 Whereas Chapter 
3 identified diabetes mellitus as being a significant risk factor for SSI, chapters 5 and 6 
did not. The increased risk for SSI in diabetic patients can be hypothesized due to micro-
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angiopathic changes that impairs wound healing due to relative local tissue ischemia and 
lower concentrations of administrated antibiotics.11 Besides the micro-angiopathic changes, 
diabetic patients have a relative suppression of their immune system due to decreased 
granulocyte function and impaired platelet-derived growth factor functioning.13,17 Due to the 
retrospective nature of data collection, we were not able to abstract detailed information 
on the type and severity of diabetes mellitus and the effectiveness of the administrated 
medication. Combining a heterogeneous group of diabetes mellitus patients has probably 
resulted in conflicting findings presented in this thesis. Similar contradicting findings were 
found in the previous literature as presented in chapter 7. In the future, further analysis to 
explain these contradicting findings should be performed whilst taking into account the 
type of diabetes mellitus, the duration of the disease, the manner and the extent to which 
diabetes mellitus is regulated, as well as the perioperative diabetes control.
Peroperative risk factors. In chapter 5 and 6, a sub-analysis was performed to identify risk 
factors for SSI within a special patient group. Chapter 5 reflects those patients who have 
surgery due to a deformity and chapter 6 reflects those patients who had an osteotomy 
during surgery. As stated in the introductions of both chapters, these subgroup of patients 
are at a higher risk for SSI due to increased peroperatieve blood loss and length of surgery. 
These findings, that both increased peroperatieve blood loss and length of surgery were 
significant risk factors for SSI in Chapter 2, were not confirmed in Chapter 5 and 6, and can 
partly be explained by selection bias of these 2 chapters.
General design limitations of this thesis 
One of the main limitations of this thesis was the utilized definition of a SSI and its sub-
categories. In Chapters 2 to 6 a SSI was defined as “any postoperative wound that required 
treatment with oral or intravenous antibiotics or surgical debridement with a minimal follow-
up of 1 year”. Using this definition and not that of the widely accepted US Center for Disease 
Control and Prevention and the American College of Surgeons (Appendix 1)14 definition 
makes this study less useful for inter-institutional comparisons. In case of strict usage of the 
definitions as stated by the CDC, cases of SSI will be missed since it is generally known that 
a SSI after spinal surgery can present itself up to more than years after surgery.8 However 
these reports are restricted to case-reports consisting of a limited number of patients and 
therefore, the significance of these additional SSI cases leads to other study outcomes. 
Therefore, we would recommend using the definition of the CDC so that inter-hospitals 
comparisons can performed by pooling of data.
Besides the limitation of the applied definition of a SSIs, the used definitions of the sub-
groups (superficial and deep), are a point of debate in Chapters 3 to 6. The used definition 
for a deep SSI was: “any SSI infection with a component beneath the fascia”. Superficial SSI 
was defined as: “any SSI infection with a component above the fascia”. Therefore, patients 
with both superficial and deep SSI components were counted in both groups. Although 
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not considered during the design of the study where these chapters are based on, one 
could argue that when a deep SSI has been determined, the presence or absence of signs 
indicating a superficial SSI is not relevant for clinical decision-making. In fact, there is a lack 
of evidence regarding the relationship between these two entities. Re-classifying patients 
having both a deep and superficial SSI to the deep SSI group, would have resulted in a 
decrease in the number of patients with a superficial SSI. Consequently, such an alternative 
approach would have resulted in a potentially different outcome. Therefore these findings 
should be interpreted with caution before being used as a reference for the development 
of future guidelines or protocols. As discussed in Chapters 7 and 8, applying standardised 
definitions will lead to increased intra- and inter-study homogeneity.
A wide variety of patients were included in Chapters 3 to 6. For example, in oncology 
patients wound healing is greatly influenced by the administered spinal radiation, 
chemotherapy and steroids.10,16 Due to the overwhelming presence of non-spinal studies, 
this group warrants special consideration.6,9,15 The inclusion of these patients and not their 
(neo-) adjuvant therapy characteristics may have confounded our study results. In the 
future, care should be given in report the type of oncology and stage, as well as the timing 
and type of (neo-) adjuvant treatment. 
Considerations for future research
During evaluation of the included studies in Chapters 7 and 8 we assessed the study design, 
analysis, and report. We found that incomplete reports of study characteristics, a variety 
of applied definitions and statistical analysis resulted in low levels of evidence, validity and 
applicability. Therefore the outcomes of these studies warrant caution before being applied 
as a foundation for the development of clinical guidelines to decrease the risk for SSI.
As previously discussed, the use of standardised definitions may lead to an increased 
understanding of the reader and improved inter-hospital comparisons because of improved 
data pooling possibilities. Therefore, prior to the commencement of future studies to 
identify risk factors for SSIs, a list of standardised definitions of potential risk factors and 
outcomes should be introduced and validated. The definitions of the CDC and the National 
Institute of Health (NIH) might act as a primary starting point for such purposes. When no 
standardised definition is present, an extensive literature search should be performed and 
evaluated by an expert panel to assess which definition has the highest face or content 
validity. As previously stated, we recommend the use of the definition as stated by the 
CDC of a SSI. To evaluate the validity of the definition of the CDC, additional pre-defined 
definitions can be considered. For example, the follow-up period may be extended to 
also include SSIs that present themselves after multiple years. It is, however, important 
that study reports clearly describe study outcomes for both definitions so a comparison 
between definitions can be made.
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The report and evaluation of confounders should be performed extensively. As 
suggested previously for obesity, diabetes mellitus and oncology patients, a literature 
search should be performed including all spinal and non-spinal literature to identify 
potential confounders of evaluated risk factors. Appendix 7 can be used as a tool since it 
summarizes the results of current spinal literature. During the analysis of the data, all of 
potential risk factors and potential confounding factors should be included since any prior 
exclusion may lead to incorrect study results.
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During surgery the surgeon sacrifices the primary line of defense, the skin, against 
infiltration of micro-organisms. Therefore every surgery is performed in the operating 
theatre, where disinfected healthcare equipment is used and personal surgical gear is 
worn to reduce the risk of bacterial contamination of the surgical wound. Despite these 
preventive approaches, surgical site infections (SSIs) are frequently seen. A SSI leads to 
higher morbidity and mortality, and increased healthcare costs. An average hospital bill 
exceeds $ 34.000 per instrumented fusion, if a SSI occurs this can increase a four-fold, 
making the identification of risk factors for SSI an interesting field of study.
Once risk factors have been identified, protocols can be designed to minimise the 
presence of these factors and thereby decrease the occurrence of SSIs. A number of studies 
have identified different risk factors. However, the majority of these studies consisted of 
case control and low-volume cohort studies. To re-evaluate previous findings, we primarily 
performed a large-volume retrospective cohort study within a tertiary care university-
affiliated medical centre in Baltimore, Maryland. All adult patients that had orthopaedic 
spinal surgery in the Johns Hopkins hospital between June 1996 and December 2005 were 
included, except those who had received surgery for a spinal infection. After performing 
a retrospective review, we performed a systematic review to assess the methodological 
foundation of current published studies that identified risk factors for SSIs after adult 
spinal surgery and evaluated prophylactic treatments.
A patient presenting with fever, wound-related pain, erythema, swelling, warmth, 
tenderness to palpation, and/-or wound drainage may have a SSI. In reality, not all 
patients present with all of the mentioned symptoms. Therefore the doctor can perform 
additional tests. Laboratory test are primarily requested, including white blood cell 
count (WBC), C-reactive protein level (CRP) and erythrocyte sedimentation rate (ESR). 
However, physicians are aware that each of these measures is usually elevated during 
the normal postoperative period. An aspiration culture can also be performed. In the 
case of a SSI, treatment can consist of non-surgical treatment (antibiotics) or surgical 
treatment (including antibiotics). In Chapter 2 we performed a retrospective analysis of 
all patients with a SSI (N=132) after adult spinal surgery. Wound drainage was the most 
frequently seen complaint. Additional tests (CRP and ESR) were most frequently elevated, 
however WBC was not. Staphylococcus aureus was the most frequently seen causative 
organism. Treatment of a superficial SSI was limited to antibiotic therapy and a limited 
surgical procedure was performed in a selection of cases. Standard treatment for deep SSIs 
consisted of a surgical procedure in addition to antibiotic therapy.
In Chapter 2 we also emphasised the importance of strategies that reduce the risk of 
SSIs for which independent risk factors for SSIs should be identified. To identify these risk 
factors for SSIs, we performed a retrospective study in Chapter 3, including all patients 
who underwent adult spinal surgery (N=3174) between June 1996 and December 2005. SSIs 
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(N=132) were sub-divided into deep (N=84) and superficial (N=70). Multivariate analysis 
showed that patients who are diabetic (p=0.050), had a previous SSI (p=0.012) or sustained 
more than 1 liter of estimated blood loss (p=0.017) had a significantly higher risk for SSI. 
Obesity (p=0.009) was found to be a significant risk factor for superficial SSI. Obesity 
(p=0.047) was also found to be a significant risk factor for deep SSI as were diabetes 
(p=0.033), a previous SSI (p=0.009) and surgeries lasting 2 to 5 hours (p=0.023) and 5 or 
more hours (p=0.009).
Restrictive transfusion criteria have led to decreased rates of morbidity and mortality 
in critically ill patients. However, no previous research findings have been published 
evaluating whether this is also the case in spinal surgery patients. 
Therefore, we performed a retrospective study in Chapter 4, to 
assess the influence of postoperative hemoglobin level (HGB) 
and the use of packed red blood cells (pRBC) or fresh frozen 
plasma (FFP) on postoperative patient morbidity and mortality 
rates and hospital length of stay (LOS). All adult patients who underwent spinal surgery 
with operative blood losses of more than 2 liters were included. We selected patients who 
lost at least 2 liters of blood so that any significant differences in the results of laboratory 
tests for HGB-levels and transfusion requirements would appear. We found that patients 
with an initial postoperative HGB of <8 g/dL were six times more likely to develop a SSI 
(6.37/ 1.15-35.28). The rates of deep SSI increased with greater postoperative pRBC use 
(p=0.002). FFP use in the operation room was lower in cases that developed a SSI (1.50 
versus 2.69, p=0.042). ICU and ward LOS were longer with increased postoperative blood 
product use.
Chapters 5 and 6 describe a sub-analysis of all patients included in the patient cohort 
described in Chapter 3. Frequently, patients that undergo spinal surgery to correct a 
deformity will undergo longer surgeries involving more spinal levels and greater blood 
losses than typical spinal procedures. Chapter 3 identified two of these variables, longer 
surgeries and greater blood losses, as significant risk factors for (deep) SSIs. To evaluate 
this high-risk patient group we performed a retrospective study in Chapter 5, to identify 
significant risk factors for SSIs in patients who underwent spinal surgery due to a deformity 
(scoliosis/ kyphosis) (N=830). Analysis showed that obesity (p=0.014) and a history of a prior 
SSI (p=0.041) were significant risk factors for SSI (N=46). Obesity was not only a risk factor 
for SSI in general but also for the occurrence of a superficial (p=0.013)(N=25). No significant 
risk factors for deep SSI (N=29) were identified, however obesity and procedures performed 
anterior and posterior on separate days had a tendency to be significantly related to the 
occurrence of a SSI.
Patients that undergo an osteotomy procedure are also known to have an increased 
risk for SSI since these procedures involve greater blood loss and longer surgical times 
compared to other spinal surgeries. Therefore, we performed a retrospective analysis 
Hemoglobin levels
g/dL Mmol/L
8 4.97
10 6.21
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including all patients who had an osteotomy procedure 
in Chapter 6 (N=363), to identify risk factors and rates 
of SSI after spinal osteotomy surgery and to identify 
any differences in risk between the different types of 
osteotomy. In general, there are 4 types of osteotomy 
procedures; a posterior Smith-Peterson osteotomy (SPO, 
Figure A) (resection of a portion of the superior and inferior 
lamina, ligamentum flavum and the inferior and superior 
articular process), a pedicle subtraction osteotomy (PSO, 
Figure B) (transpedicular wedge resection), an anterior 
spine osteotomy (ASO, Figure C) (resection of anterior and middle column), or a vertebral 
column resection (VCR, Figure D) (resection of the anterior, middle and posterior columns). 
We reported that obese patients had a significantly greater risk (p=0.045) of a superficial 
SSI (N=9). Those patients who underwent a VCR (p=0.042) had a significantly greater risk 
for a deep SSI (N=15). No risk factors were identified for SSI in general.
Although a number of literature reviews on risk factors for spinal SSIs have been 
published, none of these reviews performed an extensive critical appraisal of the studies’ 
methodological quality. To evaluate the methodological quality, study outcomes and to 
make recommendation for future research we performed a systematic methodological 
review including all current published studies, including our own previously presented 
studies, in Chapters 7 and 8. We report the outcome of our systematic methodological 
review of contemporary literature that evaluated risk factors or prophylactic treatments for 
SSI. References were retrieved and bias-prone study features were abstracted individually 
and independently by 2 authors. 
Chapter 7 includes 24 studies, all studies evaluated risk factors for SSIs. We found 
that the level of evidence that supported the identified risk factors for SSI was low and 
contradicting outcomes were reported. In the included studies, reporting of study variables, 
bias prone issues and eligibility criteria were limited. During evaluation of the performed 
statistical analysis, we found that not all potential confounders were included. Variables and 
outcomes were defined in numerous different ways, resulting in decreased applicability, 
validity and data pooling options. Before guidelines are introduced to minimise the risk for 
SSI, a high-volume prospective study should be performed including a wide array of well-
defined potential risk factors and potential confounders.
Chapter 8 includes 18 studies, all evaluating prophylactic strategies for SSI. Except 
for five studies, the applied definitions for SSI outcomes were ambiguous and none of 
the 12 cohort studies were adjusted for confounding by either matching, stratification 
or multivariate regression techniques. Based on these findings, the conduct of non-
randomized comparative prophylactic studies are strongly discouraged, and the use of 
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standardised definitions of putative confounders and outcomes, should be considered in 
more detail during the design phase of a randomized trial.
-Chapter 11-
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Door de huid te incideren offert de chirurg de eerste verdelingslinie van het lichaam 
tegen invasie van micro-organismen op. Daarom wordt elke operatie verricht in een 
operatiekamer, wordt er tijdens de operatie gebruik gemaakt van gedesinfecteerd materiaal 
en wordt er speciale kleding gedragen met als doel om de kans op bacteriële contaminatie 
van de wond te verkleinen. Toch worden wondinfecties (WI) met enige regelmaat gezien. 
Een WI leidt tot hogere morbiditeit en mortaliteit en een toename van de kosten. Bij een 
operatie waarbij een spondylodese (het aan elkaar vastzetten van wervels) wordt verricht 
met osteosynthese materiaal, kost dit in de Verenigde Staten gemiddeld 34.000 dollar. 
Wanneer er een WI optreedt kunnen deze kosten oplopen tot een viervoud hiervan. 
De identificatie van risicofactoren voor een WI is daarom een interessant gebied van 
onderzoek omdat dit kan leiden tot de ontwikkeling van protocollen die de aanwezigheid 
van risicofactoren verkleinen. Diverse studies hebben reeds verschillende risicofactoren 
geïdentificeerd. Het overgrote deel van deze studies zijn “case-control” studies of 
laag-volume cohort studies. Om eerdere bevindingen te evalueren, verrichtten wij een 
retrospectieve cohort studie in een academisch ziekenhuis in Baltimore, Maryland, 
Verenigde Staten. Alle patiënten die een wervelkolomoperatie ondergingen, verricht 
door een orthopedisch chirurg tussen juni 1996 en december 2005 werden geïncludeerd, 
behoudens de patiënten die een operatie ondergingen in verband met een infectie. 
Na deze retrospectieve cohort studie verrichtten wij een systematische evaluatie van 
toegepaste methodologie in de studies die als doel hadden risicofactoren te identificeren 
en profylactische strategieën voor een WI te evalueren.
Een patiënt die zich postoperatief presenteert met koorts, pijn, roodheid, zwelling, 
warmte, gevoeligheid bij palpatie van het wondgebied en/of met drainage uit de wond 
is verdacht voor het hebben van een wondinfectie. Echter, meestal hebben de patiënten 
niet alle symptomen maar een deel daarvan. Om de aanwezigheid van een WI verder te 
evalueren kan er aanvullend onderzoek verricht worden. Hiertoe behoren de bepaling 
van het aantal leukocyten, CRP (c-reactive protein) en bezinking. Elk van deze bepalingen 
zal tijdens een normaal postoperatief beloop verhoogd zijn. Ook kan er een aspiratie 
verricht worden van het aanwezige wondvocht die verder geanalyseerd kan worden op de 
aanwezigheid van micro-organismen. Een WI kan behandeld worden middels antibiotica 
al dan niet aangevuld door een operatie. In Hoofdstuk 2 presenteren wij een retrospectief 
onderzoek waarin wij alle patiënten met een WI analyseren( N=132). Wonddrainage werd 
het frequentst gezien en het CRP en de bezinking waren meestal verhoogd. Echter het 
aantal leukocyten was niet verhoogd. Staphylococcus aureus werd meestal gevonden als 
veroorzakend micro-organisme. Een oppervlakkige WI kon meestal behandeld worden 
door middel van intraveneus antibiotica met een beperkte operatieve verrichting. 
In Hoofdstuk 2 benadrukten wij het belang van de ontwikkeling van protocollen om de 
aanwezigheid van risicofactoren te beperken om zo de kans op een WI te minimaliseren. Voor 
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de ontwikkeling van deze protocollen is het van belang dat significante risicofactoren voor 
het verkrijgen van een WI worden geïdentificeerd. Om deze risicofactoren te identificeren 
verrichtten wij in Hoofdstuk 3 een retrospectieve studie waarbij alle patiënten die een 
wervelkolom operatie ondergingen (N=3174) tussen juni 1996 en december 2005 werden 
geïncludeerd. Het doel van deze studie was om risicofactoren, middels een multivariate 
analyse, voor een WI te identificeren (N=132). WI werden onderverdeeld in diep (N=84) 
en oppervlakkig (N=70). Patiënten met diabetes mellitus (p=0.050), patiënten met een 
eerdere WI (p=0.012) en patiënten met meer dan 1 liter geschat peroperatief bloedverlies 
(p=0.017) hadden een significant groter risico op een WI. Obesitas werd geïdentificeerd als 
een significante risicofactor voor oppervlakkige en diepe WI (resp. p=0.009 en p=0.047). 
Naast obesitas waren diabetes mellitus (p=0.033), een eerdere WI (p=0.009) en operaties 
met een duur tussen de 2 en 5 uur (p=0.023) én meer dan 5 uur (p=0.009) significante risico 
factoren voor een WI.
Restrictieve transfusiecriteria hebben ertoe geleid dat er een vermindering is 
opgetreden in de morbiditeit en mortaliteit bij intensive care patiënten. Echter, er is geen 
onderzoek verricht dat aantoont dat een restrictief transfusiebeleid na wervelkolom 
chirurgie ook beter is voor patiënten. In Hoofdstuk 4 hebben wij een retrospectief 
onderzoek verricht om de invloed van het postoperatieve hemoglobinegehalte, het 
gebruik van transfusies middels rode bloedcellen of plasma op de morbiditeit en mortaliteit 
en de duur van opname. Er werden 300 patiënten geïncludeerd welke peroperatief meer 
dan 2 liter bloedverlies hadden. Alleen patiënten met meer dan 2 liter peroperatief 
bloedverlies werden geïncludeerd aangezien bij deze patiëntengroep er een duidelijke 
verandering in bloedonderzoek (hemoglobinegehalte) gezien zal worden en omdat deze 
groep waarschijnlijk transfusiebehoeftig was. Patiënten met 
een initieel postoperatief hemoglobine gehalte van minder dan 
4,97 Mmol/l hadden zes keer meer kans op het ontwikkelen van 
een WI dan patiënten met een hoger hemoglobine gehalte. 
De frequentie van het aantal diepe WI steeg naarmate er meer 
rode bloedcellen getransfundeerd werden (p=0.002). Het aantal plasma-transfusies in de 
operatiekamer was lager in de groep met een WI. Het verblijf op de intensive care en op de 
afdeling was langer in die patiënten groep met hogere transfusie behoeftes.
De Hoofdstukken 5 en 6 omschrijven een subanalyse van groepen patiënten welke 
geïncludeerd waren in hoofdstuk 2. De eerste subgroep bestaat uit patiënten die een 
operatie ondergingen in verband met een deformiteit. Deze operaties duren vaak relatief 
lang, er zijn relatief veel wervels betrokken en er is relatief een groter bloedverlies. In 
hoofdstuk 3 zijn reeds 2 van deze 3 variabele, (langere operaties en groter bloedverlies) 
geïdentificeerd als significante risicofactoren voor een WI. In Hoofdstuk 5 verrichtten 
wij een subanalyse naar risicofactoren voor een WI in deze hoog-risico groep. In totaal 
werden er 830 patiënten geïncludeerd die een operatie ondergingen met als indicatie 
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een deformiteit. Obesitas (p=0.014) en een eerdere WI (p=0.041) waren beide significante 
risicofactoren voor een WI (N=46). Obesitas (p=0.013) werd ook terug gevonden als een 
risicofactor voor een oppervlakkige WI (N=25). Risicofactoren voor een diepe WI werden 
niet geïdentificeerd. Echter obesitas en procedures via anterieur en posterieur op 
verschillende dagen neigden naar een significant verschil. 
Patiënten die een operatie ondergaan waarbij een osteotomie wordt verricht, hebben 
een verhoogd risico op een WI vanwege hoger peroperatief bloedverlies en een langere 
duur van de operatie in vergelijking met andere wervelkolom operaties. Daarom verrichtten 
wij in Hoofdstuk 6 een retrospectieve studie naar risicofactoren voor een WI bij patiënten 
die een operatie ondergingen waarbij een osteotomie werd verricht. Tevens analyseerden 
wij de incidentie van een WI bij de verschillende type 
osteotomieën.(N=363) 
Er zijn 4 soorten osteotomieën: Een posterieure 
Smith-Peterson osteotomie (SPO, figuur A) (resectie 
van de lamina inferior en superior, het ligamentum 
flavum en het processus articularis inferior en superior), 
pedikel verwijderings osteotomie (PSO, Figuur B) 
(transpediculaire driehoek osteotomie), anterieure welvel 
osteotomie (ASO, figuur C) (resectie van de middelste 
en anterieure colom), en algehele resectie (VCR, figuur 
D) (resectie van de posterieure, middelste en posterieure colom). De analyse liet zien dat 
patiënten met obesitas (p=0.045) een hoger risico hebben op een oppervlakkige WI (N=9). 
Patiënten die een VCR (p=0.042) ondergingen hadden een verhoogd risico op een diepe WI 
(N=15). 
Er zijn reeds meerdere overzichtsstudies gepubliceerd, die risicofactoren en profylactische 
strategieën voor een WI evalueerden. Echter, geen van deze studies verrichtte een 
uitgebreide evaluatie van de toegepaste methodologie in de geïncludeerde studies. Om dit 
geobserveerde hiaat in de beschikbare literatuur te evalueren en om tot een aanbeveling 
voor interpretatie van de huidige literatuur en eventueel toekomstig onderzoek te komen, 
verrichtten wij een systematisch onderzoek naar de methodologische kwaliteit van de 
literatuur en onze eigen studies. In Hoofdstuk 7 en 8 presenteren wij de resultaten van de 
systematische evaluatie van de toegepaste methodologie in de studies die als doel hadden 
risicofactoren en profylactische strategieën voor een WI te identificeren. Elke studie werd 
beoordeeld op diverse methodologische punten door twee onafhankelijke auteurs.
In Hoofdstuk 7 includeerden wij 24 studies die risicofactoren voor WI evalueerden. De 
analyse van de geïncludeerde artikelen liet zien dat er een lage mate van bewijsvoering 
is ter onderbouwing van de geïdentificeerde risicofactoren voor een WI. Ook werden er 
tegengestelde uitkomsten gerapporteerd. De geïncludeerde studies omschreven in 
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een beperkte maat studie variabelen, bias gevoelige onderwerpen en inclusiecriteria. 
Gedurende de evaluatie van de statistische analyse werd duidelijk dat niet alle confounders 
geïncludeerd waren. De diverse geëvalueerde variabelen en uitkomstmaten waren in de 
geïncludeerde studies verschillend gedefinieerd. Dit resulteert in een beperkte mogelijkheid 
om de uitkomsten algemeen toe te passen, een verminderde validiteit en mogelijkheid 
om de data van de diverse studies samen te voegen. Alvorens er protocollen ontwikkeld 
kunnen worden om het risico op WI te verkleinen moet er een prospectieve studie verricht 
worden waarin veel patiënten zijn geïncludeerd en diverse goed gedefinieerde potentiële 
risicofactoren en potentiële confounders worden geanalyseerd.
In Hoofdstuk 8 includeerden wij 18 studies die alle profylactische behandelingen voor 
het optreden van een WI evalueerden. De definitie van een WI was in 13 studies discutabel. 
Geen van de 12 cohort studies corrigeerde voor confounding door “matching”, stratificatie, 
of door het verrichten van een multivariate analyse. Gebaseerd op deze bevindingen 
ontraden wij het verrichten van een niet-gerandomiseerde studie om profylactische 
behandelingen te evalueren. Tijdens het opzetten van een nieuwe (prospectieve-) studie 
wordt het gebruik van gestandaardiseerde definities van potentiële confounders en 
uitkomstmaten geadviseerd.
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Appendix 1. Criteria for defining a surgical site infection (SSI) according to the Centers for Disease 
Control and Prevention.21
Superficial incisional SSI
A. Infection occurs within 30 days after the operation 
and 
B. Infection involves only skin or subcutaneous tissue of the incision 
and at least one of the following: 
C1. Purulent drainage, with or without laboratory confirmation, from the superficial incision.
C2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial 
incision. 
C3. At least one of the following signs or symptoms of infection: pain or tenderness, localized 
swelling, redness, or heat and superficial incision is deliberately opened by surgeon, unless incision 
is culture-negative. 
C4. Diagnosis of superficial incisional SSI by the surgeon or attending physician.
Deep incisional SSI
A. Infection occurs within 30 days after the operation if no implant is left in place or within one 
year if implant is in place and the infection appears to be related to the operation 
and 
B. Infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision 
and at least one of the following: 
C1. Purulent drainage from the deep incision but not from the organ/space component of the 
surgical site. 
C2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the 
patient has at least one of the following signs or symptoms: fever (>38° C), localized pain, or 
tenderness, unless site is culture negative. 
C3. An abscess or other evidence of infection involving the deep incision is found on direct 
examination, during reoperation, or by histopathologic or radiologic examination. 
C4. Diagnosis of a deep incisional SSI by a surgeon or attending physician
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Appendix 2. Past findings.
Patient characteristics Surgical characteristics
-Age12,17,39 -Posterior surgical approach26
-Obesity3,7,12,23,26-28,43 -Combined approach12
-Diabetes12,14,27,38,43 -Tumor resection26
-Nonsteroidal anti-inflammatory drugs use10 -Increased estimated blood loss25,43
-Tobacco use12,43 -Use of blood transfusion14
-Poor nutritional status16,17,25 -Prolonged surgical time42
-Elevated preoperative or postoperative serum 
glucose27
-Multilevel surgery fusion extending to the 
sacrum29
-Alcohol abuse12 -Use of spinal instrumentation15
-Revision surgery3,43 -More than 2 residents participating in surgery27
-Urinary incontinence26
-Previous SSI12
-Presence of more than 3 comorbid diseases26
Appendix 3. Previously identified risk factors for spinal SSI.
Patient characteristics Surgical characteristics
-Age12,15,18
-Diabetes Mellitus9,11-13,15,18-20,31,36,40
-Alcohol abuse/ use12
-Obesity/ BMI13,22,26,31,33,34,37,41
-Weight loss40
-Smoking36,40
-Urinary incontinence26
-Neurological deficit35
-Comorbidities6
-ASA risk class4,22,40
-Previous spinal infection/ SSI12,31,33
-Previous spinal surgery8,36
-Functional status40
-Malignancy24,40
-Serum albumin level8
-Radiation therapy before surgery11
-Presence of dural tear during surgery or use of glue4
-Month of surgery5
-Type of skin preperation6,22
-Antibiotic prophylaxis15
-Instrumentation involved15,18,22
- Anatomical location 13,18,19,22,36
-Type of procedure19,34
-Surgical approach22,26,31
-Duration of procedure6,8,22,31
-Anaesthesiology variables22
-Transfusion37
-Hemoglobin level after sugery32
-Packed Red blood cells usage after surgery32
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Appendix 4: Applied and reported definitions of two frequently investigated risk factors.
Study Obesity* Diabetes Mellitus†
Apisarnthanarak et al.4 Males BMI >27,8, Females BMI 
>27.3
NR
Boston et al.6 BMI ≥30 NR
Chen et al.9 - Diagnosed and treated by 
primary care physician
Chen et al.8 BMI ≥30 NR
Demura et al.11 - NR
Fang et al.12 - NR
Friedman et al.13 - NR
Kanafani et al.15 - NR
Kuo et al.18 - Fasting blood sugar > 150mg/dl
Lee et al.19 - NR
Liao et al.20 - Use of medication or symptoms 
of DM including a preoperative 
plasma glucose concentration 
over 200 mg/dl
Maragakis et al.22 as noted in medical record NR
Pull ter Gunne et al.31 BMI ≥30 NR
Pull ter Gunne et al.33 BMI ≥30 NR
Pull ter Gunne et al.34 BMI ≥30 NR
Schimmel et al.36 - NR
Schwarzkopf et al.37 - NR
Veeravagu et al.40 - No or diet controlled, 
Oral agents, Insulin
Abbreviations and Symbols.
NR: Not reported, -: Not evaluated in this study, *: as defined by the CDC: BMI: ≥30,1 †:as defined 
by the NIH: Any of the following test results, confirmed by retesting on a different day: 1-A blood 
glucose level of 126 milligrams per deciliter (mg/dL) or higher after an 8-hour fast. This test is called 
the fasting blood glucose test.2-A blood glucose level of 200 mg/dL or higher 2 hours after drinking 
a beverage containing 75 grams of glucose dissolved in water. This test is called the oral glucose 
tolerance test (OGTT). 3-A random (taken at any time of day) blood glucose level of 200 mg/dL or 
higher, along with the presence of diabetes symptoms.2
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Appendix 5: Flowchart of the study screening and selection process.
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References retrieved for title/abstract screening – PubMed: 2157 
Studies excluded 
No SSI evaluation: 1450* 
Duplicate: 1352 
No spinal surgery: 1334* 
Case report, n<10: 1416 
Non-English: 505 
Pediatric patients included: 280* 
Editorial, letter, etc.: 120 
Other: 176 
Studies retrieved for full-text evaluation: 106 
Potentially appropriate studies to be included: 41 
Studies included in review: 24 
Studies excluded 
Literature review: 15 
No effect evaluation reported: 18* 
SSI grouped with other infections: 13*, † 
Pediatric patients included: 12*,‡ 
Other: 7 
Studies excluded 
Evaluated SSI prophylaxis: 18 
References retrieved for title/abstract screening –EMBASE: 
4582 
Studies retrieved 
Cross-reference check literature reviews: 0 
Abbreviations and Symbols.
*: References that fitted into more than one exclusion criterion were categorized in a single category 
at the abstractor’s discretion, †: Includes studies using the Nationwide Inpatient Sample (NIS) 
database, ‡: Two other studies reporting minimum age of 17 years were included.
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Appendix 6: Flowchart of the study screening and selection process.
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